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Abstract
A cross-sectional study was performed to explore the behaviour of female intravenous drug users
(lOUs) in Madrid, Spain, to determine the relationships between behaviour and a number of dependent
variables. We considered:
l.Sociodemographic characteristics
Drug-taking behaviour, sexual behavior (including prostitution), reproductive
health, and utilisation of services targeted at female IDUs.
2. Direct and indirect determinants ofHIV in the study population
3. Determinants of potential risk factors for HlV
4. Attitudes among women towards safer sexual practices
5. The effects of different kinds of drug treatment on risk behavior
The limitations inherent in a cross-sectional study design, such as the time sequence of events,
were addressed appropriately in the questionnaire. Because of the potential for selection bias, we
implemented sampling techniques (such as sampling from multiple sites) to correct for this. Finally, in
order to explore at different stages how the different variables might have a direct and indirect effect
on the dependent variables and how the effect may be mediated through other variables in the causal
pathway, we built a number of hierarchical models.
The foremost conclusion that can be drawn is the significance of low socioeconomic status.
Furthermore, the high-risk population is homogenous and represents an already marginalised
population. The result of regression analysis showed the most important and most predictive variable
(OR=12.2) to be having a regular partner who is HIV-positive. Other significant factors were: age 35
or over; no fixed address; history of sharing needles; and co-infection with an STD. Early age of first
pregnancy (younger than 18) was a direct determinant of prostitution and needle sharing. We also
detected a link between sexual risk behaviour and drug-taking risk behaviour. The public health
implications of these findings seems obvious. Women have a range of special needs, including
reproductive needs. Efforts directed towards peer education for men and women are likely to be
successful since the person delivering the intervention is someone the target population can identify
with.
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Chapter One
Background Information, the HIV/AIDS Epidemic,
and Literature Review
1. Introduction
The relation of gender to health, gender to drugs and gender to human immunodeficiency virus
(HIV) infection is an issue that probably depends greatly on the way society is organised.
Although organisational structure may differ widely between countries, it is likely that many
societies are characterised by major inequalities for women. Given this assumption, the principal
objective of this study isto examine risk behaviour in female intravenous drug users (IDUs). The
current chapter introduces some of the concepts pertinent to the thesis. Section Two describes
some background information that led to the implementation of this study. Section Three
presents data regarding the IDV and auto-immune deficiency syndrome (AIDS) epidemic and
drug use in both Europe and Spain. Section Four reviews the literature on gender-specific risk
factors associated with HIV/AIDS and IDU.
Women make up an increasing proportion of persons infected with HIV and AIDS. In some
African countries, men and women have been infected in approximately equal numbers since the
beginning of the epidemic. In North America and Europe, however, women originally made up a
small fraction of those infected, but the female-male ratio has shown an ever increasing trend in
recent years. In industrialised countries women now comprise the fastest growing group of
persons infected with HIV and AIDS; a situation that has multiple repercussions including, for
example, transmission to unborn children.
The main reason for the increase in heterosexual transmission of HIV among women is that they
are more wlnerable to HIV than men. This vulnerability is not only linked to a greater
anatomical susceptibility to HIV but also to social, cultural, economic and political factors. For
example, one of the major risk factors associated with heterosexual HIV infection is the presence
of sexually transmitted diseases (SIDs). SIDs are frequently asymptomatic in women, thus
females may not seek treatment as often or in as timely a manner as men. In fact, it is only
recently that the scientific community has begun to consider the possibility of gender bias in
medicine caused by making incorrect assumptions about similarities between men's and women's
health situations and risks or vice versa, about differences where there are none (Ruiz and
Verbrugge, 1997). It is proposed that these incorrect assumptions have led to inequalities in
knowledge about women's health problems, resulting in inequalities in treatment and prevention
of diseases. Other factors also put women at a disadvantage in comparison to men, especially in
developing countries, where women may have less access to information and health services, as
they are economically dependent on men and they have little power in their sexual relationships
with men.
The continuous increase in the number of cases of HIV and AIDS in female injecting drug-users
(IDUs) is a worrying feature of the current situation. Moreover, it is thought that most
HIV-positive women in western countries have been infected by sharing contaminated injection
equipment Until recently, investigations on drug-dependent women occurred infrequently. Data
on men and women were usually merged as though there were no significant differences between
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genders. Possibly for this reason, studies have not found gender-specific risks of contracting HIV
infection, despite there being important lifestyle differences that make women more likely to
engage in risk behaviour than men. Many of these lifestyle differences between men and women
stem from the different roles played by men and women. For example, women may lack
. decision-making power in their sexual relationships. While male drugs users typically resort to
drug dealing and robbery to finance their drug habits, it is often assumed that female drug users
exchange sex for money or drugs. This risk behaviour could, for example, be one factor in
determining women's increased vulnerability to heterosexual transmission. In addition, female
IDUs have male sexual partners who are also IDUs, a fact which has great implications for HIV
transmission, not only through the possibility of sharing injecting equipment, but also due to a
women's unequal power in making decisions about sex.
Despite these problems, it is surprising that studies regarding HIV transmission and control have
traditionally paid little attention to women. Many of the problems in HIV control strategies stem
from a lack of knowledge about the epidemic in women, the development of fewer prevention
measures aimed at this group and a lack of interest in the research about reproductive issues.
The lack of research interest in women has also occurred in the drug addiction field Despite the
central role played by female IDUs in the spread of the epidemic, there is also a relative paucity
of research on gender-specific HIV risk behaviours. Gender is a key variable to be taken into
account in attempting to understand any behaviour. An understanding to what extent women may
differ in their risks from their better-studied male counterparts should enhance our ability to
formulate better policies of prevention and control. Most research on IDUs' risk behaviour either
has been conducted among male subjects or has been carried out with samples in which the
proportion of women were so small that they were not considered as a separate group in the
analysis. In general, gender has not been treated as a variable, thus it has been assumed that
IDUs' behaviour and risk are gender neutral.
In fact, there are several reasons to think that female IDUs may have a higher possibility of
acquiring the HIV infection than male IDUs. Some studies have shown female drug injectors
almost never shoot drugs alone and that women almost always share needles when they inject
drugs. Most women drug users are strongly influenced by men in their drug behaviours. For
example, they often need someone else to inject the drug and this is usually the male who injects
his partner after first injecting himself.
The role played by contraceptive methods such as the pill or intrauterine devices in enhancing
HIV transmission is controversial. Despite the great impact of issues surrounding contraception
on society, it is still unclear whether or not oral contraception might facilitate HIV transmission.
In order to understand women's drug behaviour, it is necessary to take into account certain social,
cultural and economic characteristics of today's world. Such factors as job scarcity, social
isolation and marginalisation could influence drug abuse, especially among women. Women are
more frequently passive and dependent, have lower self-esteem, and may suffer from greater
social marginality than male IDUs. Consequently this gender-specific behaviour can only be
understood in the social and cultural context in which it takes place.
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On the other hand, it has been suggested that patterns of entering into treatment may also differ
between men and women, with male subjects predominating in both treatment clinics and
research studies. Thus, to date, the possible special needs of women addicts have not been
adequately assessed, and treatment programs have, to that extent, been hampered in their efforts
to treat women.
Furthermore, a large proportion of prison entrants are !DUs who have committed crimes because
of their need to obtain income to buy illegal drugs. The relation between HIV and prisons
depends on the proportion of drug users among the prison population, and the prevalence of HIV
among roUs and risk practices among them. A number of risk behaviours for HIV transmission
occur in prison including the injection of illicit drugs, unprotected sexual intercourse and
tattooing with inadequately disinfected equipment These factors potentially increase the risk of
HIV transmission among women in prison.
In summary, risk factors for HIV infection may differ substantially between men and women,
which implies that the epidemiology ofHIV in !DUs may be gender-specific. Given the extent of
HIVIAIDS, and the fact that there are not, at present, effective vaccines or therapies to fight the
disease, there is an urgent need to know specific risk factors in different populations in order to
assess and develop appropriate preventive and health education programs.
So far several questions have been posed, but few answered. Further research is particularly
needed into the many problems that have not yet been addressed but concern the links between
women, drug use and HIV. The present study is part of a European multicentre cross-sectional
study on the HIV risk behaviour of!DU women. The purpose of the Spanish study was to answer
some of those questions which have great implications on the public health of Spain. In total, 304
female IDUs recruited in Madrid (Spain) were interviewed about their drug use and sexual
behaviour, their reproductive and gynaecological history, their experience of preventive
interventions and their attitudes toward services (including health, drug dependency and social
services). The results of this research, the knowledge of risk behaviour and the evaluation of the
use of services are expected to lead to a better understanding of drug-addicted women, their needs
and the type of intervention necessary to begin to meet those needs. Such findings could facilitate
the design of more appropriate services for women and aid in the control of the HIV epidemic.
2. The HIV/AIDS Epidemic and Drug Use in Europe and Spain
2.1. The HIV/AIDS epidemic
By December 1997, an accumulated total of 11.7 million deaths caused by AIDS cases have been
reported globally (UNAIDS and WHO, 1997). In 1997 alone 2.3 million AIDS related deaths
were reported (one fifth of the total). This data, however, probably underestimates the true extent
of the pandemic. For example, the World Health Organisation (WHO), estimates that there are
30.6 million people world-wide living with HIV/AIDS, of which 12.1 million are women and 1.1
million are children (under age 15). Furthermore it is estimated that there are 16,000 new cases
daily. Of course, it should be noted that the grand majority of these cases (more than 90 percent)
occur in the developing world
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In the WHO European region, the accumulated number of all notified AIDS cases (i.e.,
paediatrics, adolescents and adults) up to December 1997 was 204,858. Of the cases notified
during 1997, nearly a third (31.6 percent) were diagnosed in Spain. Spain has consistently had the
highest reported incidence of AIDS cases in Europe since 1990. Although the AIDS incidence
. rate among homo/bisexual men appears to be leveling off, it continues to increase among IDUs
and heterosexual contact cases (see Table 1.1). However a recent age-period cohort analysis of
AIDS in Europe suggested that if you look at the most recent cohorts of homo/bisexual men and
IDU you find reduced HIV transmission, yet amongst young heterosexuals the epidemic is still
expanding (Houweling, et al. 1998). There' has also been a consistent increase in the number of
AIDS cases amongst women (Table 1.2).
Up until December 1997, 7,778 cases of AIDS amongst children (i.e., younger than 13 years) had
been notified in Europe; 37.6 percent had been transmitted via the maternal-infant route of which
36.9 percent of children were born to IDU mothers (European Centre for Epidemiological
Monitoring of AIDS, 1997).
Of the 197,073 cumulative cases ofadolescentladult AIDS cases reported inEurope by December
1997, women account for 17.4 percent, increasing from 8.0 percent in 1985 and 13.0 percent in
1990 (European Centre for Epidemiological Monitoring of AIDS, 1997). Injecting drug use is the
principal risk factor in female AIDS cases, with 50.0 percent of female cases notified by
December 1997 occurring among IDUs, and 38.5 percent associated with heterosexual contact.
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Table 1.1
Notified AIDS cases in Europe for adolescents and adults by year of diagnosis and
transmission group reported by 31 December 1997a, with adjustments for delayed
. notification
Homolbisexual men mu Heterosexual contact
Year N ercent N rcent N ercent
1991 6808 37.0 7480 40.6 2208 12.0
1992 7349 36.0 8246 40.4 2829 13.8
1993 7415 33.3 9092 40.8 3486 15.7
19-94 7721 30.7 10738 42.7 4326 17.2
1995 7203 29.2 10414 42.2 4687 19.0
1996 5747 26.1 9462 43.0 4642 21.1
1997 3598 22.9 6497 41.4 3735 23.8
"European Centre for the Epidemiological Monitoring of AIDS, 1997
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Table 1.2
Number of notified AIDS cases in Europe for adults and adolescents by year of diagnoses
. and sex reported by 31 December 1997-, with adjustments for delayed notification.
Year No. of cases Men (%) Women(%)
1991 18425 83.8 16.2
1992 20438 83.3 16.7
1993 22260 81.5 18.5
1994 25172 81.1 18.9
1995 24681 80.0 20.0
1996 21982 79.1 20.9
1997 15700 78.9 21.1
aEuropean Centre for the Epidemiological Monitoring of AIDS, 1997
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2.2. The HIV /AIDS epidemic in Spain
In Spain, a total of 48,989 accumulated AIDS cases have been notified up until December 1997,
of which 19.0 percent were female adults/adolescents and 845 (or 1.7 percent) were paediatric.
The most frequent category of transmission was IDU (64.3 percent), whilst 11.6 percent of cases
were due to heterosexual contact and 1.6 percent due to maternal-infant transmission. In 1996
heterosexual transmission increased in importance to be the second most popular category
(Centro Nacional de Epidemiologia Registro Nacional del sroA, 1996). Amongst Spanish IDUs,
the rising incidence in AIDS has been associated with specific birth cohorts, with rising incidence
rates in the successive generations born during the 1950s, peaking in men born in 1962 and
women born in 1964 (Castilla et al., 1997). Subsequent cohorts demonstrate a marked falloff in
incidence for both sexes, possibly reflecting a tendency in new generations of drug users to avoid
risky drug use practices. However, this decline appears to halt abruptly in men from the 1972
birth cohort onwards, which may reflect a return to risky behaviours among a new generation of
drug users.
As in Europe, there has been a progressive increase in the number of AIDS cases amongst women
which is illustrated by the decline in the male:female ratio of AIDS cases in Table 1.3. Amongst
Spanish women, heterosexual contact accounts for 25.3 percent of transmissions and together
with rou accounts for 89 percent of all transmissions. Furthermore the percent of female cases
reportedly resulting from heterosexual contact has increased steadily from 12.0 percent in 1986 to
34.6 percent in 1997. In other words in Spain and Europe, the current state of the AIDS epidemic
has been characterised by the increasing proportion of women infected by HIV and AIDS.
Based on the increasing number of cases in female roUs, it can be foreseen that this will be one
of the major problem areas for controlling the spread of AIDS in Europe. Considering that
heterosexual and perinatal transmission from female roUs is also becoming a serious problem, it
is evident that there is an urgent need for studies focusing on females in order to provide more
appropriate tools to public health authorities and political leaders.
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Table 1.3
Accumulated AIDS cases in Spain by men and women and male:female ratio,
. without adjustment for delayed notification, 1981 to December 1997·
Year Case Men (%) Women(%) Male:female ratio
1981-84 70 92.9 7.1 13.111
1985 242 89.7 10.3 8.711
1986 731 84.0 16.0 5.3/1
1987 1796 83.3 16.7 5.011
1988 4024 82.8 17.2 4.8/1
1989 7117 83.1 16.9 4.911
1990 10936 82.8 17.2 A.811
1991 15379 82.5 17.5 4.711
1992 20303 82.2 17.8 4.6/1
1993 25644 81.9 18.1 4.5/1
1994 32753 81.6 18.4 4.4/1
1995 39496 81.3 18.7 4.311
1996 45522 81.1 18.9 4.3/1
1997 48790 81.0 19.0 4.3/1
Total 49989b 81.0 19.0 4.3/1
"Centro Nacional de Epidemiologia Registro Nacional del SIDA, December 31, 1997.
Dnte total number of accumulated cases included 199 cases where year of diagnosis
was not known.
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2.3. The HIV/AIDS epidemic in IDUs
The prevalence of HIV infection amongst female IDUs is not well documented because little
research has been carried out on prevalence and risk factors in female injecting drug users. As
. data from drug users are not collected or analysed by gender, women are under-represented in
most studies. Risk factors for HIV infection differ substantially between men and women, and a
rising prevalence of HIV among females is shown in most studies carried out in Europe and
United States of America (USA), as can be seen in Table 1.1. It is surprising that few of the
investigators discuss this data and that until recently little attention has been paid to this important
problem.
Nevertheless, incidence studies also suggest that female mus have higher rates of HIV
seroconversion than male IDUs (Solomon et al., 1993; Salmaso et al., 1991), whilst evidence
available from the international literature also indicates that female IOUs have a higher rate of
HIV (Chin, 1991; Hankins, 1989; PHLS, 1991; European Centre for the Epidemiological
Monitoring of AIDS, 1992).
2.3.1. Addiction to IDU
As previously mentioned, up until December 1996, 39.3 percent of adolescent/adults notified
AIDS cases in Europe were associated with IOU, thus making this the principal cause of
transmission in the heterosexual population. In the heterosexual adolescent/adult population, 50.9
percent of accumulated AIDS cases in women (15,496) and 37.3 percent in men (55,325) were
associated with mu (European Centre for the Epidemiological Monitoring of AIDS, 1996). In
other words, IOU is the principal risk factor for women with AIDS. The increasing number of
AIDS cases in female IDUs is one of the major issues in Europe and, as noted elsewhere, drug
addicts constitute the principal source ofHIV transmission for heterosexuals (Des Jarlais, 1992).
2.3.2. The prevalence of HIV in mu populations
It is not possible to provide an exact estimate of the prevalence of HIV infection within the IDU
population. The majority of studies have demonstrated that, first, IDUs are not representative of
the population per se and, secondly, there are geographic variations between and within different
countries. It is also important to realise that the estimates of seroprevalence can depend on the
type of investigation, the protocol followed in the study and where the sample was collected (i.e.,
AIDS clinic, drug-addiction treatment centres, on the street, etc.).
In Europe, IDUs account for the largest and an increasing proportion of AIDS cases. The
reported prevalence ofHIV among IOUs in several western European cities was found to be over
40 percent in the mid-1980s (Robertson et al., 1986; Re:zza et al., 1994; Sopelana et al., 1991;
Rebagliato et al., 1995). In a report on the HIV prevalence rates among IDUs in European
countries from 1985 to 1995, Hamers et al. (1997) noted that decreases in prevalence rates have
been observed in several cities, including Madrid (74 percent in 1986 to 59 percent in 1990).
However, as these authors warn, declines in HIV prevalence should be interpreted with
considerable caution, particularly in high prevalence settings, where this does not necessarily
imply a reduction in new infections. Rather, declining prevalence rates may be due to differential
loss (through cessation of injecting or death) whereby IOUs who were infected early in the
epidemic have not been completely replaced by newly infected IDUs.
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2.3.3. HIV prevalence rates in female versus male mus
In concordance with the increase in HIV and AIDS cases amongst women, the majority of
. investigations that have studied female IDUs have found higher levels of seroprevalence when
compared to male IDUs, although some of these results have not been statistically significant. For
example, in a study undertaken in Baltimore, United States of America (USA), between 1988 and
1989, IDUs were recruited into the study from drug treatment centres, health services and from
the street. A quarter (24.1 percent) of the total study population (n=2921) was seropositive, with
a seroprevalence rate of 25.9 percent amongst female IDUs versus 23.7 percent of male users
(Nelson et al., 1991). Amongst active drug users (within the past year, n=2616), the HIV
seropositive rate increased to 25.3 percent, with a non-significant gender difference (27.0 percent
amongst women versus 24.9 percent amongst men). It is, however, interesting to note that when
the sample was stratified by sexual orientation, there was a statistically significant gender
difference (V1ahov et al., 1990). In San Francisco (USA), however, a lower rate of
seroprevalence (11.4 percent) was observed in a study of female IDUs (n=403) recruited in the
community between 1991 and 1992 (Watters et al., 1994b).
Some European studies have also observed a higher rate of seroprevalence in female IDUs. A
multicentre study in Italy in 1987, found a global seroprevalence rate of 33.2 percent amongst
IDUs that were attending public centres for drug dependency. In this sample of 14,363 IDUs
there was a statistically significant difference in the rates of HIV infection between female and
male IDUs (40.3 percent versus 36.5 percent respectively) (Sasse et al., 1989). In a study in the
following year, a North-South geographical variation was demonstrated with regards to the
prevalence of HIV amongst IDUs (47.0 percent of respondents in the north Italy were HIV
positive compared to 19.0 percent in the south). This gradient is probably due to the fact that the
AIDS epidemic started in northern Italy. This study identified no gender differences: the rate of
seroprevalence among 1,348 IDUs was 38.0 percent for women and 37.9 percent for men
(Salmaso et al., 1991).
In London, Stimson et al. (1996) reported a reduction in HIV-l prevalence rates amongst IDUs
recruited from multiple sites. Between 1990 and 1993 the prevalence rate declined from 12.8
percent to 6.9 percent. They found no difference in prevalence rate by gender or in length of time
of injecting drug use.
InMadrid, Spain, between 1985 and 1990, 60.0 percent of drug addicts admitted to a hospital
detoxification unit were HIV-positive (Sopelana et al., 1991). Moreover the rate was 65.0 percent
for the mus who accounted for 91.0 percent of the sample. However, a progressive, and
statistically significant, decrease in the rate of seroprevalence was observed for the study
population: 74.0 percent of drug addicts were HIV-positive in 1985 and 59.0 percent in 1990 (p <
0.05). Likewise, for mus, 74.0 percent were HIV-positive in 1985 compared to 59.0 percent in
1990 (p =0.05). Finally, 67.0 percent of female addicts were HIV-positive compared to 65.0
percent of male addicts. However, the prevalence of HIV amongst IDUs recruited in Madrid may
not be representative of the Spanish IDU population, in light of large regional variations that have
been reported (Lardelli et al., 1993). This study also failed to demonstrate a statistically
significant (i.e., p < 0.05) gender difference for HIV infection.
In Valencia, Spain, the HIV-I seroprevalence rate observed in a sample of 2,687 !DUs recruited
between 1987 and 1991 was 50 percent. No gender differences were reported with
seroprevalence rates of 50 percent for men and 51 percent for women (Hernandez-Aguado and
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Bolumar, 1993). However, a study of 650 intravenous drug addicts admitted to a Hospital
Detoxification Unit in Barcelona between 1987 and 1993 did find higher rates of HIV
seroprevalence in females, especially when the time-period of addiction was shorter than 24
months (p < 0.05) (Egea et al., 1996).
InAustria, mv seroprevalence was found to be 49.2 percent from a sample of users of an AIDS
and drug dependency clinic (n=268) (Zangerle et al., 1992). There were no significant
differences between female (56.5 percent) and male (45.5 percent) patients. There was, however,
a tendency for the number of IDUs admitted to the drug dependency clinic to decline (72.2
percent in 1985 to 12.5 percent in 1990) with a progressive increase in the numbers using the
AIDS clinic. Similarly, in Berlin, a progressive decrease in the global figures for seroprevalence
between 1985 (25.0 percent) to 1992 (3.2 percent) has been reported for IDUs that were admitted
for the first time to a clinic (Stark and Muller, 1993). The overall rate of seroprevalence between
1992 and 1993 was 19.1 percent amongst IDUs in Berlin, without any significant gender
differences (23.1 percent of women versus 17.1 percent of men).
In Greece, between 1986 and 1989, data also suggests a decline (of around 10 percent) in the
number of IDUs who presented themselves at an AIDS clinic who were seropositive. There was
also a decline in the number of prisoners who reported being IDUs (of around 2 percent). For the
IDUs who were not in prison, 3.8 percent of women and 2.2 percent of men were seropositive
(Papaevangelou et al., 1991).
A number of other studies have also shown a higher rate of mv seroprevalence in male IDUs
than in female IDUs, although, as with a number of the previously cited studies, the differences
were not statistically significant For example, in a study of mv seroprevalence amongst 473
IDUs attending a methadone maintenance programme in New York (USA), between 1985 and
1986,41.2 percent of men were Hlv-positive compared to 37.4 percent of women (Schoenbaum
et al., 1989). Likewise, in 1990 in New Jersey (USA), global seroprevalence was reported to be
47.6 percent for drug addicts who had injected within the last six months and were not in
treatment. Amongst men the rate was 48.8 percent and amongst women 43.2 percent (Freeman et
al., 1994). It has also been observed that seroprevalence was lower (39.0 percent) amongst
heterosexual IDUs of an Italian neighbourhood considered to be a low-risk area In this study
there were no statistically significant gender differences (41.0 percent of men were mv-positive
compared to 33.0 percent of women) (Serraino et al., 1991).
2.3.4. The size of the Spanish mu population
It is estimated that there are 150,000-200,000 IDUs in Spain. Although it is difficult to know the
exact rates, in the Community of Madrid the number of female drug users is estimated to be
between 2000 and 3000.
A network of drug treatment programmes distributed throughout Spain offers services to nearly
50 percent of IDUs. In 1988, a surveillance system was set up by the Spanish government in
order to gather information about drug users attending the general health care system and the
public drug treatment centres. In 1995, among the 6,048 women who sought advice and
treatment from the system, 2,736 were prior attendees (defined as individuals who had already
been in treatment in previous years) and 3,059 were new entrants (defined as individuals seeking
drug treatment for the first time). Specifically for the Madrid area, among the 717 women
treated, 255 were prior attendees and 379 were new entrants (National Plan on Drugs, 1995).
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3. Gender-Specific Risk Factors ofHIV/AIDS amongst IDUs
It is likely that risk factors for HIV infection differ substantially between men and women. For
example, there is evidence that in heterosexual populations, women have a greater susceptibility
of contracting HIV infection via IDU and/or heterosexual contact. In addition to differential
biological risk, women are also likely to be exposed to a greater risk of HIV infection from a
range of sociocultural and economic factors. The remainder of this section reviews the literature
on gender-specific risk factors associated with both IDU and the transmission ofHIV/AIDS.
3.1. Sharing injecting equipment
A nwnber of studies have demonstrated that the sharing of drug injecting equipment is a principal
risk factor associated with the transmission ofHIV in IDU populations (e.g., Marmor et al., 1987;
Des Jarlais, 1992). That is, the re-using and sharing of injecting equipment, whether it is
borrowed or lent, contaminated or inadequately sterilised, increases the likelihood of intravenous
transmission between different IOUs (Freeman et al., 1994). In Berlin, for example, a study
undertaken between 1984 and 1988, reported that 88.0 percent of 741 heterosexual IDUs
interviewed had ever shared injecting equipment (Stark et al., 1990). Likewise, a study in Italy
reported that 97.9 percent of drug addicts had intravenously injected drugs and that 70.8 percent
of this sub-population reported to have at sometime shared injecting equipment (Salmaso et al.,
1991). Moreover, Nicolosi et al. (1992b) demonstrated that the 69.6 percent of a sample of
seronegative IDUs interviewed had shared needles and syringes. In Spain, the rates of sharing
injection equipment appear to be lower. For example, in a nationwide sample of Spanish IDUs
(n=I,074), 31.9 percent shared or had shared injecting equipment (Bravo et al., 1994).
Furthermore, a large study oflOUs in Valencia (n=3,755) found that 18.0 percent reported recent
sharing of injection equipment (in the last month) (Hernandez-Aguado et al., 1994). In a
multicentre Spanish study of prostitutes (n=I,556), 19.9 percent had injected drugs at some time
and the majority of these had shared injecting equipment (Estebanez et al., 1992).
It has also been shown that the probability of infection is greater for those IDUs who frequently
share injecting equipment when compared to those IDUs who never share (e.g. the odds ratio
(OR) = 13.2 for Nicolosi et al. 1992b). Also in the study ofIDUs in Baltimore, for those who had
injected drugs in the previous year of the study, risk of HIV infection was associated with the
sharing of needles and/or syringes (OR = 1.59~Vlahov et al., 1990), and especially with the use of
injecting equipment attained in "shooting galleries" (OR = 2.21~ Vlahov et al., 1990). Similarly,
in Italy the principal risk factor ofHIV for IDUs is the sharing of injecting equipment (OR = 9.5;
Sasse et al., 1989). Serraino et at. (1991) make the same observation, that it is the sharing of
injecting equipment that is the principal risk factor of'Hlv infection and an independent predictor
of seropositivity (OR = 4.4; Serraino et al., 1991).
It has been suggested that for IDUs, women could have a greater chance of acquiring HIV than
men, and that this may be associated with the practice of risk-taking behaviours. It seems that the
proportion of female IDUs that frequently share equipment is greater than that of men. In an
examination of sharing injecting equipment and sexual behaviour in a nationwide sample of
Spanish IDUs (n=1074), gender was shown to be associated with needle sharing with females
sharing significantly more frequently than males (42.7 percent versus 29.8 percent respectively)
(Bravo et al., 1994). According to a study conducted in Madrid in 1990, in which 45.0 percent of
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IDUs studied had used lent syringes in the previous six months, women shared injecting
equipment more frequently than men (53 percent versus 42 percent respectively) (Estebanez et
al., 1992). Sasse et al. (1989) in a study of 1323 IDUs have also shown that more women than
. men share equipment to prepare the drugs (58 percent of women versus 53 percent of men) and/or
for injection (69.1 percent of women versus 61.6 percent of men). Furthermore, Freeman et al.
(1994), found that 42.9 percent of female IDUs and 43.0 percent of males had, at least once, lent
equipment and 18.9 percent of women and 25.8 of men had, at least once, borrowed equipment.
However Hernandez-Aguado et al. (1994) reported no gender differences in recent (within the last
month) sharing of injection equipment (16 Percent for men and 21 percent for women).
One of the major explanations for the tendency of female IDUs to share injecting equipment is
that women often inject in groups and/or with their sexual partner. For example, it has been
shown that female IDUs are more likely than men to be injected in the company of other people
(Zunzunegui et al., 1993). In addition, for those IDUs that tend to inject with other people,
women are more likely to share equipment than men, and are more likely to be injected by their
sexual partner (Sotheran et al., 1992). InMadrid, it has also been observed that female IDUs who
have a stable partner who is also an IDU, share their equipment more frequently than those whose
partners were not mus (58.0 percent and 44.0 percent respectively) (Zunzunegui et al., 1993).
Similar results have been reported in other studies examining risk behaviours of HIV amongst
IDUs. For example, women are more likely than men to inject with their sexual partner or with
friends, while men inject with a colleague or "running partner" or alone (Barnard, 1992).
Furthermore, female IDUs share injecting equipment with their partner with a greater frequency
than men and are more likely to be injected after their partner has injected (Freeman et al., 1994).
According to the authors of this study, female IDUs would therefore have a greater chance of
infection than male heterosexuals.
3.2. Prison
Although the use of drugs in jails and prisons is not generally permitted, there is evidence that
drugs are available in the majority of prisons and it would seem that a large percentage of IDUs
have reported to have continued their habit whilst incarcerated. Moreover, the ability to procure
sterile injecting equipment in jails and prisons is reduced as the practice is prohibited
Consequently, the sharing and re-use of needles and syringes is a common practice between
imprisoned mus. In a study carried out in Scottish prisons it was observed that 27.5 percent of
prisoners had a record ofIDU before arriving at the prison. In addition, 7.7 percent had injected
at least once whilst incarcerated and of the 5.7 percent that had previously shared equipment 17.3
percent had continued with this practice in prison (power et al., 1992). In a study of 145 female
prisoners conducted at HMP (Her Majesty's Prison) Comton Vale, Scotland, 46 percent of female
inmates had injected drugs and 57 percent of these injector-inmates reported to have injected
whilst in prison (Gore et al., 1997). In the United Kingdom, 27.4 percent of prisoners have
reported to have injected drugs during their stay in prison (Turnbull et al., 1991). In Australia,
over half of the needles and syringes found in three prisons in Adelaide seemed to have been
utilised a number of times, suggesting that equipment sharing was prevalent (Seamark et al.,
1994). In a multicentre study of seroprevalence conducted amongst 472 lOUs (of which 33.1
percent were women) in Berlin, 69 percent had been in prison (76.3 percent of the men and 53.8
percent of the women). In addition, almost half of the men (44.9 percent) and 2l.2 percent of the
women had injected drugs whilst in prison. This survey demonstrated a strong association
between HIV infection and the use of shared needles for injecting during the stay in prison (OR =
3.9~Confidence interval (Cl): l.8 - 8.5) (Stark and Muller, 1993). Previous surveys in the same
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city reported lower rates of injecting drug use in prison. For example, 63.2 percent of IDUs
studied between 1984 and 1989 reported to have been in prison, of which 29.5 percent of men
and 22.6 percent of women had injected drugs during their stay (Stark et aI., 1990).
. In a Canadian study conducted between 1988 and 1989, on seroprevalence and risk factors of
HIV in women recently imprisoned, it was demonstrated that, when compared to an average
seroprevalence of 6.9 percent in the sample population, 92.6 percent of seropositive women and
45.5 percent of seronegative women had a record of!DU prior to imprisonment (OR = l4.9~
Hankins et al., 1994). Moreover,76.2 percent of the seropositive women and 44.3 percent of the
seronegative reported to have shared injecting equipment with a stranger before imprisonment
(OR = 4.0), thus increasing the probability of infection by a factor of six when the person sharing
the equipment was also seropositive.
3.3. Sexual behaviour
It has been suggested that the risk of acquiring IDV is the result of a complex interaction of drug
use and sexual behaviour (Schoenbaum et al., 1989). Furthermore, as Freeman et al. (1994) point
out, heterosexual female IDUs have an elevated risk of HIV infection from an infected partner,
principally through sexual contact, but also as a result of shared injecting equipment as many of
these women are injected by their partner after he has injected himself
3.3.1. Heterosexual transmission
Heterosexual contact accounted for 14.9 percent of notified adolescent/adult AIDS cases in
Europe up to 30 September 1997. However, this category of transmission differs between men
and women. Heterosexual contact is the only category of transmission in which the proportion of
cases of AIDS in women surpasses that of men (European Centre for the Epidemiological
Monitoring of AIDS, 1996). More than a third (38.7 percent) of accumulated AIDS cases in adult
and adolescent women, up until 30 September 1997, were attributed to heterosexual contact
compared with 10.2 percent of men. A recent age-period cohort analysis of AIDS in Europe
suggested that if you look at the most recent cohorts of homo-/bisexual men and IDU you find
reduced IDV transmission, yet amongst young heterosexuals the epidemic is still expanding
(Houweling, et al. 1998). Furthermore a national study of AIDS surveillance in the United States
has also shown that the number of AIDS cases attributed to heterosexual contact is increasing at a
faster rate than are the numbers of those acquired through other routes (Neal et al., 1997). These
authors report that at this point in the U.S., persons with heterosexually acquired AIDS remain
disproportionately women (65 percent) who report sexual contact with a male IDU partner (47
percent).
3.3.2. Heterosexual relations with an mu partner
A number of studies have shown that heterosexual contact with an IDU partner is an important
independent risk factor for HIV. Sasse et al. (1989) observed that sexual relations with a drug
addict was associated with seropositivity with an estimated risk of 1.73. For the heterosexual
sample (91.5 percent of the study population), HIV infection was most frequent among those that
had had an IDU partner (OR = 1.34), with a further increase in risk for those who had had an
increase in the number of partners. Similarly, a study by Schoenbaum et al. (1989) showed that
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heterosexual contact with an IDU was an independent factor associated with HIV infection, and
that this risk was higher for women. Evidence suggests that the importance of heterosexual
behaviour as a risk factor is elevated by the number of partners and IDU partners and is more
important for female IDUs than male IDUs. The probability of HIV infection for women
. increased by 24.0 percent with every additional IDU partner, demonstrating the increased mv
risk for women associated with heterosexual behaviour.
The possible impact of the sexual transmission of mv by IDUs to the general population is
reflected in a study undertaken in England and Scotland in 1988 to determine possible changes in
sexual behaviour of IDUs that were attending a needle exchange service. It was reported that the
majority oftbis population was sexually active and that 46 percent of users had had a non-IDU as
a sexual partner. In addition 38 percent of the sample population had used condoms in sexual
relations during the preceding three months. The authors estimated that, if it was assumed an
average of two non-IOU partners for every sexually active IDU (69 percent of the 60,000 IOUs
estimated in United Kingdom), then 82,800 non-IOUs were potentially at risk of acquiring HIV,
in a three-month period, from an IOU partner (Donoghoe et al., 1989). In another study
undertaken in England, for the 73 percent of the sample that declared heterosexual relations, over
half (54.5 percent) of the non-commercial sexual partners of seropositive IOUs were not
themselves IOUs. This was more frequent for casual partners (71.4 percent) than regular pairs
(39.6 percent) (Rhodes et al., 1993). In Madrid, a higher rate (49.0 percent) of mixed IDU
partners (i.e., one IOU and one non-IDU) was reported amongst stable partners (Zunzunegui et
al., 1993).
It is thought that the probability of HIV transmission, via heterosexual contact from an IDU
partner would be greater for women than for men, as various studies have demonstrated that
heterosexual male IDUs are more likely to have non-IDU female partners. Murphy (1988)
observed that among heterosexual IDUs who were attending a drug dependency clinic, 70.0
percent of male roUs had a sexual partner who was not an IDU compared to 40.0 percent of
female IOUs. In London, 78.0 percent of female drug users (heroin or cocaine) with a regular
sexual partner stated that their partner had used heroin compared to 55.0 percent of male drug
users (Powis et al., 1996). In New York (USA), 45.4 percent of male IOUs (almost all
heterosexual) who were attending methadone maintenance programs had had a female IOU
partner, compared to 57.0 percent of women who had had a male IOU partner (Schoenbaum et
al., 1989). In Berlin, between 1984 and 1989, in a study of predominantly heterosexual IOUs,
85.2 percent of women and 75.5 percent of men reported to have had a sexual partner who was an
IOU (Stark et al., 1990). In an American study, 42.1 percent of female drug addicts interviewed
had had a male IDU sexual partner (Kline and Strickler, 1993). In a study of seroconversion
carried out in northern Italy on a sample of 635 HIV seronegative lOUs, over half of the women
studied had had a male IDU partner who was also seronegative, compared to 41.2 percent for men
(Nicolosi et al., 1992b). Almost 69 percent of female IOUs questioned by Freeman et al. (1994)
had a male IOU partner. According to the authors, the probability of having a heterosexual
partner who was an IDU was two times greater for women than for men.
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3.3.3. Heterosexual relations with a seropositive partner
Numerous studies have associated the transmission ofHIV with a heterosexual relationship with a
seropositive partner. For exampJe, in Austria it was estimated that the risk of seroconversion for
. IDUs was greater if the stable partner was a seropositive IDU (Zangerle et al., I992). Likewise,
Stark and Muller (1993) observed that in a sampJe of 472 IDUs, HIV infection was associated
with heterosexual relations with a seropositive partner (OR = 3.0; Cl: 1.5 - 9.2). In a multicentre
study reported by Salmaso et al. (1991), in which 97.9 percent of the population were IDUs,
heterosexual activity with an HIV-positive partner or with a partner of unknown serostatus, was
associated with HIV infection (OR = 5.6; Cl: 1.6 - 8.9 and OR = 2.6; Cl: 1.9 -3.6 respectively).
The authors also noted that women had a seropositive heterosexual partner more frequently than
men (41.0 percent of women compared with 18.0 percent of men). The same relationship was
found in another Italian study of IDUs in which having a sexual partner who was HIV-positive
was independently associated with HIV infection (OR = 4.0; Cl: 1.5 - 10.4) (Nicolosi et aI.,
1992b). Furthermore, more women (26.4 percent) than men (13.9 percent) had a seropositive
partner. Thus according to these authors and as demonstrated in the previous section, women are
more likely to have a seropositive partner than men, putting them at greater risk of sexual
transmission ofHIV than men
3.3.4. Gender-specific susceptibility to HIV infection
Being exposed to a male seropositive partner is not the onJy gender-specific risk of Hlv infection
for women For example, it has been suggested that women are two to three times more
susceptible to HIV transmission from a man, than a man is from a women. Nicolosi et al. (1994a)
carried out a case-control study to determine the relative efficiency of the male-female and
female-male transmission for people only exposed to risk from having an HIV-positive partner.
The risk factors for infection in women included: a high number of sexual relations (OR = 2.0),
anal sexual intercourse with an AIDS infected partner and a history of SIDs such as syphilis (OR
= 5.2), and genital warts (OR = 6.2). The significant risk factors associated with seropositivity in
male-female transmission were: vaginal intercourse more than twice per week (OR = 2.0), anal
sexual intercourse (OR = 2.3), partners with AIDS (OR = 2.6), partner with fewer than 400 CD4
(OR = 2.2), history of SIDs (OR = 2.9), vaginitis (OR = 4.5) and the use of the IDD (OR = 2.5).
In the female-male transmission, significant associations with ffiV infection were: vaginal
intercourse more than twice per week (OR = 5.2) and an AIDS infected partner (OR = 7.8). This
study lead the authors to conclude that relative efficiency of the male-female transmission is 2.3
times more efficient than that of female-male.
Further evidence for this hypothesis is available from a multicentre study, undertaken in Spain, on
risk factors for the heterosexual transmission of HIV from men to women. The overall rate of
male-female transmission was 16 percent, although no difference between male-female and
female-male transmission was observed (although this may be due to the small number of
partners studied for the female-male transmission). A significant association was observed for the
following risk/factors for the heterosexual transmission to a woman in a stable relationship: CD4
(OR = 4.1), history of SID in the woman (OR = 4.0), and anal sexual intercourse (OR = 3.1).
The CD4 and the history of SIDs are independent factors associated with the heterosexual
transmission from man to woman. According to the authors, the risk of heterosexual transmission
for a partner with a case index that is CD4 and in a woman that has a history of SIDs and
practiced unprotected anal sexual intercourse is almost 14 times greater than in a partner without
these factors (Zunzunegui et al., 1992).
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33.5. Use of condoms
The use of condoms amongst !DU heterosexuals is rare, especially with stable partners.
Consequently, the use of this barrier method seems to be most frequent when a partner is not an
!DU or when one member of the pair is known to be seropositive. The majority of drug-
dependent men and women (79.3 percent and 73.5 percent respectively) studied by Nicolosi et al.
(1992b) stated that they never or almost never used condoms during heterosexual relations. In the
study by Stark and Muller (1993) only 12.9 percent of heterosexual IDUs declared to have always
used condoms during sexual relations with a regular or casual partner during the previous six
months. Also, a multicentre WHO study observed that the use of condoms between IDUs was
low, and that the majority of IDUs interviewed stated that they never used them with their regular
partner, although the most frequent usage was with casual partners (WHO Collaborative Study
Group, 1993). The same conclusion was arrived at by Rhodes et al. (1993) who showed that for
seropositive IDUs, 73.2 percent never used condoms during heterosexual relations with a regular
partner compared with 20.0 percent that stated they never used the same barrier method with a
casual partner. Likewise, among sexually active heterosexual !DUs (n=315) interviewed in
Madrid in 1990, only 22 percent were always or almost always using condoms during sexual
relations, and more frequent use was reported with casual, as opposed to stable, partners (22.0
percent never used a condom with a casual partner and 49.0 percent with a regular partner). The
most frequent use of condoms was reported for pairs in which one partner was a non-IDU (33.0
percent were always or almost always using condoms) (Zunzunegui et al., 1993).
In a study of injection equipment sharing amongst 3,755 IDUs in Valencia, Spain, the proportion
of subjects who never used condoms for vaginal intercourse was 57 percent These authors noted
that sharing of injection equipment was associated with not using condoms for vaginal intercourse
in both univariate and multivariate analysis (Hernandez-Aguado et al., 1994).
Ina cross-sectional study undertaken in North America amongst female drug addicts, 66.0 percent
stated that they never had used a condom in spite of that fact that 46.2 percent had a sexual
partner who was an IDU or an ex-IDU. Furthermore 47.5 percent of these cases did not know the
serostatus of their partner (Kline and Strickler, 1993). In a study carried out in London, 59
percent of male heroin users and 65 percent of female heroin users stated that they never or
almost never had used condoms during heterosexual relations in the past year. For cocaine users,
condom use was marginally greater, although 47 percent of men and 46 percent of women stated
they only rarely or never used a condom in the past year (Strang et al., 1994). A study by Freeman
et al. (1994) also showed that the use of condoms was rare for heterosexual IDUs, especially
among those with only one sexual partner. For example, 72.4 percent of men and 81.8 percent of
women interviewed never used condoms with their partner. In the case of having multiple
heterosexual partners, the female IDUs reported to use condoms more frequently than men,
although only 17.6 percent stated that they always used them. According to Rhodes et al. (1994)
the use of condoms is inversely related with the number of sexual relations. Paone et al. (1995)
have also noted that female IDU participants in a syringe exchange program in New York City
were more likely to «always" use condoms with casual partners than with primary partners. The
authors also reported that 60 percent of prostitutes reported "always" using condoms.
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Another aspect is that sexual behaviour appears to be safer with regular partners who know of
their IDV seropositivity than with partners who are unaware of their serostatus. Sasse et al.
(1989) observed in a sample of drug addicts attending a treatment centre that only 7.1 percent of
. the population and 7.6 percent of the heterosexual population, were always using condoms, and
that their use was most frequent among those who were seropositive (c2 for trend = 35.07, P =
0.00001) and in heterosexual relations with a non-IOU partner (c2 for trend = 13.5, P = 0.001).
Also in the study by Rhodes et al. (1993) IOUs that knew that they were seropositive were more
likely to use condoms than those who 'did not (58.3 percent compared to 18.2 percent
respectively). The risk of heterosexual transmission between IOUs and non-IOU partners is
dependent, in part, on the knowledge of seropositivity and subsequent use of condoms.
In a sample of 317 IOUs collected in the street, 33 percent of heterosexual IDUs declared to have
always used condoms with their partner in the previous month and a significantly greater number
used them during sexual relations with a seropositive partner or a non-IOU partner. The use of
condoms in relationships between seropositive IOU and non-IOU was 68 percent (Friedman et al.,
1994). Another American study also carried out amongst female IOUs observed that the use of
condoms was generally low: 34 percent of women stated that they always used condoms during
sexual relations. For seropositive women, condom prevalence was 28 percent compared to 6
percent for seronegative women. For stable partners, 42 percent always used condoms, with 36
percent of seropositive women using condoms and 6 percent of seronegatives (Watters et al.,
1994b).
Therefore the risk of sexual transmission of mv is high for the partners of IDUs, especially for
women and in particular for female IDUs. It has been suggested that for female IOUs the
principal risk factor for mv could be unprotected sexual activity (Watters et al., 1994b).
Moreover, female !DUs have a greater risk of transmission through heterosexual relations with an
IOU partner than from transmission via IOU itself (Schoenbaum et al., 1989). Rhodes et al.
(1994) pointed out that the risk of heterosexual transmission for an IOU is progressive as injecting
drug use would continue to be a particular risk. For example, 27.7 percent ofIOUs with stable
partners who were non-IDUs had shared needles at least sometime during the time of their study,
and similarly 36.0 percent of IOUs with a casual non-IOU partner reported needle sharing. This
would suggest a greater risk for women as male !DUs are most likely to have as a regular partner
a non-IOU woman than vice versa
3.4. STDs and prostitution
Sexually transmitted diseases, which are prevalent amongst those who engage in unprotected
sexual activity, occur more frequently within the IOU population than the general population,
especially amongst women. For example, 67.7 percent ofIDUs studied in Berlin between 1984
and 1989, were positive for hepatitis B; a disease also strongly associated with HIV seropositivity
(Stark et al., 1990). In a study of IDUs attending drug treatment in Dublin, gender differences
were found with a greater proportion of women testing positive for the hepatitis C virus, the
prevalence of' which can be an indicator of HIV-related risk behaviour (Smyth et al., 1994).
Furthermore, in a study of HIV seroprevalence carried out with IDUs in Baltimore, 60.0 percent
of drug addicts had had some type of SID, with an increased frequency for female heterosexual
IOUs (syphilis and genital herpes). According to the results of the statistical analysis, women
with a record of syphilis would have a greater major risk of IllY infection than male
heterosexuals with similar backgrounds (OR = 1.78; Cl: 1.02 - 3.10) (Nelson et al., 1991).
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The greater frequency of SIDs amongst female IDUs is probably due to the more frequent
exchange of sex for drugs andlor money when compared to men. Serraino et al. (199]) observed
that for an IDU heterosexual population, women were more likely to be prostitutes than men.
Likewise, according to an ltaJian study of seronegative IDUs, women would have exchanged sex
for drugs or money more frequently than men (19.8 percent and 1.5 percent respectively)
(Nicolosi et al., 1992b). In Berlin, one of the highest reported rates of prostitution among
interviewed IDUs was recorded: 73.1 percent of women and 12.7 percent of men reported to
have worked as a prostitute (Stark and Muller, 1993). Also, in London, female IDUs interviewed
were more likely to be prostitutes than men (OR = 10.9; Cl: 3.28 - 39.9) (Rhodes et al., 1994).
Furthermore, three quarters ofIDU women that participated in the study by Freeman et al. (1994)
had exchanged sex for money in the preceding six months. According to the authors, the
probability of being a prostitute for female IDUs was over five times greater than for male mus.
It is important to realise that, in some cases, the clients as well as the steady partners of prostitutes
put these women at increased risk oflllV infection. In the study by Zunzunegui et al. (1992) 40
percent of seropositive men interviewed said that they had had commercial sexual relations with a
prostitute. Although Nicolosi et al. (1992b) found that only 12.2 percent of HIV-positive males
reported this type of sexual encounter (ranging from 22 percent in Milan to 2 percent in Turin).
In Spain, it was shown that two thirds of IOU prostitutes interviewed had a stable partner who
was a male IDU, compared with 8.6 percent of non-IDU prostitutes (Estebanez et al., 1992).
According to Van Ameijden et al., (1994) 63 percent of prostitutes interviewed in Amsterdam had
a stable partner, of which 28 percent were currently male IDUs. For Astemborski et al. (1994)
female IDUs who had had over two sexual IDU partners were more likely to have been a
prostitute with the greatest number (i.e., > 50) of customers.
Some of the studies undertaken amongst prostitutes in Europe and North America have shown
that the relationship between prostitution and HfV infection is closely associated with the
intravenous injection of drugs. In a study of HIV seroprevalence amongst prostitutes in nine
European countries, 5.3 percent of the global population were seropositive, but HIV infection was
more frequent amongst IOUs than nOD-IOUs (31.8 percent and 1.5 percent were seropositive
respectively), and IOU was the principal risk factor for HIV (European Working Groups on ffiV
Infection in Female Prostitutes, 1993). According to the results of a Spanish study of female
prostitutes, 60.2 percent ofIDUs were positive for HIV-l compared to 3.4 percent of Don-IOUs.
Consequently, IDU was the principal risk factor associated with ffiV infection for prostitutes (OR
= 47.6), along with unprotected sexual activity for nOD-IOUs (Estebanez et al., 1992). In
Amsterdam. the estimated seropositivity was 30 percent amongst prostitutes examined in the city,
all of which had a record ofIDU (Van Ameijden et al., 1994). In the study by Astemborski et al.,
(1994) in which the 39.2 percent of IDU women had exercised prostitution at least once in the
previous 10 years, the overall seropositivity for ffiV was 24.6 percent and the rate for IOU
prostitutes who had had more than 50 customers was greater than those with fewer than 50
customers (47.6 percent versus 23.2 percent).
According to the results obtained from these diverse studies amongst female mus, prostitution
and a history of SIDs are independent risk factors with a strong association with HIV infection,
providing evidence of the risk of sexual transmission of HIV in this population. Of the female
prostitutes studied in Amsterdam between 1986 and 1992, the relative risk for SIDs was 2.92,
due to the high rate of SIDs in seropositive women (92 percent) compared to seronegative
women (57 percent) (Van Ameijden et al., 1994). In a study carried out in San Francisco amongst
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femaIe IDUs it was shown that prostitution was independently associated with seropositivity (OR
= 3.11) (Watters et al., 1994b). Also Astemborski et a1. (1994), observed that for prostitutes,
having more than 50 customers (OR = 3.0) and previous SIDs (OR = 1.84) were independently
associated with mv infection.
On the other hand, in the study by Serraino et aI. (1991), prostitution was not a predictive risk
factor of HIV infection for the global population and it was only associated with infection when
the analysis was conducted for women alone (OR = 3.1; 0: 0.9 - 10.1). Amongst imprisoned
women in Canada with a history of IOU: the strongest predictors of HIV seropositivity were
sexual or needle contact with a seropositive person, self-reported genital herpes, and having had a
regular IOU sexual partner, but it was not predicted by prostitution (Hankins et al., 1994). In the
study by Watters et al. (1994b) on female IDUs, a record of syphilis was independently associated
with HIV seropositivity (OR = 3.30; Cl: 1.36 - 7.99).
The use of condoms by prostitutes varies according to the country studied. There is a lower use in
the countries of southern Europe than in northern and central Europe (Estebanez et al., 1992). It
has been suggested that IOU prostitutes do not seem to be a major cause ofIDV transmission to
the general population. Although clients of prostitutes can expect to be infected, it is the private
sexual relations, where condom use is extremely low, that are associated with transmission (Van
Ameijden et al., 1994). It seems to be the case that, although the use of condoms by prostitutes is
generally low, frequency is greater during commercial sexual relations than during private sexual
relations, despite the fact that these women have male IOUs as partners. Paone et al. (1995)
found that close to 60 percent of women engaging in commercial sex work, in a study of IOU
women participating in New York City syringe exchange programs, reported "always" using
condoms. In a cross-sectional study carried out in 11 Spanish provinces, almost 50 percent of
prostitutes included stated that they used condoms "always" or "almost always" during vaginal
sexual intercourse with clients. IOU prostitutes were using condoms with customers less
frequently than with non-IDU partners (p = 0.05). Without doubt, sexual relations with stable
partners are also at risk as 96.3 percent declared that they never used condoms during oral sex and
90.2 percent never during anal sexual intercourse (Estebanez et aI., 1992).
3.5. Early sexual experience
Early sexual experience, including childhood sexual abuse, has been linked to a number of factors
which also have links to mv risk. Studies of sequellae of childhood sexual abuse (victimization
is reported more often by women than men) have identified associations with substance abuse
(Briere & Runtz, 1988), prostitution (Zierler et al., 1991), low self-esteem (in Johnsen and
Harlow, 1996), adult depression (in Johnsen and Harlow, 1996), risky sexual behaviour (Zierler et
al., 1991; Johnsen & Harlow, 1996), younger age at first intercourse (Johnsen & Harlow, 1991),
and early age of first pregnancy (Zierler et al., 1991). Furthermore, a study of early sexual
experience (defined as becoming sexually active between the ages of 10 and 14) also noted links
to risky sexual behaviour and SIDs (Greenberg et al, 1992). A study of prostitutes versus
"normal women" found that prostitutes had generally initiated sexual activity at a younger age
and had a higher incidence of early involvement in abusive sexual encounters (incest and rape)
(James and Meyerding, 1977). As Greenberg and colleagues suggest, early sexual experience (or
age at first intercourse) should be used as a marker for identifying women at risk for SIDs (and
HIV) and a target for preventive interventions.
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3.6. Factors determining reproductive outcome amongst female IDUs
As already mentioned above (Section 3.3.4), the efficiency of the sexual transmission of Hlv will
rely on the infectivity of the case index, the susceptibility of the partner and the type of sexual
. relation (Najera and Cols, 1990). However, the proceeding discussion is limited to the
susceptibility of IDV transmission between heterosexual contact between men and women.
Women are more susceptible to infection due to a series of biological, anatomical and histological
factors, that make them more vulnerable to heterosexual IDV transmission. For example, vaginal
secretions are less infectious than semen due to the pH of vaginal acid which makes the vagina an
unfavourable environment for IDV. On the other hand, the base pH of semen is not only more
favourable for IDV, but the survival of the virus is prolonged in the interior of vagina following
ejaculation (Voeller and Anderson, 1992). In addition, the deposited semen in the vagina
suppress the proliferation of T cells, thereby permitting the survival of HIV in the female genital
tract (Anderson and Hill, 1991). Furthermore, the time of exposure is prolonged, as the semen
remains in the reproductive tract following sexual intercourse until it has been completely
absorbed. The anatomical and histological differences between male and female genital organs
also contribute to the increased susceptibility of women, as female organs present a greater
surface area of contact than do the male organs and thus are more receptive to HIV. Inmen, the
foreskin provides a protection from infection which, in the absence of ulcers or abrasions, would
make the penis inwlnerable to I-llV (polk, 1985).
Other additional factors that would influence the greater susceptibility of women would include:
the presence of recurrent vaginitis (Nicolosi et al., 1994a) and other SIDs (Zunzunegui et al.,
1992) which, due to inflammation in the vagina and/or lesions, would facilitate infection (Holst et
al., 1987); the use of the IUD (Nicolosi et al., 1994a; Zunzunegui et al., 1992) as this can
produce chronic inflammation of the cervix and can cause micro-lesions after being inserted
(Musicco et al., 1994); sexual relations during menstruation (Hellman et al., 1991; Green et al.,
1990); anal sexual intercourse (Zunzunegui et al., 1992) due to the traumatic effect on the rectal
mucus; and possibly the use of oral contraceptives. This last factor is debated as some authors
conclude that oral contraception is associated with infection (Simonsen et al., 1990; Plummer et
al., 1991), while others think: that it provides a protective effect (Nicolosi et al., 1994a; Goedert et
al., 1988; Mati et al., 1990).
3.6.1. Menstrual cycle
A number of studies have reported that female IDUs have irregular menstrual cycles. It is likely
that high prevalence of irregular periods is caused by a number of interacting factors including the
use of opiates (Bai et al., 1989) and other drugs, stress, weight gain (caused by obesity) and
weight loss (caused by anorexia nervosa) (Symonds, 1987). It should, however, be noted that the
cessation of menses, concomitant with the use of drugs (and opiates in particular), is due to
amenorrhea and does not imply that a women is infertile (Ralph and Spigner, 1986). This has
been illustrated by the reported increase in fertility among 20 I opiate-dependent women on
enrollment into a methadone maintenance programme in Liverpool, UK (Morrison et al., 1995).
Menstrual abnormalities have also been associated with HIV infection. In a study of 248
premenopausal HIV-infected women without AIDS and 82 Hlv-negative women, the IDV-
infected women were found to have an increase in amenorrhea (> 3 months) and in menstrual
cycle intervals (> 6 weeks) and lower rates of premenstrual breast symptoms. Changes in
menstrual function were also significantly associated with a past history of, but not current,
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substance abuse, suggesting the possibility that socioeconomic factors rather than biologic effects
of drugs may be responsible (Chirgwin et al., 1996).
. 3.6.2. Contraceptive efficacy
It has been suggested that IDUs have a lower uptake of contraceptives due, amongst other factors,
to the (partly misguided) belief that opiates and other drugs cause infertility (Ralph and Spigner,
1986). The use of contraceptives, it is thought, is lower amongst female IDUs than for the
population per se. For example, in a study of 115 heroin-addicted women from California, USA,
25.8 percent reported any type of contraception compared to 48.5 percent of a national sample
(Ralph and Spigner, 1986). Likewise, in the study of201 opiate users from Liverpool, UK, 21.4
percent of women reported condom use compared to 46.5 percent of young women attending
British Family Planning Clinics (Morrison et al., 1995).
Efficacy, safety and acceptability are all factors which need to be considered when prescribing a
contraceptive method. Further, these factors need to be matched to individuals and communities
(Williamson and Joanis, 1994); that is whilst one method may be appropriate for the general
population, it may be inappropriate for IDUs and other marginalised groups. Thus, in: light of the
high prevalence of hepatitis amongst IDUs, the contraceptive pill may be an inappropriate
method It has also been suggested that the use of hormonal contraception may be associated
with a reduction in the use of barrier contraception such as the condom. Another complicating
factor is the concurrent use of petroleum-based lubricants. A recent European study identified the
use of petroleum-based lubricants to be a risk factor for mv infection in non-IDUs (European
Working Group on mv Infection in Female Prostitutes, 1993). Another issue to consider is the
"dual" use of barrier contraceptives. A number of studies have suggested a reduction in the rates
of sexually transmitted diseases (SIDs), including mv, for women who use condoms with a
spermicide (reviewed in Roddy, 1994). Whilst the evidence is not yet conclusive, it is important
to stress that both methods must be used concurrently (Cain and Williamson, 1994). Finally, the
IUD has been associated with IDV infection in a number of studies (reviewed in Carlin and Boag,
1995).
3.6.3. Pregnancy
A number of studies have concluded that female IDUs are as likely to have children as the general
population (reviewed in Wells and Jackson, 1992), as illustrated by the 70.0 percent of
ever-pregnant female IDUs reported from an American study (Brown, 1989). There are a number
of reasons why female IDUs have a higher rate of pregnancy and, in particular, teenage
pregnancy. For example, female IDUs often lead a somewhat "traditional" lifestyle with low
levels of educational attainment and employment (Wells and Jackson, 1992). Self-esteem is
probably low, and it may be perceived that childbirth may break this cycle. Another possibility is
that female lOUs often experience irregular menstrual cycles resulting in infertile periods and
many women then assume they are infertile and do not need to take precautions to avoid
pregnancy.
A number of studies have suggested that pregnancy itself may be a risk factor for HIV infection.
Although as yet there is no consensus, what cannot be disputed is the increase in the number of
mv-infected pregnant women. Indeed this is probably a reflection of the sociodemographic
characteristics of'HfV in women. In Europe, for example, 76 percent of AIDS-diagnosed females
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are in the 15-49 age group (European Centre for the Epidemiological Monitoring of AIDS, 1996).
It is therefore important that policy makers and public health practitioners alike are aware of the
effects of pregnancy on the natural history of HIV. It has been suggested that HIV pregnant
women may be susceptible to atypical immunological changes and that this will facilitate the
. progression from HIV to AIDS. To date, studies examining immunological changes have
produced contrasting results. More evidence, however, is available with regard to the effects of
drug use. Whilst there seems to be no relationship between opiate use and disease progression,
there is evidence that continued !DU may accelerate progression from HIV to AIDS. Although
there is no evidence of gender-specific difference in the progression rate, the interaction of
pregnancy and/or IDU with IDV-infected women makes this likely. The confused state of
knowledge with regard to the reproductive health of pregnant women demonstrates the need to
examine the association between HIV/AIDS and pregnancy.
The effect of HIV seropositivity on pregnancy outcomes has also been examined. In general,
most of these studies have looked at' the effect on obstetric or neonatal complications (e.g.
premature rupture of membranes, intrauterine growth retardation) and concluded that in
industrialized settings the impact of asymptomatic HIV infection is negligible. A few studies
have looked at the impact of seropositivity on reproductive decisions. One such study which
compared the rates of reproductive events before and after HIV diagnosis in a cohort of women
aged 20-34 years with HIV infection found that diagnosis of HIV infection in women produced a
44 percent decline in age-adjusted live-birth rates (Stephenson et al.•1996). The decline was
attributed to increases in termination of pregnancy (50 percent). decreases in overall pregnancy
rate and an increase in miscarriages. Thus the diagnosis of Hlv infection may have a substantial
impact in reducing live-birth rates which has significant implications for expanding HIV testing in
women and highlights the need for better contraceptive support for HIV-infected women.
3.7. Sociocultural, educational, and economic factors
Sociocultural. educational and economic factors are likely to be negatively associated with !DU
populations, thus creating difficulties in developing and implementing health education
campaigns aimed at decreasing and modifying risk behaviours. In spite of the inherent risks of
treating roUs as a collective group, the sociodemographic characteristics most often observed in
different studies have included: a low level of education (Vlahov et al., 1990) unemployment
(Sasse et al., 1989; Salmaso et al., 1991); a low income (Vlahov et al., 1990); high levels of
prostitution (Stark and Muller. 1993; Freeman et al., 1994; Stark et al., 1990; Van Ameijden et
al., 1994; Astemborski et al., 1994); and, theft or drug dealing in order to finance a habit, thereby
causing a high rate of previous imprisonment (Sasse et al., 1989; Sopelana et al., 1991; Serraino
et al., 1991; Stark et al., 1990; Estebanez et al.• 1992).
It has also been observed that the sociodemographic characteristics of roUs differ according to
whether the drug addict is receiving treatment or not. According to a study undertaken amongst
an IDU population in Madrid, participants recruited in the street (as opposed to those recruited in
treatment centres) were more likely to have less education, less employment, a record of previous
imprisonment and were less likely to live with partners or family. The authors of this study
suggested that IDUs recruited in the street were less socially integrated than those in treatment
centres (Zunzunegui et al., 1990). This being the case, then social isolation will probably be
associated with a greater vulnerability to lITV infection due to the lack of assimilation within
preventive health programmes and continued risk-taking behaviour; all of which could lead in
itself to a greater sense of social isolation.
23
Another indicator of low socioeconomic status and a high degree of social marginalisation is not
having a fixed address. Although studies of homelessness in IDU populations are rare or don't
exist, studies of homeless populations have identified elevated levels of HIV risk practices,
. including IDU, crack cocaine use, sexual relations with an IDU, exchange of sex for money or
drugs, multiple sexual partners and inconsistent condom use (Fisher et aI., 1995~Nyamathi et al.,
1997).
Psychological factors associated with rnarginalisation, social isolation and low self-esteem, also
play an important part in designing and implementing prevention strategies. A number of studies
have detected high levels of psychological distress and depressive disorders among homeless
women, drug-recovering women and drug-using prostitutes (Nyamathi et al., 1997~Fisher et al.,
1995~El-Bassel et al., 1997~Alegria et al., 1994). Furthermore these women have been found to
have partners who are also at high risk for emotional distress and risky behaviours (Nyamathi et
al., 1997). Poor mental health combined with the negative impact of their closest sources of
social support may undermine the motivation and ability to help themselves, whether in seeking
and following through with drug treatment or in adopting safer sex behaviour.
Numerous studies of black or Hispanic populations, which have been historically marginalised,
have shown significantly higher rates ofHIV infection (Nelson et al., 1991~Vlahov et al., 1990~
Schoenbaum et al., 1989~Lehman et al., 1994~Vlahov et al., 1991). Female IDUs may also be
more likely to suffer greater social isolation than men. According to some studies, these women
live alone more frequently than men, have more children under their care, and do not live with the
family of origin (Freeman et al., 1994~Estebanez et al., 1992). This situation could drive these
women to greater isolation and social marginalisation. Moreover, marginalisation could lead to
prostitution, and thus to greater marginalisation and lower esteem. We have already shown that
women are more likely to be prostitutes than men, while men are more likely to turn to robbery or
to the sale of drugs (Stark et al., 1990). It has also been observed that amongst IDUs, more men
than women have a principal source of income (Freeman et al., 1994), which would help
integration into the wider society.
The importance of psychosocial factors has not been recognised with regard to gender-specific
infection ofHIV. For example, prevention campaigns have stated that the principle mode ofHIV
transmission is the use of shared injection equipment, and to a lesser degree the practice of
unprotected sex. Consequently, drug addicts and the general heterosexual population, have
avoided (or reduced) the sharing of needles and syringes whilst underestimating risk of
unprotected sexual activity (Kline and Strickler, 1993). This could explain why IDUs have
modified their risk behaviour with regard to sterilising or not sharing injecting equipment
(Watters et al., 1994a; Donoghoe et al., 1989). Likewise, there could exist a certain tendency
amongst women to under value the risk of sexual activity with an IDU partner, as opposed to
sexual risk behaviour per se. We have already commented on the specific risk of sexual relations
between a non-IDU female and an IDU partner. It may be the case that emotional factors
including dependence and/or economics, reduce the capacity of a woman to introduce change into
her sexual relations and that the social status of the partnership could influence the perception of
the risk. In relations like these, women have to trust their partners with regard to current and/or
past risk behaviour. In casual relations the reverse may be the case and the women would not
necessarily trust the partner. It has been suggested that this would be an erroneous perception of
risk, as it would impede these women from utilising condoms with their stable partner (Kline and
Strickler, 1993).
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The scarcity of dedicated studies into the social context of HIV risk factors makes it difficult to
differentiate between global and gender-specific IDU behaviour. Women have a greater
likelihood of sharing injecting equipment than men, as women are more likely to share in a group
and use shared equipment from men. Although both have a greater probability of sharing
equipment with their sexual partner than with other types of companions, women are more likely
to inject with their partner (Freeman et al., 1994; Sotheran et al., 1992), which for women means
that they are more likely to have a sexual relationship with an IDU partner (Murphy, 1988).
Moreover, women are also likely to be injected afterward, thus further increasing the risk of
transmission for these women (Freeman et al., 1994).
3.8 Access to and utilisation of treatment
There exists little documentation of the utilisation of drug dependency services by this population,
although it seems that uptake is low. Of the 104 confirmed seropositive IDUs examined by
Rhodes et al. (1993),43.1 percent had never received help or treatment for drug dependency and
52.2 percent had not been formerly tested for HIV. It was also observed in London that 42.0
percent of heroin addicts and 75.0 percent of cocaine users had never received treatment for drug
dependency (Strang et al., 1994). In a study carried out in Madrid amongst IDUs, only 42.0
percent of those interviewed in the street had received some type of help or treatment for drug
dependency. Of these, 21.6 percent had received treatment in a municipal centre for drug
dependence, 21.1 percent had received methadone treatment, 22.9 percent had been to a hospital
detoxification unit, 22.9 percent had received ambulatory detoxification, and 30.0 percent had
received care in the community (Zunzunegui et al., 1993). According to the results of a European
study (conducted between 1989 and 1990 in 12 countries) on the knowledge, attitudes and beliefs
of IDUs about measures taken for HIV prevention, the low utilisation of drug dependency
services could be due to the low opinion of these services amongst IDUs. By comparison, the
direct provision of sterile injection equipment was generally welcomed (Richardson et al., 1994).
Inequalities between men and women also occur with regard to attending services and to
assimilating information, The inequality of access and/or utilisation of health services could
explain the difference of survival according to a study following the progress of HIV-infected
patients between 1990 and 1993 in North America According to the results, women-
irrespective of being roUs- had lower survival rates than seropositive men, as women had a
lower rate of utilisation, and access to, health services (Melnick et al., 1994). In another North
American study examining the utilisation of health services by HIV infected people, it was
observed that women and roUs tended to use health services in an emergency. The authors
suggest that roUs, and women in particular, are slow to seek medical help until the problem
becomes a medical emergency (Mor et al., 1992). Furthermore a multi-site U.S. study on access
to care for drug abusers with mv reported that multiple barriers in access to service exist for
drug-using women (Weissman et al., 1995). The most important barriers were cost and waiting
times. The authors also noted that significantly fewer women than men received pre- and post-
test counseling and were advised to get medical services after their first positive HIV test.
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According to the data recorded amongst drug addicts interviewed in Madrid in 1990, women had
a lower rate of uptake into drug dependency services, although the differences were not
statistically significant (Zunzunegui et al., 1993). About 50 percent of men and 40 percent of
women in the study were recruited from drug dependency centres, suggesting a lower rate of
. access and/or utilisation for these women. Although data on the use of social services amongst
these women was not recorded, it is probable that drug-dependent women have lower rates of
access due, in part, to feelings of guilt andlor the fear that the state might consider removing their
children.
Gender differences in the process and response to drug treatment have also been examined. As
men have traditionally accounted for a higher proportion of those addicted to heroin and therefore
a higher proportion of those entering treatment facilities, it has only recently been questioned
whether treatment intervention methods and goals are too "male-oriented" and not appropriately
geared for women. In general women are found to be more likely to drop out of treatment than
men, though when they do carry through with treatment they have similar rates of success
(reviewed in Anglin et al., 1987). Studies of the factors which contribute to positive treatment
outcome for women, though few, have consistently indicated that a partner's involvement in
entry into treatment and continued support in attending treatment are critical (reviewed in Anglin
et al., 1987). In a study of behavioural differences between men and women during and after
methadone maintenance treatment, it was noted that women may actually have higher motivation
for treatment in that they took less time than men to seek entry into their first methadone
maintenance treatment programme after addiction. They entered more often without direct legal
pressure, fewer were discharged for negative reasons, and they complied to a greater extent with
treatment regulations than men (Anglin et al., 1987). Yet they were no more likely than men to
have positive treatment outcomes. Some of the factors observed to be associated with poor
outcomes included: having a partner who is also a narcotics user, and a lack of social and
vocational skills necessary to relate to and become assimilated into the non-drug-using world
Furthermore, studies of gender differences in treatment populations have indicated that women in
treatment report more medical, psychiatric, family-social and employment problems than men
(McLellan et al., 1992; Brown et al., 1993). Thus it has been suggested that drug treatment
programmes need to modify their services to specifically address women's issues by taking into
account the important role the partner plays in treatment, by addressing women's health and
vocational needs, and by addressing child care needs.
Furthermore, a more recent study into the apparent gender paradox in drug treatment found that
although women have more "risk factors" associated with drug-use relapse, they are no more
likely to relapse than men, and found that women become more engaged in treatment specifically
by participating more in group counseling (Fiorentine et al., 1997). They did not find support for
the drug severity hypothesis (women are less likely to relapse because their drug-use histories are
less severe) or the social support hypothesis (women are less likely to relapse because they have
higher levels of social support, facilitating recovery). The authors attribute the differences in
treatment engagement to gender norms concerning help-seeking, personal independence, strength,
and control.
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4. Conclusion
This chapter has sketched the outline of the epidemiological and sociological literature on !DU
and particularly female !DUs, with reference to the HIV/AIDS epidemic. Despite its importance,
. very little research has been carried out in order to establish if female !DUs have additional risk
factors and to increase our knowledge of this population so that more appropriate intervention
programmes can be developed. In view of the problems outlined above, it is important to answer
the following research questions:
• Does gender have an effect in the risk oflllV prevalence in roUs?
• Are there any socioeconomic characteristics responsible for the low use of prevention
measures?
• What support services are appropriate for female IDUs in order to limit the AIDS epidemic?
It is therefore the objective of this thesis to address these research questions. In the following
chapter the formal objectives are presented. Chapter Three describes the methodology and data
collection. Chapter Four presents the characteristics of the female IDUs interviewed for this
study, including their sociodemographic characteristics, drug-taking risk behaviour, sexual
behaviour, prostitution, reproductive health, and utilisation of services. Chapter Five examines
the determinants of ffiV seropositivity in this population. Chapters Six, Seven, Eight and Nine
study the determinants of prostitution, imprisonment, syringe sharing, and condom use,
respectively. Chapter Ten looks at the utilisation of social services and drug treatment amongst
these women. Chapter Eleven provides a summary of all findings and presents concluding
remarks on directions for future interventions and research with this population.
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Chapter Two
Aim and Objectives of the Study
1. Introduction
Following the literature review in Chapter 1 (Section 4), three research questions were identified
(Chapter 1, Section 5):
• Does gender have an effect in the risk ofillY prevalence in IDUs?
• Are there any socio-economic characteristics responsible for the low use of prevention
measures?
• What support services are appropriate for female IDUs in order to limit the AIDS epidemic?
In order to address these questions it is appropriate to formulate the specific aim and objectives of
the study (Section 2). In addition, this chapter introduces the methodologies used and will
describe the background of the study, study design, sampling, field work, and data analysis. In so
doing, the difficulties in recruiting a suitable representative sample of female injecting drug users
(IDUs) from different research settings will be demonstrated.
2. Aim and Objectives of the Study
To study the social and behavioural determinants of HIV infection in female IDUs in Madrid in
order to improve implementation of appropriate prevention programmes to control the AIDS
epidemic inSpain.
2.1. Objectives
The general study framework was structured with the following objectives:
1. To descnbe the sociodemographic characteristics, drug-taking behaviour, sexual behaviour
(including prostitution), reproductive health, and utilisation of services of female intravenous
drug users in Spain.
2. To assess the direct and indirect determinants ofHIV in the study population.
3. To identify determinants of potential risk factors for mv.
4. To study attitudes among women towards safer sexual practices; and
5. To assess the effects of different kinds of drug treatment on risk behaviour among female
IDUs.
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2.2. Operational objectives
To achieve these objectives, the following operational objectives were structured.
2.2.1. Objective I
To describe the sociodemographic characteristics, drug-taking behaviour, sexual behaviour
(including prostitution), reproductive health, and utilisation of services of female
intravenous drug users in Madrid, Spain.
Specific objectives:
i) To provide baseline information about HIV risk factors in Spanish female IDUs so that changes
in prevalence of HIV and risk behaviour can be measured over time.
ii) To describe HIV and STD prevalence in the study population.
iii) To describe the reproductive health of the study population.
iv) To assess the extent of social service, drug treatment, and health service utilisation in the study
population.
2.2.2 Objective n
To assess the direct and indirect determinants ofHIV in the study population.
Specific Objectives:
i) To evaluate the risk of heterosexual transmission ofHIV infection amongst female IDUs.
ii) To study the effect of injection practices on HIV prevalence in women IDUs.
iii) To examine the role of social factors in transmission ofHIV.
2.2.3 Objective ID
To identify determinants of potential risk factors for HIV.
Specific objectives:
i) To identify direct and indirect determinants of prostitution.
ii) To identify factors associated with previous imprisonment
iii) To identify determinants of "needle sharing."
iv) To identify determinants of "never-used condoms."
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2.2.4 Objective IV
To study attitudes among women towards safer sexual practices.
Specific objectives:
i) To study knowledge and attitudes towards measures to prevent HIV.
ii) To study attitudes towards pregnancies.
iii) To assess the extent to which women make decisions about sexual behaviour.
2.2.5. Objective V
To assess the effects of different kinds of drug treatment on risk behaviour in female IDUs.
Specific objectives:
i) To assess the effect of health care and drug services utilisation on mv risk behaviour.
ii) To identify determinants of having "never attended treatment."
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Chapter Three
Methodology and Data Collection
1. Background to the Study
The data used in the thesis was collected from a sample of 304 female IDUs recruited in Madrid
at the time of interview. This sample is a subset of a five-centre study (paris, Madrid, Rome,
London and Berlin) funded by the European Union and coordinated by the author of this thesis
(Estebanez et al., 1996).
2. Study Design
An observational cross-sectional design was chosen as the most appropriate way to fulfill the
objectives of the study (i.e., to estimate the behaviour of female IDUs and to explore the
associations between behaviour and a number of dependent variables, such as HIV positivity,
prostitution, prison record, etc.). However, there are a number of limitations to these methods
which need to be addressed in order to place the results in the appropriate context. (Hennekens
and Buring, 1987).
First of all, a cross-sectional study is carried out at one point in time; therefore it only measures
the prevalence and not the incidence of a disease. Thus the influence of certain risk factors which
have been modified over time cannot be measured with this design. This limitation was lessened
because we designed the questionnaire to assess past behaviours using a six-month recall period
and dichotomous variables, such as "ever-shared injection equipment" versus "never", as
advocated by McElrath (1994). Secondly, there is the issue of the consistency of behaviour over
time. Whilst these two problems theoretically could be overcome with a prospective cohort
study, the recruitment and retention of a sufficiently large sample of initially seronegative IDUs
would be extremely difficult Finally, a limitation which applies to all studies of IDUs is that of
the representativeness of the sample. Due to the characteristics of the population studied, and
their inaccessibility (due to the illicit and clandestine nature of drug injecting), random sampling
methods cannot be used leaving a potential for selection bias. To minimize this bias we recruited
subjects from a variety of settings (for more details see
Section 6).
3. Study Sample
3.1. The social context of the study
Madrid, like many other Spanish and European cities, underwent an epidemic of heroin use in the
early 1980s. The use of illicit drugs, particularly heroin and cocaine, remains high, with police
and drug agencies reporting an increase in the availability of heroin and cocaine in the 1990s
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(National Plan on Drugs, 1995). The economic recession in the late 1980s and the geographical
position of Spain as a bridge for drug trafficking into Europe seems to have increased IDU in the
areas surrounding Madrid including, for example, the Chabolismo slums, Gypsy populations and
. marginalised groups. The increased realisation of this problem by society due, in part, to the
AIDS epidemic has resulted in government and non-government organisations (NGOs)
developing an extensive network of drug services in the region.
3.2. Population
Based on estimates from the Plan Nacional de Drogas, in 1996 there were approximately
150,000-200,000 IDUs in Spain, with about 15,000-20,0000 in Madrid Although exact figures
are not available, it is estimated that in the Autonomous Community of Madrid the number of
female drug users is between 2,000 and 3,000.
3.3. Profile of the study population in Spain
In the absence of a recent population census or a study of IDUs that could provide a sampling
frame for Madrid, we used a surveillance system set up by the Spanish government in 1988 in
order to gather information about drug users attending the general health care system and the
public drug treatment centres.
3.4. Network in health and social services
In order to obtain the support of recruitment centres and health and social services, we studied the
current system for the provision of national health services, with particular regard to drug
treatment This information was collected in 1995.
3.4.1. Health services
The current Spanish public health system (as of 1995) can be divided into the following
administrative levels:
• Central level. The Ministry of Health & Consumer Affairs manage public health at the
central level.
• Autonomous Community. Autonomous Communities have control over health promotion
and prevention. The responsibility for health care is assumed by the autonomous
communities rather than by central government.
• Health areas. Care is provided for 200,000 - 250,000 people. There is at least one health
area per province. According to the Health Law, health areas should carry out their activities
by working in teams in order to serve individuals, families and communities, through
progrnrnmes for health promotion and prevention, treatment and rehabilitation.
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The health areas are divided into basic health zones that constitute a national framework for
primary health care. The Social Security system provides health care to 98 percent of the
population of the Autonomous Community of Madrid. Health services act in the health areas of
this Community at three levels:
• Primary health care. Health reforms in the 1980s led to the creation of Health Centres.
Interdisciplinary teams work on the diagnosis, treatment and cure of diseases using specific
protocols, and in community health thro~gh prevention and health promotion programmes.
• Specialised health care. Health care needing specialised professionals, technology and
treatment can be carried out in outpatient centres with specialised surgeries, laboratories and
diagnosis, supporting both the specialised level and primary health care.
• Hospitals. In some areas there are hospital day units for specific diseases such as AIDS and
cancer.
General health care for drug users should be carried out by a doctor at the primary health care
level. Nevertheless it is wen known that drug addicts are usually reluctant to visit a doctor and
prefer direct access to hospitals through casualty services.
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3.4.2. Drug treatment services
The Regional Plan on Drugs is a General Programme, an assistance network, aiming to provide a
. response to the drug dependency problem on three different levels of intervention: prevention,
assistance-rehabilitation and social reintegration. This network of drug treatment programmes
distributed throughout Spain offers services to nearly 50 percent of IDUs. It is targeted at both
female and male drug users that either want to stop taking drugs or don't want to or are not able to
give them up. During 1995 only 20 percent of the total number of individuals assisted by this
Plan were women. Services are all free of charge.
General intervention resources could be summarised as follows:
• Council centres and day centres. Local Centres that offer prevention, social rehabilitation
and reintegration for drug users. Treatment is also offered
• Detoxification units. Physical detoxification may be carried out as an outpatient in a Day
Centre/Council Centre or as an inpatient in a hospital Detoxification Unit In the Region of
Madrid there are only 2 Units with a total capacity of22 beds. Access is restricted. to pregnant
drug users, those with a cardiovascular pathology or another serious illness. A patient must be
referred by a Local Centre and must be over 16 in order to gain access.
• Therapeutic communities. This service aims to offer individuals, through a wide counselling
programme, the personal tools needed to complete their rehabilitation in an outpatient Local
Centre. Access is only for those drug users with a minimum age of 18 referred by a Local
Centre.
• Methadone programmes. This programme is extremely limited and is offered only to
pregnant drug users, to drug users with a serious organic pathology, and to individuals highly
adapted to drug consumption. Access to this programme is limited to drug users referred by a
Local Centre and a minimum age of 18 is required
• Isidro bus. A service designed to reach drug users on the street in Madrid. This service
provides information on health and social resources, injecting equipment, health advice, etc.
• Sitade. A twenty-four-hour phone line that provides information on the programmes offered
by The Regional Plan on Drugs.
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3.4.3. Social services
The current social and community services available are:
• IMI (Minimum Integration Income). This programme has been devised to fulfill the basic
needs of those people who have social problems and have no income. The philosophy of the
Programme is to give economic support to those prepared to commit themselves to beginning
a specific Programme to deal with their 'problems.
• Women's Services. This is a social welfare service of the Ministry of Social Integration of
the Region of Madrid The main aim of the Service is the total integration of women who are
at risk and in marginal positions. The folIowing programmes form part of this service:
• Programme for abused women and their children. Legal advice about women's rights and
duties when they have been victims of some kind of abuse. Admittance and shelter at a
residence centre, when needed Counselling and treatment.
• Programme (or pregnant young women and for single mothers and their children.
• Programme for young women with personaJ and/or family problems. The first goal is to
give women an integral training including: basic educational training, sexual and sanitary
information, and work training. Help is also given to drug users.
• Programme for prostitutes. This programme is focused mainly on giving financial support
for the maintenance of a Centre where street prostitutes can take a break from their work, get
condoms and syringes. talk with a social worker. etc. However, access to this programme is
difficult for IDU women.
The Council of Madrid also provides financial help with school dinners, domestic help, and books
for children.
3.5. Criteria (or Inclusion
The study population comprised women who had:
( I) injected drugs for more than one month and in the six months prior to the date of interview;
(2) decided to participate in the study after being informed of its objectives; and,
(3) given their informal (oral) consent to be interviewed.
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4. Sampling
One of the main difficulties in preparing this research is a cornmon problem for research on
. IDUs; that is the lack of a sampJing frame for the population under study. The precise number of
IDUs in Madrid is unknown, hence it was necessary to employ non-random methods of sampling.
It has also been suggested that, given the general inaccessibility of IDUs, convenience samples
should be accepted. Another problem arises from the degree to which users from one setting
differ from users in other settings with respect to, for example, demographic characteristics, risk
practices and the prevalence of HIV infection. For example, Powis et al. (1996) noted a higher
proportion of women in their sample of drug users recruited from community settings when
compared to the proportion normally found among treatment populations. Differences were also
illustrated by Lampinen (1992) who identified a two-fold risk of HIV seropositivity among
community-recruited IDUs compared with entrants to drug-treatment programmes. However
Alcabes et al., (1992) has found that the correlates ofHIV infection in IDUs are not substantially
different when comparing subjects currently in treatment and those not in treatment.
Nevertheless, since it is the aim of this study to provide descriptive as well as bivariate and
multivariate findings. we decided to recruit in different settings, as has been recommended in the
international literature (Stimson, 1992), while attempting to control for differences between
settings statistically. In summary, after reviewing the Spanish literature, looking "at previous
studies commissioned by the European Union and talking with professionals in this area, we
decided to recruit the sample in three different settings: treatment centres, methadone centres, and
outreach programmes.
4.1. Treatment centres
In 1992, among the 6,048 women who sought advice about and/or treatment for drug use, 2,736
were prior attendees (defined as individuals who had already been in treatment in previous years),
and 3,059 were new entrants (defined as individuals seeking drug treatment for the first time).
For the Madrid area, among the 717 women treated, 255 were prior attendees and 379 were new
entrants.
In the emergency services of Madrid in 1992, 1,718 women were treated for drug use problems,
of whom 31 died.
4.2. Methadone centres
Methadone programmes at the time of the study (1995) were scarce and overly restricted due to
controversies in health policy. At that time, there were 50 female drug users in methadone
programmes and 1,565 in day-centres run by the "Community of Madrid".
4.3. Outreach programmes
Needle exchanges are administered by NGOs. In 1993, 437 female IDUs used the needle
exchange buses which tour the area of Madrid In addition, about 14 women IDUs started
treatment in the project named "HOMBRE", and 102 in specialised detoxification centres.
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4.4. Recruitment strategy
. The current sample of 304 women IDUs who completed questionnaires were recruited as follows:
Drug dependency units
One hundred and seven (35.2 percent) were recruited from drug dependency units. This sample
was taken from different services: "Proyecto Hombre", "CADs", and "ISIDRO BUS".
• "Proyecto Hombre ". Fifty-nine women' were approached, but only 26 fulfilled the criteria of
injecting drugs in the last six months. Of the 26 women eligible, 1 refused to participate.
• GovernmerualInstittuions: "CADs" and ''ISIDRO BUS". Eighty-two eligible women were
recruited by the staff at these centres.
Methadone services
Fifty (16.4 percent) women were recruited from different methadone units: governmental and
non-governmental. Many of the women approached were currently engaged in a methadone
programme and therefore not currently injecting (in the last six months), so a high proportion
were not eligible (105 of 157 approached), and two of them refused to participate. Thirteen
questionnaires were completed at the "Centro de Metadona Cruz Roja de Fucar'\ 32 at the
"Centro Metadona Cruz Roja de Marroquina", and 5 at the "Servicios de Metadona de los CADS
de San BIas y Tetuan".
Outreach Services
One hundred forty-seven (48.4 percent) were recruited from outreach services, including the
"Medicos del Mundo" bus scheme for needle exchange. Of the 250 women approached., 95 were
ineligible for having begun to inject too recently or failing to complete the questionnaire, and 8
refused to participate.
Thus, overall, 11 women out of 315 (3.5 percent) refused to participate in the study. We have no
information about these women, but since the refusal rate was so low, we feel this will not bias
our results. It should be noted that the refusal rate was higher among women recruited through
outreach programmes versus regular treatment centres. We think this is due to the fact that those
in treatment centres are more likely to have an established relationship with the staff and therefore
feel less threatened by the interview. Furthermore, we believe we were able to attain such a low
refusal rate because the interviewers hired for this study had a great deal of experience in working
with drug users.
5. Data Collection
Two forms of data collection were used. A questionnaire was administered in a face-to-face
interview to all eligible females, and a specimen of blood was collected to assess the HIV status
of al] who consented and had not been recently tested. Those who had been tested were asked to
present their medical card which indicates their HIV status. These cards are issued by the
medical services, and many drug users carry them to avoid problems with the police.
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5.1. The questionnaire
The questionnaire used in this study for assessment of risk behaviour and use of services was
based, with modifications, on: (1) that used in another study in Europe for males; and (2) national
. health surveys of women in Spain. The interview was checked in the pilot phase of the study for
consistency and reliability in the five centres of the European study.
The questionnaire was geared towards !DUs by using a theoretical framework based on plausible
biological risk characteristics about transmission of agents by parental and sexual routes, and by
ethnographic observations.
In spite of the limitations of retrospective self-report on behaviour relating to sexual practices and
drug use, this method has been evaluated in numerous studies. It is accepted that the use of
retrospective self-report is a valid method for assessing HfV risk behaviour. We have chosen a
recall period of six months based on the work of McElrath (1994) whose findings supported the
use of retrospective self-reported data although there was moderate disagreement between the
retrospective and the prospective data sets by the six-month follow-up (memory decay). These
authors suggest certain strategies for maximizing the reliability of retrospective data, including the
use of dichotomous measures of risk behaviour, careful construction of research instruments, a
thorough training period for interviewers, and specific methods to enhance subject's recall.
Another concern in asking questions related to sexual behaviour is the reliability, depending on
who asks the question and how the respondent reacts to such questions. Due to the very intimate
nature of the questions asked, interviewers were trained to take care of these issues together with
subcultural aspects, such as the slang used by these women (Pickering, 1988).
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5.1.1. Subjects of the questions
After encountering problems with the pilot questionnaire about the length of the interview,
, wording of some questions and the assurance of confidentiality, the final questionnaire was
structured as follows:
• Sociodemographic characteristics. Questions related to age, marital status, educational
attainment, etc,
• Drug use. Our emphasis is on unprescribed drug use as reported by respondent, covering the
following types of drugs: heroin (and other opiates), cocaine (and crack), amphetamines,
barbiturates, benzodiazepines, ecstasy, hashish, alcohol and tobacco. There are also questions
related to recency of consumption, injection drug use, frequency of injection and risk
behaviours, including sharing of injection equipment, cleaning equipment, and injecting in
pnson.
• Sexual behaviour. Questions related to sexual relationships with regular partners, casual
partners and clients. Number of fllV-positive partners and IDU partners. Frequency of oral
sex, vaginal and anal intercourse. (Criteria for regular or casuaI partner and 'client were
included in the questionnaire.)
• Use of condoms. Questions to achieve a better knowledge of the determinants of the use of
condoms by this population, such as: reasons to start using condoms; sources of condoms; and
frequency of condom use with regular and casual partners and clients during oral sex, vaginal
and anal intercourse.
• Reproductive health. Questions including age at first period, frequency of periods,
contraceptive methods used, pregnancy, number of miscarriages and abortions, number of
children, smear test, SIDs, Hl'V-positive children, and IDV tests.
• AIDS public education campaigns. Questions included knowledge of public health
campaigns, etc.
• Women's experience of health, drug and social and community services at local levels.
These questions were related to frequency of use and reasons for using each service, and to
women's perception of the usefulness and the accessibility of each service. Measurement of
service utilisation is scored on a series of items covering encounters with three different types
of services - health, drug, and social. There were multiple service utilisations, so this wil1
represent the total number of different types of service systems utilized during the previous six
months.
• HIV test At the end of the interview, study participants were asked if they had been tested
for HlV. If they responded that they had been tested for HIV, they were asked to provide a
written confirmation of their test results by their doctor. It should be noted that it is common
in Madrid for the medical services to issue a medical card indicating HIV status and that it is
common for drug users to carry these cards in order to avoid problems with the police. Those
who had not been tested and who gave their informed consent were asked to provide a blood
sample for HIV testing.
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5.1.2. Formatting and coding of variables
Data were collected on more than 84 sociodemographic, behavioural, and health variables. All
centres used the same protocol for sampling and administration and the same core questionnaire.
Questionnaires were coded to ensure the anonymity and confidentiality of the study participants
In the pilot study some difficulties were met with in the content and format of some types of
variables, and after discussion with the collaborators these variables were reclassified using
continuous (such as the number of sexual relationships, number of injections) and categorical
(such as dichotomies (yes/no» variables. However, it should be noted that the level of detail
required by continuous scales may exceed the capabilities of some participants and for this reason
some responses are categorised using, for example: "always", "very often", "almost never," and
"never".
5.1.3. Types of variables
• Qualitative and categorical variables
- Demographic characteristics (i.e., sex, marital status, educational attainment,
residence, source of income, etc.).
-illV prevalence.
- Probable risk factors (i.e., prison, drug practices and variables concerning sexual
behaviour).
- The use of health services and social networks, and variables about knowledge,
attitudes, access and acceptability of these services.
For the multivariate logistic regression analysis we used different scales, including dichotomous,
nominal, and ordinal variables. Dummy variables/reference categories were assigned as the
group with the least risk.
• Quantitative variables
- Continuous variables (i.e., age, age of first injection, age of first period, etc.).
- Discrete variables (i.e., parity, number of children, abortion, frequency of sexual
relationships, frequency of injection, etc.).
Continuous variables were measured in the appropriate scale (i.e., years, etc.). Some of the
continuous variables were recoded into categorical variables for the multivariate logistic
regression analysis.
5.2. Testing for HIV status
HIV antibody testing was performed only after informed consent had been given. Refusal to be
tested was not grounds for exclusion from the study, and was recorded. Samples of blood were
collected and tested by ELISA (enzyme-linked immunosorbent assay for saliva) with positive
tests confirmed by Western Blot
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5.3. Training of interviewers
The data collection period was preceded by a session of training for the interviewers. Around 10
potential interviewers participated in the training sessions. The training was conducted by the
main investigator who presented to the interviewers the background and objectives of the study,
and discussed each item and question on the questionnaire. The training session placed particular
emphasis on completing questionnaires with each participant Following training, the person
responsible for the field work carried out the first questionnaire with each interviewer and
conducted a special session on coding skills',
The interviewers were mostly workers in the treatment centres and people who have been
working in research on drug users.
6. Field Work
6.1. General guidelines
Interviewers were selected from the staff of different centres. For the outreach 'sample, the
process of "snow balling" the sample was used to increase the number of female IDUs
interviewed This involves making initial contacts with respondents and then using respondents
to provide access through personal introductions and recommendations to friends and colleagues.
6.2. Strategies in the field
Originally, field work was planned to span over a six-month period, commencing in October 1994
and finishing in April 1995. However, unforeseen obstacles arose, and the data-collection phase
was delayed and extended.
6.2.1. The first phase
The participating centres' staffs met on two occasions to prepare the questionnaire to be used in
this study. This questionnaire was translated into Spanish and pre-tested in a pilot phase
conducted between January and October 1994 when 25 women were interviewed. Results from
this pilot study were used to refine the questionnaire and to adapt the wording of questions.
In this period, the major activities were to develop and adapt the final questionnaire for the main
survey. Based on the final questionnaire, an interviewer's manual was prepared, and a technical
training workshop was held for interviewers in order to achieve standardisation in the enrollment
of participants and data collection.
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6.2.2. The second phase
Between October 1995 and January 1996, the project was delayed in the recruiting of centres and
interviewers due to political repercussions from changes in the Autonomous Government of
Madrid. The main investigator and research assistant held numerous meetings with relevant
individuals and organisations to explain the objectives of the study.
6.2.3. The tbird phase
Between October 1995 and March 1996, 309 face-to-face interviews were conducted by trained
personnel, using the structured questionnaire which had previously been tested during the pilot
phase of the study
7. Statistical Analysis
7.1. Treatment of missing values
First of all, participants with incomplete questionnaires were excluded from the study.
Participants who failed to provide written confirmation of their HIV test were coded as "not
known" in the mv prevalence variable so that the rest of the data collected from these
participants is included in the study. However, when HIV prevaIence is the dependent variable in
the multiple logistic regression analysis, the "not known" cases were excluded. This approach is
warranted provided that the missing data occurred completely at random (Heitjan, 1997).
7.2. Descriptive analysis
In order to identify the risk factors for HIV infection and the predictive factors for other "at risk"
situations (including risk behaviours), such as prison, sharing injecting equipment, prostitution,
lack of treatment, we have done a univariate analysis considering each of these risk variables as
the dependent variable.
Categorical variables
Frequency distributions and percentages were calculated using 2x2 tables. For categorical and
discrete variables, levels of significance were tested using the chi-square test for proportions.
Each variable was studied and their potential relationships as main effect and as confounders
were analysed. This was done through univariate analysis using the Mantel-Hanzel statistic to
obtain the odds ratio (OR) between the dependent and independent variables. The OR provides a
measure of association but does not imply a causal relationship. However it is a very useful
method to identify those risk factors which are associated with the variable of interest
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Quantitative variables
For continuous data, differences in means were tested using the approximated normal
distribution, with the t-test and the z-score. The use of the normal distribution was justifiable due
to the large sample size.
We transformed continuous variables into categorical intervals and calculated the frequency
distributions.
7.3. Multivariate logistic regression analysis
Few attempts have been made to develop conceptual models of the complex relationship between
injecting drug use and AIDS using multifactorial analysis. Frischer et al. (1993) used the Linear
Structural Relations Program (USREL) technique to develop a model to represent the grid of
relationships among the observed data in a large-scale cross-national study of IDU in Scotland.
The USREL approach involves the construction of measurement and structural models. The
measurement model consists of a number of underlying or latent variables that account for the
common relationship among a nwnber of observed variables. Each latent variable is defined by
at least two valid indicators. In addition to the latent variables, exogenous variables can be
included in the model, which are considered to be predictive of, but not predicted by the latent
variables. These variables are generally sociodemographic in nature. The structural model
involves path analysis, which has been defined as: ..the process of estimating the coefficients of a
set of linear structural equations (i.e., regressions) representing the predictive relationships
hypothesized by the investigator" (Frischer et al., 1993). One of the advantages of the USREL
model is its ability to consider the model as a system of equations and estimate all the structural
coefficients simultaneously.
Although path analysis is not used in the current study, the grid of relationships modeled by
Frischer et al. (1993) did influence our conceptual framework and plan for logistic regression
analysis. First of all. we chose the causal model rather than the predictive model because we are
interested in studying behaviour, and this is the more appropriate model for explaining the
behavioural process. The primary dependent variable we studied was HIV seropositivity. Then
we examined various latent factors including: prostitution, imprisonment, unsafe drug use, unsafe
sex, exposure to drug treatment and the exogenous factors associated with them, including
sociodemographic and socioeconomic factors.
For each dependent variable, the relationship between the dependent variable and independent
variables was evaluated through crude and adjusted odds ratios with their 95-percent confidence
intervals. Those variables which had a statistically significant association with the dependent
variable were included in the logistic regression models.
The strategy used for analysis in the multivariate logistic model followed a stepwise approach. A
logical and hierarchical structure was used to simulate reality and determine the direct and
indirect effects of the explanatory variables. In other words, the explanatory variables were
grouped into 'explanatory groups or models and each group of variables was forced into the
regression sequentially. The explanatory groups used to study each of the dependent variables
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generally included age, socioeconomic status, marginalisation factors, risk behaviours, and co-
infection with SIDs or hepatitis B, in that order, although the models included varied' according
to the dependent variable being studied in each chapter,
The order in which each group was entered into the regression was established based on the
biological and sociological hierarchy of their effect on the dependent variable with the more
proximal determinants entered first and distal determinants entered later, These effects were
estimated based on published literature as well as the author's knowledge of this topic. We also
checked variables for interaction effects because in the causal model the effect can be changed by
interaction between variables.
The idea behind building these different groups at different stages was to be able to see how each
variable works WIder different "at-risk" situations and be able to consider the whole picture. For
example, an explanatory variable such as "age" may have a direct effect on the dependent
variable such as "HIV status" (via the decline in immune function with age) and it also may have
an indirect effect on the dependent variable, HIV in this case (via exposure to risk factors, such as
imprisonment). Inother words, the hierarchical structure allows one to see how the relationship
between an explanatory variable and the dependent variable changes when certain other
explanatory variables are introduced. That is, it permits the identification of indirect, intervening,
and direct effects, which is particularly useful in the study of HIV with such a variety of
interrelated explanatory variables. Furthermore, in the study of IDV the identification of indirect
effects can provide useful "risk behaviour markers" for targeting preventive interventions. For
example, cocaine use may not be directly associated with HIV status but its direct relationship
with lack of condom use, which is directly associated with HIV highlights cocaine use as a useful
"risk behaviour marker".
Using the statistical software programme SPSS, each of the explanatory groups is entered into a
stepwise logistic regression. For each step, when a group is entered, the most parsimonious
model is chosen. through a process of backward elimination, and then the next group of variables
is added. Therefore the final regression model is comprised of the best variables from each of the
five explanatory models. The regression models are compared using the improvement in the -2
Log likelihood value (-2LL) measured with the Chi-Square. To determine if there are any
significant interaction effects which should be included, interaction terms are defined and
systematically analysed for all the variables included in the final model. The addition in goodness
of fit gained by including interaction terms is then examined
Thus, the final picture we obtain from the five different explanatory models is one which allows
us to evaluate the effect of how these different variables have a direct effect on the dependent
variable and how their effect is mediated through other variables in the causal pathway (see
Figure 1).
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8. Conclusion
In summary, we have chosen a cross-sectional study to explore the behaviour of female IDUs and
determine the relationships between behaviour and a number of dependent variables. We have
considered the limitations inherent in a cross-sectional design such as the time sequence of events
and have adopted appropriate measures in the questionnaire. Because of the potential for
selection bias given the population we studied, we implemented sampling techniques to correct
for this, such as sampling from multiple sites. Finally, we have built a number of hierarchical
models which at different stages explore now the different variables have a direct and indirect
effect on the dependent variables and how their effect is mediated through other variables in the
causal pathway.
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Chapter Four
Characteristics of Female mus
1. Introduction
Women make up an increasing proportion of people infected by the Human Immunodeficiency
Virus (IDV). Originally, and in contrast with some African countries where the incidence of HIV
and AIDS has been approximately equal in both men and women since the beginning of the
epidemic, in North America and Europe women represented only a small fraction of the HIV-
infected population. However, the female-to-male ratio has shown an ever increasing trend in
recent years: of the 24,920 cases of AIDS reported in Europe by the end of 1996, women
accounted for 21 percent of cases among adults and adolescents (European Centre for
Epidemiological Monitoring of AIDS, 1996). This represents an increase from 8 percent in 1985
and from 13 percent at the end of 1990 (European Centre for Epidemiological Monitoring of
AIDS, 1990).
The increase in female HIV/AIDS cases is due to a set of biological, social, cultural, economic
and political factors that make women more vulnerable to HIV transmission than men.
Heterosexual transmission, accounting for almost a third of female AIDS cases (European Centre
for Epidemiological Monitoring of AIDS 1996), is favoured by a woman's anatomical features,
and the relative efficiency rate of male-to-female transmission has been found to be over twice as
high as female-to-male transmission (Nicolosi et al., 1994). Women are generally more
susceptible to sexually transmitted diseases (SIDs), a history of which has been identified as a
major risk factor in heterosexual HIV infection (Holst et al., 1987; Musicco et al., 1994). In
addition, women tend to have less access to information and health services, are economically
dependent on men and have low levels of negotiating power in their sexual relationships with
men.
However, the main identified risk factor tor HIV transmission in women is injecting drug use,
which in Europe accounts for more than half of reported female AIDS cases (European Centre
for Epidemiological Monitoring of AIDS 1996). There are a nwnber of gender-specific lifestyle
differences which may be putting female injecting drug users (IDUs) at a greater risk of acquiring
HIV than male IOUs. Prostitution as a means of financing a drug habit, for example, is more
common in women than in men, and has been linked to HIV in both Europe and the United
States (European Working Group on HIV Infection in Female Prostitutes, 1993; Watters et al.,
1994b). Also, previous studies have shown that female roUs are more likely to have
seropositive male partners and to practice high-risk sexual behavior (Cohen et al., 1989; Klee et
al., 1990; Estebanez et al., 1991). The sharing of needles, identified as a major risk factor for HIV
transmission (Marmor et al., 1987~Des Jarlais, 1992) also appears to be more common in female
than male roUs (Salmaso et al., 1991; Sotheran et al., 1992).
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Even though there is evidence of gender-specific high-risk behaviours, studies on HIV
transmission in drug-dependent populations have failed to include gender-specific data Thus,
little research has focused on the role played by reproductive health in the complex relationships
among women, drug use and IDV.
Evidence indicates that female IDUs do not constitute a homogeneous population and that
different subpopulations may be identifiable on the basis of certain sociodemographic
characteristics or behaviours involving the risk of transmitting IDV. The documentation of these
characteristics and risk behaviours in female IDUs is important to predict the future course of the
AIDS epidemic in the community and to define policies which can appropriately target
subgroups at the highest risk. Before predictions can be made, it is important to examine the
range of factors specific to women which may possibly influence IDV risk, such as reproductive
health, as wen as the types of sexual behaviour and the degrees to which injecting equipment is
shared, and of course the rate of infection in this group.
Thus by knowing more about the social context within which these women live and their gender-
specific needs, such as reproductive health, more effective policies and treatment programmes
can be established.
This chapter will present the descriptive results from the interviews with 304 female IDUs
recruited from a variety of settings in Madrid with two objectives in mind Firstly, it is the
author's intention that the baseline data presented herein wiIl aid in the formation of policy for
this population. Secondly, the data presented will allow the reader to have a firm understanding
of the population at hand before examining the multitude of possible bivariate and multivariate
relationships between the characteristics of female IDUs and HIV (Chapter Five, prostitution
(Chapter Six), previous imprisonment (Chapter Seven), needle sharing (Chapter Eight), condom
use (Chapter Nine), and exposure to treatment (Chapter Ten). The sociodemographic
characteristics are described in Section 2~ Drug-taking risk behaviour in Section 3~ Sexual
behaviour in Section 4; Prostitution in Section 5~Reproductive health in Section 6~and Service
use in Section 7.
2. Sociodemographic Characteristics
Selected sociodemographic characteristics of the total sample population are presented in Table
4.1. The data presented in Table 4.1 identified a young population: more than 60 percent of
interviewed female IOUs were less than 30 years old and the median age was 29 years. Almost
55 percent had left school when they were 15 years old, indicating that educational attainment
was at a medium level. That is, the majority of the population completed secondary school
education (i.e., up to the age of 16), but further education was rare.
In addition, other characteristics presented in Table 4.1 indicate that the population sample was
marginalised and of a disadvantaged socioeconomic status. For example, almost one quarter
(22.7 percent) are homeless, having no fixed address, although 22.0 percent report living with
their parents. Furthermore, only 12.8 percent of women earned a regular salary whilst,
conversely, 20.7 percent of women earned their main source of income through sex work and
24.3 percent through illegal activity. Moreover, 32.2 percent of female IOUs recruited into the
study reported having been in prison since first injecting drugs.
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When the sociodemographic data for Madrid were compared with the four other centres (Paris,
Rome, London and BerJin) which participated in the study (Estebanez et al., 1996), no major
differences were identified. For example, the median age for all five centres ranged from 29
. years (in Spain) to 31 years (in France, Italy, and Germany). However, Spain recorded the lowest
mean age of leaving education (the other four countries ranged from 17.08 in Italy to 20.01 in
Germany) and the highest rate ofhomelessness (the other four countries ranged from 6.9 percent
in Italy to 17.6 percent in France). Spain also recorded the highest rate of reporting illegal
activity (theft. dealing, etc.) as their main source of income (the other countries ranged from 17.6
percent for England to 9.5 percent for France). In contrast, the proportion of Spanish IDUs
reporting their main source of income as sex work was higher than the rates reported by Italy (8.3
percent) and England (10.9 percent), but lower than France (24.4 percent) and Germany (28.2
percent). Surprisingly, Spain recorded the lowest rate of previous imprisonment (the other
countries ranged from 35.7 percent in England to 58.5 percent in Germany). Finally, a marked
difference in living patterns was apparent between the northern European countries (England and
Germany) and the southern European countries (Spain and Italy). For example, in Italy, 39.0
percent of female IDUs lived with their parents, compared to 2.7 percent in England
When we look at data from a 1991 Spanish national survey, we find that amongst women aged
16 to 44 years, 6 percent were illiterate or had had no education, 29 percent completed primary
school, 45 percent completed middle school, 9 percent completed professional training. and II
percent completed university or higher (Instituto de la Mujer, 1991). If we look at
unemployment, it appears that 23 percent of Spanish women who want to work are unemployed.
This compares to 50 percent of the IDUs in the current study if we combine the following source
of income categories: unemployed with regular income from state (6.3 percent), welfare from
state (8.2 percent), illegal income (24.3 percent), and no source of income (4.9 percent). Another
interesting point of comparison is the rate of living with parents. According to a study by Juan
Antonio Fernandez Cordon of the Institute of Economy and Geography of the Superior Council
of Scientific Investigations (CSIC), the rate of living with one's parents for Spaniards between
the ages of25 and 30 varies between 74 percent for those who are unemployed and 58.6 percent
for those who are employed (Diaz de Tuesta, 1997).
In other words, two inferences can be made from the data presented in Table 4.1. First, as would
be expected from a study into the risk behaviour of female IDUs, the sociodemographic
characteristics of the sampJe population are not typical of society in Madrid per se and represent
a marginalised young community of women. In fact, this sample from Madrid appears to be
more marginalised than the samples from other European capitals, as evidenced by their having
less education, more homelessness, more illegal income, and more prison experience. Of
particular concern is the relatively high rate ofhomelessness. This subgroup of female IDUs may
be at particularly high risk for mv given the risk behaviours frequently associated with
homelessness (drug abuse, alcohol abuse, trading sex for money or drugs, sexual relations with
drug-using partners, multiple sexual partners, unprotected sex) and the relationship of
homelessness to other health risks, such as mental distress, depression, and trauma, including
battery and rape (Fisher et al., ]985; Nyamathi et al., 1997).
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Secondly, and of considerable interest, was the number of women (45.5 percent) who reported
earning their main source of income through sex work or an illegal activity. It has often been
assumed that male IDUs financed their drug habit through theft and drug dealing, whilst women
have traditionally been assumed to do so through prostitution. In these data, there is evidence
. that women use both sources of income in roughly equal proportions. This finding coincides
with the findings of a study of criminal activity among women crack addicts which indicated that
the women are not only involved in prostitution but also in petty crimes and drug-selling
activities and the levels of involvement in these activities are approaching those of their male
counterparts (McCoy et al., 1995). .
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Table 4.1 Sociodemographic characteristics of the studied population
Variable N percent
Age at the time of interview
15-19 7 2.3
20-24 66 21.7
25-29 110 36.2
30-34 72 23.7
35-39 42 13.8
40-44 5 1.6
45+ 2 0.7
TOTAL 304 100.0
Age left full-time education
10-13 88 29.1
14-15 82 27.2
16-18 73 24.2
19+ 56 18.5
still studying 3 1.0
TOTAL 302 100.0
Living with
Parents 67 22.0
Relatives 25 8.2
Partner 76 25.0
Children 6 2.0
Partner and children 22 7.2
Friends 13 4.3
Alone 60 19.7
Other 35 11.5
TOTAL 304 100.0
Where they lived during the past 6 months
No fixed address 69 22.7
Room rented on a daily basis 27 8.9
Rented flat 29 9.5
Your own (or partner's) flat 76 25.0
Someone else's flat 39 12.8
Shelter, welfare residence
.., 1.0.)
Other 45 14.8
Your parents'/relatives' flat 16 5.3
TOTAL 304 100.0
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Table 4.1 (continued) Sociodernographic characteristics of the studied population
Variable N percent
Source of income during the last 6 months
Employed with regular salary 39 12.8
Unemployed with regular income from state 19 6.3
Temporary work 21 6.9
Welfare from state (allowances) 25 8.2
Self-employed 11 3.6
Sex worker 63 20.7
Illegal income (theft, dealing, etc.) 74 24.3
Other 37 12.2
No source of income 15 4.9
TOTAL 304 100.0
Who finances the major part of your expenses
Yourself
Your partner
Your family of origin
The social support system
Others
182 59.9
45 14.8
58 19.1
14 4.6
5 1.6
TOTAL 304 100.0
Been in prison since first injection
Yes
No
98 32.2
206 67.8
304 100.0TOTAL
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3. Drug-Taking Risk Behaviour
Consistent with the marginalised socioeconomic characteristics of the study population (Section
2), the age at the time of first injection was quite young (Table 4.2). The median age of first
. injection was 19 years (range 11 to 35 years). More than half (53.4 percent) started injecting
drugs before the age of20. This, without a doubt, has an important impact on their psychological
development and social behaviour as it is in this stage of life when the basis of their adult
personality is established Therefore, in these women future behavioural problems are found with
greater frequency than in those who started injecting drugs later in life.
With regard to drug-taking behaviour there is some evidence that the practice of needle sharing
had declined with time. For exampJe, 71.6 percent of female IDUs reported having ever shared
needles or syringes and 34.2 percent reported sharing in the past six months. However, the valid
proportion for the past six months (i.e., the proportion of female IDUs who have shared over the
past six months to those who have ever shared) was 47.9 percent In fact, there is evidence that
drug users in a variety of countries are modifying their risky practices. In a study conducted in
the U.K, Hunter et al (1995) reported a decline in the proportion of IDUs that had shared
injecting material during the six months prior to the interview over four consecutive years (from
1990 to 1993). Specifically they found a decline from 46.8 percent in 1990 to 39.3 percent in
1993. This reduction in recent needle sharing is comparable to rates found by Estebanez et al.
(1996) in other E.E.C. countries: in the U.K there was a reduction from 69.2 percent that had
ever shared injection equipment to 38.5 percent who had shared in the previous six months; the
reduction in Germany was from 56.4 percent to 26.9 percent; in Italy from 47.2 percent to 26.3
percent; and in France, where rates were quite a bit lower, from 34.4 percent to 10.0 percent.
These data provide encouraging evidence that a decline is underway in the risky behavior of
IDUs perhaps as a result of public health interventions advocating harm-reducing behaviour
during the 1990s.
The proportion offemale IDUs that shared needles in the past 6 months was 34.2 percent, and the
frequency of at least once a month or less was 51.0 percent, although a significant number (30.6
percent) shared needles at least once a day (Table 4.2), thus reducing the real number at risk from
transmission of IDV by this means to 9.9 percent (The 30.6 percent of the 34 percent). These
figures imply that habits concerning the sharing of needles have changed and that mv prevention
campaigns aimed at the drug-using population have been successful
Almost half of the women questioned (49 percent) injected drugs for the first time with their
regular sexual partner. In a study of male and female drug users, Powis et al. (1996) also
reported that half of female injectors (51 percent) reported having been given their first injection
by a male sexual partner. (Male injectors more often received their first injection from a friend)
This demonstrates the great influence a stable male partner has over a woman, and must be taken
into account when developing strategies against drug addiction. Maybe one of the most effective
measures to prevent drug addiction in women would be to persuade the drug-using partner to
discourage the women from taking drugs and to inform him of the enormous influence he can
have in this regard and the consequent responsibility.
Unlike men, very few women (1 percent) participate in drug-taking behaviour alone (Barnard,
1992). This implies that women, more than men, need to feel supported by someone in making
decisions of this kind, involving the transgression of a behavioural norm, This is another
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indication of the great difference between men and women in the drug-injecting experience.
Women are seen to be more affected by prejudice than men and thus need to have someone
reaffirm their behavior and push them into action. The explanation for this can be found in the
roots of a society which establishes different roles according to one's sex, producing gender
. differences.
Women most commonly shared needles with a regular sexual partner (47.5 percent), whilst 17.8
percent shared with a male friend and 10.9 percent with a female friend The main source of
injecting equipment for women was the pharmacy or chemist. although 56.6 percent of women
reported the use of needle exchange schemes. This observation, however, probably reflects the
sample characteristics of recruitment and thus any comparison with other (associated or
independent) studies would be meaningless.
Another interesting observation is the types of drugs consumed in the past six months: 89.9
percent of female IDUs reported taking heroin; 63.8 percent cocaine; and 53.3 percent, a
combination of both cocaine and heroin. Crack cocaine was used by 15.1 percent of women in
the past six months. Pills, such as benzodiazepines and barbiturates, were consumed by 60.6
percent of this sample. The vast majority (97.7 percent) offemale lOUs smoked tobacco.
In spite of beliefs to the contrary, alcohol consumption is high, with 70 percent of the sample
reporting alcohol consmnption in the last six months. These data are similar to those obtained by
Estebanez (1996) in the U'K However, in the other countries consumption was significantly less:
35.5 percent in Italy, 49.8 percent in France, and 44.4 percent in Germany.
The most commonly injected drugs in Spain were heroin (78.9 percent), cocaine (52.6 percent)
and heroin and cocaine together (49.7 percent). When compared to the other four centres, rates
of heroin injection were higher for Italy (99.5 percent), rates of cocaine injection were lower for
Italy (10.6 percent), England (25.8 percent) and France (16.3 percent), and rates of injecting both
heroin and cocaine were lower for all four countries (ranging from 9.0 percent for England to
39.4 percent for France) (Estebanez, 1996).
Neither does our data coincide completely with that of other Spanish studies such as Bravo et al.
(1996), carried out among drug users of both sexes, in which 38.3 percent had injected cocaine
and 7l.2 percent had injected heroin and cocaine.
Chitwood and Comerford (1990) found that injectors of cocaine used in combination with
opiates were more likely to have multiple sex partners and high-risk injecting behaviour than
cocaine-only or opiate-only injectors. Kowalewski (1990) reported that the disinhibiting effects
of cocaine may predispose users to mv infection through high-risk sexual behaviour. These
findings are supported by the work of Joe & Simpson (1995) who reported that I-llV risks
increased as a direct function of cocaine usage level, though only for males. Among females,
low-to-intermediate levels of cocaine use (less-than-weekly) were associated with high-risk
behaviours. We were not able to establish statistically significant associations with any of these
relationships.
Only 15.5 percent used crack in a non-injected form, a finding which coincides with data from
the Spanish study by Bravo (1996) in which 13.4 percent used it in the month prior to the study.
However, there is quite a bit of variation in crack use reported in other countries studied by
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Estebanez (1996), with 11.8 percent in France, 0.9 percent in Italy, 0.4 percent in Germany, and
48.4 percent in England In a study carried out in the US.A by Watters (1994b), abouthalf(54.3
percent) of the women IOUs reported smoking crack in the 30 days before the interview.
. Crack is thought to be an important risk factor for fllV infection and other STDs because of the
associated behaviours of the users, including a tendency toward unprotected sexual intercourse
and multiple sexual partners (Wilson, 1997~Watters, 1994b~ Sterk, 1988~Goldsmith, 1988).
Furthermore, studies of criminal activity among women crack addicts indicate that they are not
only involved in prostitution but also in petty crimes and drug-selling activities, and the levels of
involvement in these activities are approaching those of their male counterparts (McCoy et al.,
1995).
Indeed it should be stressed that drugs apart from heroin can be injected and thus need
examining. For example, in a sample study based in North West England, Klee (1993) concludes
amongst other things, that the injecting of amphetamines was associated with a greater frequency
of intercourse which in itself may be associated with a greater risk ofHIV infection.
It is interesting to note that 32.7 percent of those who were in prison injected drugs during that
time. Drug use in prison has been widely reported. For example, a recent study of female
prisoners in Scotland's Corton Vale prison, found that 46 percent of inmates reported IOU and
57 percent of these injector-inmates reported to have injected whilst in prison (Gore et al., 1997).
There is also evidence from a study of 559 Scottish inmates (480 males and 79 females) in
which 7.7 percent reported IOU on at least one occasion during a period of imprisonment (Power
et al., 1992).
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Table 4.2 Drug-use habits
Variable N percent
Age at first injection
13 OT- 11 3.6
14-16 70 23.1
17-19 81 26.7
20-22 67 22.1
23-25 44 14.5
26-29 24 7.9
30or+ 6. 2.0
TOTAL 303 100.0
Injected drugs for the first time with
A regular sexual partner 148 49.0
A female friend 58 19.2
A male friend 35 11.6
Alone 3 1.0
Multiple users 45 14.9
Others 10 3.3
A relative 3 1.0
TOTAL 302 100.0
Drugs "used" within the last 6 months (n=304; multiple responses possible)
Heroin 271 89.9
Cocaine 194 63.8
Heroin and cocaine simultaneously 162 53.3
Methadone 72 23.7
Other opiates 45 14.8
Amphetamines 21 6.9
Benzodiazepine 113 37.2
Barbiturates 71 23.4
Crack 46 15.1
Ecstasy 19 6.3
Alcohol 213 70.1
Tobacco 297 97.7
Hashish 126 41.4
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Table 4.2 (continued) Drug- use habits
Variable N percent
Drugs "injected" within the last 6 months (n=304; multiple responses possible)
Heroin 240 78.9
Cocaine 160 52.6
Heroin and cocaine simultaneously 151 49.7
Methadone 9 3.0
Other opiates 6 2.0
Amphetamines 3 1.0
Benzodiazepine 11 3.6
Barbiturates 3 1.0
Crack 1 0.3
Ecstasy 1 0.3
Ever shared used needles or syringes
Yes
No
217 71.6
86 28.4
TOTAL 303 100.0
Shared needles within the last 6 months
Yes
No
104 34.2
199 65.8
TOTAL 303 100.0
Frequency of needle sharing in the last 6 months
Once a month or less
Once a week
Once a day
More than once a day
No response
TOTAL
50 48.1
18 17.3
11 10.6
19 18.3
6 5.7
104 100.0
Sharing behaviour in the last 6 months
Only borrowing
Only lending
Both, but more borrowing
Both, but more lending
Both equally
No response
TOTAL
9 8.6
3 2.9
16 15.4
25 24.0
48 46.2
3 2.9
104 100.0
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Table 4.2 (continued) Drug-use habits
Variable N percent
Get used needles from
A regular sexual partner 48 47.5
A female friend 11 10.9
A male friend 18 17.8
Other 24 23.8
TOTAL 101 100.0
Give your used needles to
A regular sexual partner 46 48.4
A female friend 10 10.5
A male friend 15 15.8
Other 24 25.3
TOTAL 95 100.0
Method used to clean used needles
Cold water 47 46.1
Hot water 10 9.8
Boiling 0 0.0
Bleach 18 17.6
Alcohol 4 3.9
More than one method 10 9.8
Other 2 2.0
I dont clean them 11 10.8
TOTAL 104 100.0
Why you refused the offer of a used needle
Because ofHIV/AlDS 119 40.3
Because of hepatitis 1 0.3
Appearance of needle/syringe 12 4.1
Because of person offering 29 9.8
Because I never borrow 66 22.4
For other reasons 68 23.1
TOTAL 295 100.0
Injected drugs in prison
Yes 32 32.7
No 66 67.3
TOTAL 98 100.0
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4. Sexual Behaviour
The sexual behaviour of female IDUs is examined with respect to regular partners, casual
partners and clients. The characteristics and sexual behaviour of prostitutes (i.e., with clients) are
. examined in Section 5. Selected characteristics describing the sexual behaviour with regular
partners are presented in Table 4.3.
Contrary to the popular belief that !DUs are less sexually active than the general population, there
are many recent studies that show that the majority of drug injectors are having sex: 82 percent in
England (Donoghoe, 1991), 88 percent in North West England (KJee, 1990), 77 percent in
Amsterdam (Van den Hoek et al., 1990),93 percent in South Florida (Chitwood, 1990), and 89
percent of a sample of female injectors in New Jersey (Freeman, 1994). Similarly, our study
concluded that out of those interviewed, most were sexually active.
Regular partner: The vast majority (i.e., 96.4 percent) of female IDUs reported ever having a
regular sexual partner, and 61.4 percent reported having a regular partner at the time of the study.
Furthermore, 87.7 percent of women reported ever having a regular partner who was an !DU.
This high percentage of lOU partners is confirmed in other studies (Cohen et al., 1989; Mulleady
et al., 1990; Dolan et al., 1991; Donoghoe, 1989) and is explained by the fact that there are many
more male !DUs than female !DUs. Moreover, in the current study 49.5 percent of women
reported ever having a regular partner who was HIV positive.
Vaginal intercourse was the most common (i.e., 88.8 percent) sexual activity. Oral sex was also
common with 70.8 percent of women reporting it in the past 6 months. Anal intercourse was less
common with 28.1 percent of women reporting "always" or "sometimes" having it in the past six
months.
If these results are compared with sexual practices in the general population in Spain, according
to the study by Usieto (1992), we find that they are comparable only as far as vaginal intercourse,
in which 9 percent reported never or rarely having it Comparing rates of anal and oral sex, there
were big differences from the general population. Oral sex was practiced less in the general
population (42 percent of women and 45 percent of men) than in our study. Usieto also reported
that only 9 percent of men had ever had heterosexual anal intercourse in their lives, and no data
was available on the anal sex practices of women. However, another study conducted in Spain
amongst lOUs by Bravo (1994) found that 18.3 percent of women had had anal sex.
Similar figures were obtained by Strang (1994) in a study in London in which 20 percent of
female heroin users had experienced anal intercourse within the last year and 10 percent within
the last month. In another study on women attending a SID clinic in london by Sherr (1991), 10
percent reported anal intercourse with a frequency of 1-30 occasions over the previous month.
Spira (1993) in his study about trends in sexual behaviour found that the occurrence of anal
intercourse varies greatly from one country to another, and notes an important increase during the
last 20 years. Spira found that 26.2 percent of French women and 21.7 percent of Danish women
reported ever having anal intercourse. Clearly, preventive programmes need to address the risks
of anal sex amongst heterosexuals.
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Condoms were "always" used by 22.3 percent of women in our study who reported having
vaginal intercourse in the past six months. These data coincide with those found by Van den
Hoek (1992) who found that 25 percent of IDUs with steady partners reported using condoms for
vaginal intercourse.
In anal intercourse, only 22 percent reported "always" doing so with condoms. Similarly, a study
among California heterosexuals found that only 13.5 percent of women reported "always" using
condoms for anal intercourse and 74 percent reported "never" using condoms (Erickson et aI,
1995).
Finally, very few women used condoms during oral sex. For example, only 2.4 percent of
women who had had oral sex in the past six months, "always" used a condom. Although
generally considered a "lower-risk sexual behaviour", the transmission of HIV by unprotected
receptive oral-genital contact (with and without ejaculation) is being described with increased
frequency, particularly as the frequency of higher-risk sexual behaviour declines (Berry and Shea,
1997). As these authors suggest, recommendations for safer sex practices need to include
discussion of the risks of receptive oral-genital contact
There is a significant association between never using condoms with the regular partner and other
risk factors, such as having shared needles in the last six months. In fact, the risk of having shared
injecting equipment is 3.5 times higher for those women who never used condoms in vaginal
intercourse with their regular partner, as can be seen in Table 4.5
Casual partner: As illustrated in Table 4.4, 79.5 percent of women reported having casual sexual
partners. In the study by Van de Hoek in Holland, only 23 percent of the women IDU's had had
casual partners in the previous six months. The proportion of women who reported having a
casual partner who was also an IDU or was Hlv-positive was 66.4 percent and 30.1 percent,
respectively. Condom use was higher with casual partners. For example, 51.0 percent of women
who reported having vaginal intercourse with a casual partner in the past six months, "always"
used a condom. Likewise, 40.0 percent of women, "always" used condoms during anal
intercourse with a casual partner, and 12.0 percent during oral sex.
With respect to casual partners, a significant association was also found between never using
condoms and having shared needles in the last six months. In fact, the risk of sharing needles is
7.3 times higher for women who never use condoms in vaginal relationships with a casual partner
(Table 4.6).
Condom use requires a degree of confidence within the relationship to be able to talk about sex.
However, this is not always the case, as sex is often a spontaneous event. The results of the
survey into sexual activity imply that female IDUs are at an increased risk from heterosexual
transmission ofIDV, putting a greater emphasis on the man as he is expected to take the lead in
sexual relations and should therefore be responsible for the supply of condoms.
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Table4.3 Sexual relationship with regular partner
Variable N percent
Ever had regular partner
Yes 293 96.4
No 11 3.6
TOTAL 304 100.0
Ever had regular mu partner
Yes 257 87.7
No 36 12.3
TOTAL 293 100.0
Ever had regular HlV+ partner
Yes 138 49.5
No 141 50.5
TOTAL 279 100.0
Changed behaviour with regular HlV+ partner
Yes 64 46.7
No 73 53.3
TOTAL 137 100.0
How behaviour changed with regular HIV+ partner
Stopped having sexual contacts 19 30.2
Stopped vaginal sex 1 1.6
Stopped anal sex 0 0.0
Stopped oral sex 0 0.0
Stopped sex during your periods 0 0.0
Increased condom use 43 68.3
TOTAL 63 100.0
Current regular partner
Yes 180 6l.4
No 113 38.6
TOTAL 293 100.0
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Table 4.3 (continued) Sexual relationship with regular partner
Variable N ~ercent
Frequency of sexual relationships with current partner
Never 43 23.9
Once a month 55 30.6
Once a week 61 33.9
Once a day 21 11.7
TOTAL 180 100.0
Kind of sex in the last 6 months
-Vaginal intercourse
Always/sometimes 158 88.8
Never 20 11.2
TOTAL 178 100.0
-Anal intercourse
Always/sometimes 50 28.1
Never 128 71.9
TOTAL 178 100.0
-Oral sex
Always/sometimes 126 70.8
Never 52 29.2
TOTAL 178 100.0
Condom use in the last 6 months
-Vaginal intercourse
Always 35 22.3
Never/sometimes 122 77.7
TOTAL 157 100.0
-Anal intercourse
Always II 22.0
Never/sometimes 39 78.0
TOTAL 50 100.0
-Oral sex
Always 3 2.4
Never/sometimes 123 97.6
TOTAL 126 100.0
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Table 4.4 Sexual relationship with casual partner
Variable N percent
Ever had casual partners
Yes 241 79.5
No 62 20.5
TOTAL 303 100.0
Ever had casual mu partners
Yes 156 66.4
No 79 33.6
TOTAL 235 100.0
Ever had casual HIV+ partners
Yes 53 30.1
No 123 69.9
TOTAL 176 100.0
Kind of sex in the last 6 months with casual partners
-VaginaJ intercourse
Always/sometimes 98 96.1
Never 4 3.9
TOTAL 102 100.0
-Anal intercourse
Always/sometimes 15 14.7
Never 87 85.3
TOTAL 102 100.0
-Oral sex
Always/sometimes 75 72.8
Never 28 27.2
TOTAL 103 100.0
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Table 4.4 (continued) Sexual relationship with casual partner
Variable N percent
Condom use in the last 6 months with casual partners
-Vaginal intercourse
Always 50 51.0
Never/sometimes 48 49.0
TOTAL 98 100.0
-Anal intercourse
Always 6 40.0
Never/sometimes 9 60.0
TOTAL 15 100.0
-Oral sex
Always 9 12.0
Neverlsometir.nes 66 88.0
TOTAL 75 100.0
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Table4.5 Condom use with regular partner and sharing injecting equipment .
Equipment shared
Condom use Yes No TotaJ OR(95 % Cl)
Vaginal intercourse
Always 5 30 35 (22.3 %) 1(reference)
Never/sometimes 45 77 122 (77.7 %) 3.5( 1.2-11.1)
157 (100 %)
Anal intercourse
Always 1 10 11 (22.0%) 1(reference)
Never/sometimes 15 24 39 (78.0 %) 6.2(0.7-143.8)
50 (100 %)
Oral intercourse
Always 3 3 (2.4 %) I(reference)
Never/sometimes 47 76 123 (97.6 %) undefined
126 (100 %)
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Table 4.6 Condom use with casual partner and sharing injecting equipment
EQUIPMENT SHARED
Condom use Yes No Total OR(95 % Cl)
Vaginal intercourse
Always 7 43 50(51.0 %) 1(Reference)
Never/sometimes 26 22 48(49.0 %) 7.3(2.5-21.9)
98 (100 %)
Anal intercourse
Always 6 6(40.0%) 1(reference)
Never/sometimes 2 7 9(60.0 %) undefined
15 (100 %)
Oral intercourse
Always 3 6 9(12.0 %) 1(reference)
Never/sometimes 23 43 66(88.0 %) 1.1(0.2-6.0)
75 (100 %)
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5. Prostitution
Selected characteristics, describing the sexual behaviour with clients can be found in Table 4.7,
where it is shown that 46.1 percent of women, reported ever having a client. The median age at
. first client was 22 years. The median number of clients per month was 9, range: minimum 0 and
maximum 240. It should be noted, however, that 64 of the women (or 40.4 percent) could be
considered ex-prostitutes (i.e., they had no clients in the past six months).
Condom use was higher with clients in comparison to regular and casual partners (Tables 4.3 and
4.4). For example, 66.7 percent of women who "always" or "sometimes" had vaginal intercourse
with a client, "always" used a condom. Similarly, 40.9 percent of women did so during anal
intercourse; 28.6 percent during oral sex; and 5.6 percent whilst mastmbating a client. It should,
however, be noted that these figures may be subject to small number problems.
The reported rate of prostitution in Spain (46.1 percent) was similar to that reported for all five
centres in the European study (45.7 percent; range: 33.5 percent in Italy to 62.0 percent in
Germany; Estebanez et al. 1996). These rates are higher than those observed by Donoghoe et al.
(1991) who reported that between 7 and 10 percent of drug injectors had accepted drugs for sex.
Likewise, in a study of drug injectors in South Florida, 21 percent reported trading sex for money
and 21 percent sex for drugs (McCoy and Khoury, 1990). The relationship between drug use and
prostitution is also highlighted by data looking at IDU amongst sample populations of prostitutes.
For example, in a study of prostitutes in Frankfurt, 74 percent of women were IDUs (Doerr et al
1990); in Madrid, 45 percent of female prostitutes were IDUs (Colomo et al., 1990); and in
Glasgow, 59 percent offemale prostitutes were drug users (McKeganey et al., 1990).
In the current study, the majority of women (63 percent) reported that they initially exchanged
sex for drugs or money, in order to pay for drugs. This relation has been documented frequently,
but there has been no conclusive evidence as to whether drug use was the cause or effect of
prostitution (Serraino et al., 1991; Nicolosi et al., 1992). These data, however, provide some
evidence that drug taking is the cause of prostitution, as opposed to its effect In this study, 81
percent of prostitutes reported that drugs carne first and afterwards carne prostitution. To explore
this relationship in further detail the determinants of prostitution are examined through bivariate
and multivariate analysis in Chapter 6. However, it is worth stressing that the link between drug
use and sexual behaviour is complicated by a multitude of other factors including, for example,
the disinhibiting effects of drugs, direct pharmacological effects on sexual behaviour and the
"milieu in which sexual opportunities are interwoven with drug and alcohol use, such as bars and
clubs" (Donoghoe, 1992).
With respect to sexual relations with clients, a significant association was shown between never
using condoms and sharing needles, with the risk of sharing needles 4.8 times higher in women
who never use condoms (Table 4.8).
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Table 4.7 Sexual relationship with clients
Variable N percent
Ever had clients
Yes 140 46.1
No 164 53.9
TOTAL 304 100.0
Age at first sex with client
17or- 20 14.6
18 to 22 52 38.0
23 to 27 43 31.4
28or+ 22 16.1
TOTAL 137 100.0
Which came first
Drugs III 81.0
Prostitution 17 12.4
Both 9 6.6
TOTAL 131 100.0
Why did you first do this
I needed money for drugs 88 62.9
I needed money other than for drugs 47 33.6
I needed somewhere to stay 4 2.9
Other 1 0.7
TOTAL 140 100.0
Average number of clients per month during the last 6 months
Ex-prostitute 55 40.4
1 to 30 20 14.7
31 to 60 14 10.3
61 to 90 13 9.6
91 to 120 13 9.6
121 to 150 14 10.3
151 or + 7 5.1
TOTAL 136 100.0
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Table 4.7 (continued) Sexual relationship with clients
Variable N percent
Kind of sex in the last 6 months with clients
-Vaginal intercourse
Always/sometimes 78 91.8
Never 7 8.2
TOTAL 85 100.0
-Anal intercourse
Always/sometimes 22 25.9
Never 63 74.1
TOTAL 85 100.0
-Oral sex
Always/sometimes 77 90.6
Never 8 9.4
TOTAL 85 100.0
-Masturbation
Always/sometimes 72 85.7
Never 12 14.3
TOTAL 84 100.0
Condom use in the last 6 months with clients
-Vaginal intercourse
Always 52 66.7
Never/sometimes 26 ...,..., ...,s s.s
TOTAL 78 100.0
-Anal intercourse
Always 9 40.9
Never 13 59.1
TOTAL 22 100.0
-Oral sex
Always 22 28.6
Never 55 71.4
TOTAL 77 1000
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Table 4.7 (continued) Sexual relationship with clients
Variable N percent
Condom use in the last 6 months with clients (cont.)
Masturbation (n=72)
Always 4 5.6
Never 68 94.4
TOTAL 72 100.0
Usually ask the client to use a condom (n=109)
Yes 88 80.7
No 21 19.3
TOTAL 109 100.0
Behaviour if the client refuses to use a condom (n=87)
Lose the client 46 52.9
Have sex and worry later 17 19.5
Have sex and do not worry 15 17.2
Other 9 10.3
TOTAL 87 100.0
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Table 4.8 Condom use with clients and sharing injecting equipment
Equipment shared
Frequency condom use Yes No Total OR(95 %CI)
Vaginal intercourse
Always 13 39 52(66.7 %) 1(Reference)
Never/sometimes 16 10 26(33.3 %) 4.8(1.6-15.0)
78 (lOO%)
Anal intercourse
Always 3 6 9(40.9 %) 1(reference)
Never/sometimes 6 7 13(59.1 %) 1.7(0.2-14.4)
22 (100 %)
Oral intercourse
Always 7 15 22(28.6 %) 1(reference)
Never/sometimes 22 33 55(71.4 %) 1.4(0.54.6)
77 (100 %)
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6. Reproductive Health
The reproductive and sexual health of the sample population is summarised in Table 4.9. The
majority of women (67.4 percent) reported having irregular periods, although 46.3 percent of
. women had not consulted a health professional about this. Most of the women (89.2 percent),
suggested that their irregular periods were due to drug taking (for which there is a biological
explanation due to hormonal changes). This could confirm the link between heroin and the
female reproductive system and the need to investigate this area which has been largely
unexplored until now. However, the gynaecological effects of HIV may also be an explanation,
and further study is needed in order to explore the possible cause-effect relationship.
As noted above, a women's fertility is partly determined by her ability to conceive. A number of
studies have reported that female IOUs have irregular menstrual cycles, an observation confirmed
by the current data (Table 4.9). It is likely that high prevalence of irregular periods is caused by a
number of interacting factors including the use of opiates (Bai et al., 1989) and other drugs,
stress, weight gain (caused by obesity) and weight loss (caused by anorexia nervosa) (Symonds,
1987). The association between IOU and irregular periods was known by the majority of women
who reported their disorder to be ''because of drugs". It should, however, be noted that the
cessation of menses, concomitant with the use of drugs (and opiates in particular), is due to
amenorrhea and does not imply that a women is infertile (Ralph and Spigner, 1986). This has
been illustrated by the reported increase in fertility of 201 opiate-dependent women on
enrollment into a methadone maintenance programme in Liverpool, UK (Morrison et al.. 1995).
Menstrual abnormalities have also been associated with HIV infection. In a study of 248 pre-
menopausal HIV-infected women without AIDS and 82 HIV-negative women, the HIV-infected
women were found to have an increase in amenorrhea (> 3 months) and in menstrual cycle
intervals (> 6 weeks) and lower rates of premenstrual breast symptoms. Changes in menstrual
fimction were also significantly associated with a past history of, but not current, substance
abuse, suggesting the possibility that socioeconomic factors rather than biologic effects of drugs
may be responsible (Cbirgwin et al., 1996).
Three-quarters (75.7 percent) of women had ever been pregnant, although at the time of the
interview only 4.6 percent of women were pregnant; 21.7 percent of women reported ever
having a miscarriage. One-third experienced their first pregnancy before the age of 18. As a
point of comparison, Spanish demographic indicators from 1995 estimate that the fecundity rate
is 1.13 and that the median age of first birth is 28.6 (Demografia y Salud, 1996). In other words
the study population appears to be experiencing pregnancy at a younger age than the general
population.
Moreover, a number of studies have concluded that female IDUs are as likely to have children as
the general population (reviewed in Wells and Jackson, 1992). The rate of reporting "ever being
pregnant" (75.7 percent) is nearly identical to the 70.0 percent of "ever-pregnant" female IDUs
reported from an American study (Brown. 1989). In a comparison of European countries,
teenage pregnancy rates in Spain (31.3 percent of women were first pregnant between 15-17
years) were siinilar to Germany (30.2 percent) and England (29.9 percent), though lower than
France (40.9 percent) and higher than Italy (16.1 percent) (Estebanez, 1996).
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There are a number of reasons why female IDUs have a higher rate of pregnancy and, in
particular, teenage pregnancy. For example, female IDUs often lead a somewhat "traditional"
lifestyle with low levels of educational attainment and employment (Wells and Jackson, 1992).
Self-esteem is probably low, and it may be perceived that childbirth may break this cycle .
. Although the current data do not provide evidence to examine this hypothesis, the inclusion of a
question on desired family size in future studies may be of use.
Rates of miscarriage, however, appear to be similar to those reported in other countries. For
example, in a household survey of 15 to 59 'year olds in the UK conducted between May 1990 to
November 1991, 20.7 percent of all women reported a lifetime experience of a miscarriage
(Wellings et al., 1994). In Italy, for 1993, the ratio of the number of miscarriages to live-births
was 26.2 percent (Statistiche della Sanita, 1995).
There was a higher rate of voluntary abortions amongst this sample of female IDUs than the
population per se. For example, 39.1 percent of women reported ever having an abortion (Table
4.9). Reasons given for voluntary pregnancy termination included: "Because of drugs" (18.6
percent); "Because I do not want a child/more children" (14.4 percent); "It was too much
responsibility" (25.4 percent); and, "Because I am HIV+" (22.0 percent). The highest reported
lifetime experience of abortion was 15.4 percent amongst women aged 35 to 44 (Johnson et al.,
1994). In Italy, the rate for voluntary abortions was 10.4 percent (Statistiche della Sanita, 1996).
This rate should be considered in light of the findings of a recent study which found that rates of
pregnancy termination doubled after diagnosis with HIV (Stephenson et al., 1996). It should be
noted that there is a considerable deficit in the scientific literature with regard to female IDUs
and pregnancy termination and that the data from the current study are almost unique for Europe.
Close to 45 percent of those interviewed regularly have a smear test Over 16 percent have had an
abnormal result from a smear test at some time in their lives.
There was a high prevalence (28.2 percent, i.e., 100 percent minus 71.8 percent; Table 4.9) of
SID amongst female IDUs. The most common self-reported SID in the last year was
candidiasis (15.8 percent), followed by genital warts (10.3 percent) and herpes (8.4 percent).
Finally, hepatitis B and C were the most commonly reported infectious diseases (25.4 percent and
31.3 percent respectively), although the reliability of these data along with the SID information
has to be queried in light of its self-reported nature.
Compared to other studies, there are variations between the prevalence and incidence of SIDs
probably reflecting social geographical and climatic factors. For example, in a European sero-
prevalence study of mv among patients with SIDs (for both men and women) the most
frequently reported diagnosis was genital warts. The second most frequent diagnosis was male
urethritis followed by chlamydia infections (European Working Group on mv Infection in
Prostitutes, 1993). In a sample of 220 heterosexual female IDUs from Sydney, Australia, 1.4
percent reported ever having syphilis in their lifetime (Ross et al., 1991). More importantly, the
viral SID may be significantly associated with HIV, with injecting drug use facilitating this
process (Musicco et aJ., 1994).
The role of SIDs in transmitting HIV cannot be underestimated. For example, there is
significant evidence that SIDs are the major risk co-factor associated with the HIV epidemic
(Beck et al., 1996). It is likely that conditions that increase the number of lymphocytes in the
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female genital tract, such as SIDs that elicit an inflammatory response, may potentiate the risk of
HIV transmission by increasing the pool of infected cel1s in a seropositive person or the pool of
target cells in a seronegative person (Kreiss et al., 1988). In addition, the high-risk sexual
behaviour of IDUs may fwther exaggerate this problem, although to date the literature on the
. relationship between drug or alcohol use during sexual activity and the likelihood of participating
in high-risk sexual activity is inconsistent (Stall and Leigh, 1994). Nevertheless, in examining
SIDs in a sample of 1245 IDUs (for both sexes) in Sydney, Australia, Ross et al., (1991)
conclude that the lifetime prevalence of SIDs in IDUs is high and that previously recognised
gradients of SIDs across sexual orientation, with homosexual men having generally higher
reported SID rates than heterosexual men, with bisexual men at intermediate risk, is also
apparent For women the pattern was generally consistent with the finding that fewer
homosexual women wou1d have SIDs than heterosexual women. Finally, it is worth
emphasising the relationship between human papillomavirus (HPV) infection of the female
genital tract, cervical cytology, and human immunodeficiency virus (IDV): Increased rates of
positive smear tests among a growing population of young HIV-infected and
immunocompromised women may herald an increase in cervical carcinomas in this popu1ation
(Feingold et al., 1990). Indeed a high rate of invasive cervical cancer among female IDUs with
AIDS has been reported in Italy (Serraino et al., 1996).
As illustrated in Tables 4.9 and 4.10, the type of contraception used by IDUs differs from the
total female population. In the previous five years, a large number had relied on withdrawal as a
means of contraception (40.4 percent). For female IDUs, condoms were the most popu1ar form
of contraception; 84.9 percent reported their use. The pill, which is an inappropriate method for
IDUs due to their hepatic pathology, was used by 42.3 percent of women. This compares to a
survey of a representative sample of Spanish women aged 15 to 49 from 1997 in which the most
utilized contraceptive methods were: condoms (21 percent); the pill (14.26 percent); IDU (5.68
percent); tubal ligation (5.20 percent); withdrawal (1.49 percent); rhythm (0.87 percent);
diaphram (0.29 percent); spermicide (0.10 percent); and others (0.19 percent). Over fifty percent
of the population reported using no methods of contraception (Schering Espaiia, 1997).
It has been suggested that IDUs have a lower uptake of contraceptives due, amongst other factors,
to the (partly misguided) belief that opiates and other drugs cause infertility (Ralph and Spigner,
1986). In the five years preceding the current survey only 4.3 percent of women reported using
no form of contraception (Table 4.9). This finding is in contrast to other studies which have
noted that the use of contraceptives tends to be lower amongst female IDUs than the population
per se. For example, in a study of 115 heroin-addicted women from California, USA, 25.8
percent reported any type of contraception compared to 48.5 percent of a national sample (Ralph
and Spigner, 1986). Likewise, in the study of201 opiate users from Liverpool, UK, 21.4 percent
of women reported condom use compared to 46.5 percent of young women attending British
Family Planning Clinics (Morrison et al, 1995).
Efficacy, safety, and acceptability are all factors which need to be considered when prescribing a
contraceptive method. Further, these factors need to be matched to individuals and communities
(Williamson and Joanis, 1994); that is, whilst one method may be appropriate for the general
population, it may also be inappropriate for IDUs and other marginalised groups. Thus, in light
of the high prevalence of hepatitis amongst IDUs (Table 4.9), the contraceptive pill may be an
inappropriate method. Despite this, and as noted above, 29.9 percent of women surveyed
reported using the contraceptive pill (Table 4.9). It has also been suggested that the use of
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hormonal contraception may be associated with a reduction in the use of barrier contraception
such as the condom. Whilst there is little evidence of this in the current data (81.3 percent of
women report condom use; Table 4.6), another complicating factor is the concurrent use of
petroleum-based lubricants. A recent European study identified the use of petroleum-based
lubricants to be a risk factor for HIV infection in non-IDUs (European Working Group on HrV
Infection in Female Prostitutes, 1993). Another issue to consider is the "dual" use of barrier
contraceptives. A number of studies have suggested a reduction in the rates of sexually
transmitted diseases (SIDs), including HIV, for women who use condoms with a spermicide
(reviewed in Roddy, 1994). Whilst the evidence is not yet conclusive, it is important to stress
that both methods must be used concurrently (Cain and Williamson, 1994).
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Table 4.9 Selected variables describing reproductive and sexual health
Variable N percent
Women reporting regular periods
Yes 99 32.6
No 205 67.4
TOTAL 304 100.0
They have consulted a health professional about this
Yes
No
109 53.7
94 46.3
TOTAL 203 100.0
Why they think the periods are not regular
Because of drugs
Is my constitution
Other
165 89.2
6 3.2
14 7.6
TOTAL 185 100.0
Type of contraception used in last 5years (percentage using each contraception)
Condoms 247 81.3
Withdrawal 123 40.5
Contraceptive pill 91 29.9
Spennicides 45 14.8
IUD 21 6.9
Cap/diaphragm 10 3.3
Depro-provera injection 6 2.0
No contraception used 13 4.3
Ever been pregnant
Yes
No
230 75.7
74 24.3
TOTAL 304 100.0
Are pregnant now
Yes
No
14 4.6
290 95.4
TOTAL 304 100.0
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Table 4.9 (continued) Selected variables describing reproductive and sexual health
Variable N percent
Ever had a miscarriage
Yes
No
66 21.7
238 78.3
TOTAL 304 100.0
Ever had a voluntary abortion
Yes
No
119 39.1
185 60.9
TOTAL 304 100.0
Have a regular smear test
Yes
No
134 44.4
168 55.6
TOTAL 302 100.0
Ever had an abnormal smear test
Yes
No
49 16.2
253 83.8
TOTAL 302 100.0
Self-reported STD, in last year (percentage for each STD) (N=273)
Candidiasis 43 15.8
Genital warts 28 10.3
Herpes 23 8.4
Syphilis 13 4.8
Chlamydia 7 2.6
Gonorrhea 5 1.8
SaJpingitisIPID 0 0.0
Other STD 4 1.5
No STD 196 71.8
Self-reported infectious diseases in last year (percentage for each disease) (N=284)
Hepatitis A 8 2.8
Hepatitis B 72 25.4
Hepatitis C 89 31.3
Hepatitis D 2 0.7
Tuberculosis 45 15.8
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7. Service Use
Before reviewing the results of the survey with regard to services used (Tables 4.10, 4.11 and
. 4.12), it is important to be aware of the limitations of a comparative analysis such as this. As the
data were collected from a convenient sample of female IDUs, information on awareness and
attitudes may simply reflect differences in the sample population studied. For example, if some
female IDUs are interviewed whilst attending a drug dependency clinic, it would not be surprising
that awareness of this service was high. This being said, it is important to review this data because
drug-dependent women are at an increased 'risk for a variety of medical and social problems and
because this burden is shared by a wide variety of public agencies.
The majority of female IDUs reported using health services in the last six months. This is contrary
to the perception that, although women seek medical care more readily than men, female IDUs are
confronted with unique barriers making them less likely to use such facilities r:vv eisner and Schmidt,
1992). For those women who did not use health services in the past six months, 67.2 percent
stated that they "Did not need them". Over half(i.e., 78.1 percent) of the population reported using
GP or primary health services, followed by casualty services (41.4 percent), hospitals (32.1 percent)
and AIDS screening (25.7 percent). The remainder of health services listed in Table 4.10 were
used, on average, by less than ten percent of female mus.
The number of female mus reporting that the health services they used were "very helpful" was
26.5 percent. However, only 57.7 percent of the sample considered the health services used to be
"accessible". The major inference to be made from these findings is that female IDUs find atypical
health services to be more accessible than standard services. Thus it would be appropriate for
female IDUs to be a target group for specific medical care (Dawe, Gerada and Strang, 1992), and
for treatment to be available from a wide variety of public health services r:vv eisner and Schmidt,
1992). It should also be noted, that in a comparison oflDU and homosexual men in the USA, no
difference between recorded satisfaction was found, thus indicating that gender-specific differences
may be limited (Johnston, 1994).
As with the analysis of health services, the type of drug service provided will partly depend on how
the sample population was recruited. However, as primary care for IDUs with HIVI AIDS may be
the responsibility of medical personnel and hospital staff: drug-abuse treatment programmes will
involve a multi-disciplinary team of individuals and agencies (Mondanaro, 1987).
Finally, the provision of social services to both IDUs and HIV-positive women is imperative.
These women are subject to an interplay of psycho-social factors which require the attention of
many different agencies (Harrison, 1989). As part of a multi-disciplinary approach, health and drug
services should be supplemented by complementary social services (Glass, 1993). Despite these
requirements, the current study identifies alarmingly low utilisation of social services by female
roUs. Only 25.7 percent of women had used these services in the past 6 months (Table 4.12).
Moreover, the quality and accessibility of social services was, generally speaking, lower than the
health and drug services. It seems likely that some of the non-utilisation is caused by administrative
problems and lack of accessibility.
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Drug-using women have multiple health-care, drug-treatment and social-service needs. A multi-
disciplinary, multi-agency approach is needed to meet these requirements. However, policy makers
must be aware that many women may believe that these services do not meet their needs and it is
therefore important that gender-specific policy be implemented. Indeed, the preceding review of
the provision of health, drug, and social services demonstrates that female IDUs utilise a wide range
of different facilities. Because drug-dependent women are at an increased risk from a variety of
medical and social problems (Mondanaro, 1987), it is appropriate that policy should focus on a
range of settings including, for example, medical centres, mobile drug units, the criminal justice
system, welfare agencies, etc., (Weisner andSchmidt, 1993). In implementing such a policy it is
important the providers are aware that treatment is available from a number of sources and that low
utilisation may not necessarily impact on the effectiveness of a particular service (Weisner and
Schmidt,1992). It is encouraging to note the relatively high utilisation of services by female mus
in Europe (Estebanez, 1996). Indeed this contradicts perceived opinion which may have been
formulated from studies based in the USA. The fact that European countries predominantly
operate public (as opposed to private) health services may qualify a number of findings made based
on the American system.
Policy discussion should consider the nature and quality of health, drug and social services utilised
by female IDUs, and progranunes must assist drug-dependent women to escape from a passive role
(Mondanaro, 1987). Again, these data seem quite encouraging in this regard in light of the low
number of women who reported that they "did not care" when asked why they did not utilise a
specific service. Furthermore, treatment goals should continue to be based on a policy of harm-
reduction with the specific aim of retaining women in any treatment/maintenance programme.
Less encouraging is the heterogeneity of services, emphasising the need for a European programme
of standardisation. This is especially important for social policy which, according to these data, has
failed in the delivery of services to female mus and HrV women in Europe (Estebanez, 1996).
Likewise, any European (or Spanish) policy should be specifically targeted at women as these data
suggest that policy to date is non-gender-specific (hence the low provision of family planning
services).
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Table 4.10 Type of health services used by pooled female IDUs
Variable N percent
Ever used health services in last 6 months
Yes 237 78.0
No 67 22.0
TOTAL 304 100.0
Why never used health services
I did not need them 45 67.1
I did not care 9 13.4
Too faraway 4 6.0
Administrative problems 4 6.0
Personal or social problems 3 4.5
No medical insurance 2 3.0
TOTAL 67 100.0
Health services used (percentage using each service) (n=237)
GP or primary health care 185 78.1
Out-patient clinic 47 19.8
Casualty hospital 98 41.4
Hospital 76 32.1
Family planning 9 3.8
SID clinic 7 3.0
Psychiatric settings 6 2.5
Private sector 30 12.7
AIDS screening 61 25.7
Quality of health services used (n=237)
Useless 23 9.7
Not very helpful 36 15.2
Helpful 116 49.0
Very helpful 62 26.1
Accessibility of health services (n=237)
Not accessible 25 10.5
Accessible 137 57.8
Very~ible 75 31.7
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Table 4.11 Type of drug services used by pooled female IDUs
Variable N percent
Ever used drug services during last 6 mo~ths
Yes 249 82.2
No 54 17.8
TOTAL 303 100.0
Why never used drug services
Idid not need them 24 44.4
Idid not care 13 24.1
No confidentiality 9 16.7
Too faraway 4 7.4
Personal or social problems 3 5.5
Administrative problems 1 1.9
TOTAL 54 100.0
Drug services used (percentage using each service) (n=249)
Mobile drug-dependency unit 178 71.5
Drug dependency units 94 37.8
Out-patient rehabilitation centre 56 22.5
Methadone distnbution centre 54 21.7
Therapeutic community 31. 12.4
Residential rehabilitation centre 15 6.0
NGO, self-help groups 9 3.6
Quality of drug services used (n=249)
Useless
Not very helpful
Helpful
Very helpful
13 5.2
25 10.0
125 50.1
86 34.6
Accessibility of drug services (n=249)
Not accessible
Accessible
Very accessible
29 11.6
120 48.2
100 40.2
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Table 4.12 Type of social services used by pooled female IDUs
. Variable N percent
Ever used social services during last 6 months
Yes 78 25.7
No 225 74.3
TOTAL 303 100.0
Why never used social services
I did not need them 89 40.1
I did not care 43 19.4
Administrative problems ··38 17.1
Service refused 19 8.6
Personal or social problems 1I 5.0
No confidentiality 10 4.5
Long waiting list 6 2.7
Too faraway 3 1.3
No social benefit 3 1.3
TOTAL 222 100.0
Social services used (percentage using each service) (n=78)
Children support services 36 46.2
Services providing financial help 19 24.4
Housing services 18 23.1
Support specific for drug users 15 19.2
Legal assistance 15 19.2
Quality of social services used (n=78)
Useless 3 3.9
Not very helpful 10 12.8
Helpful 37 47.4
Very helpful 28 35.9
Accessibility of social services (n=78)
Not accessible 15 19.2
Accessible 49 62.8
Very accessible 14 18.0
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8. Conclusion
The foremost conclusion to be drawn from this descriptive analysis of the characteristics of
female IDUs is the low socioeconomic characteristics. Moreover, it is also worth noting that the
. population is pretty homogenous; that is (on average), the sample of female IDUs examined
represents a very marginaJised population located in Madrid. This has major implications for the
forthcoming analysis of ffiV prevalence (Chapter 5), drug use and prostitution (Chapter 6), and
drug use and prisons (Chapter 7). It is therefore essential that the reader is consistently aware of
the exceptional nature of the sample population. That is, in analysing the results of this project,
the applicability of research and policy conclusions has to be put in context
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Chapter Five
Determinants ofHIV amongst Female IDUs
1. Introduction
ffiV prevalence in Spain is one of the highest in Europe, as noted in Chapter 1. A study of drug
users receiving ambulatory treatment in Spain (the majority of which were men), reported
significant variation in fllV seropositivity by the 17 autonomous regions (Lardelli et al., 1993).
For example, the lowest rate was for Navarre (14.3 percent) and the highest rate in La Rioja (66.7
percent). The rate in the community of Madrid was 46.3 percent. The current study found an
ffiV prevalence of 52.6 percent amongst the 304 female IDUs (see Table 5.1). After adjusting for
the 15.5 percent of women with unknown test results, the headline prevalence rate of HIV
amongst female IDUs was 62.3 percent (for n = 257). Although this rate appears to be
surprisingly high, one needs to reconsider the population from whence it came. This is an
extremely marginalised group of women with a multitude of possible risk factors, living in the
largest metropolitan area of a country with one of the highest rates ofHIV in Europe. In fact, this
study has perhaps succeeded in capturing a sample of a population which most likely represents
one of the highest risk subgroups in Europe.
The purpose of this chapter is to explore the multitude of possible risk factors associated with
HIV in this population of female IDUs and to develop a model to explain and/or examine direct
and indirect determinants ofHIV.
2. Methods
The methods used for this study are descnbed in Chapter 3. The sample size for this chapter is
257, as 47 cases were removed because the fllV status was unknown. In a majority of cases (97.3
percent) mv status was determined from a medical report.
First, a bivariate analysis will be conducted to identify significant relationships between mv and
a variety of independent variables. As concluded in Chapter 4, the sociodemographic
characteristics of female IDU describe a marginalised population with a low socioeconomic
status. Whilst none of the significant risk factors associated with HIV infection are known to
have a direct causal effect, the status of the population acts as a generic proximate determinant of
HIV infection. Through the analysis of specific risk-taking and risk-avoiding behaviours it may
be possible to identify specific proximate determinants of HIV infection. In doing so, it is
important to be aware of the limitations of bivariate analysis where, for example, specific risk
factors may be either confounding and/or interacting with other risk factors.
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The only variation from the methods described in Chapter 3 occurs in the logistic regression
model in which the following five groups of explanatory variables have been identified:
Group 1: Age
. Biological age is the first explanatory variable entered into the model because of its known
relationship with HIV, as well as its influence on other independent variables.
Group 2: Socioeconomicstatus
Three variables were selected to define the general socioeconomic status of female IDUs: age left
full-time education; source of income during past six months (illegal and prostitution versus
legal); and, place of residence in past six months (no fixed abode versus abode). Each of these
factors has been identified in prior research as having an influence on HIV status (see literature
review in Chapter 1).
Group 3: Marginalisation
In addition to socioeconomic status, three variables were chosen to characterise the extreme
marginalised nature of the sample population. These dichotomous variables were: previous
imprisonment; having a regular partner who is an lDU; and prostitution. A number of earlier
studies have identified these variables as potential determinants of HIV status (see Chapter 1).
Group 4: Sexual and drug-taking risk behaviour
Specific known risk behaviours of HIV infection were included in the fourth group. These
included: the average number of clients a female IOU has had per month for the past six months
(coded into four categories: never, i.e., not a prostitute; no clients, i.e., an ex-prostitute; 1 to 60
clients; and, 60+ clients); age at first injection; condom use; cocaine injection; heroin+cocaine
injection; and a regular fITV-positive sexual partner. All of these risk behaviours were selected
based on evidence from previous research of their potential or known influence on HIV status.
Group 5: Co-infection
The final group contained two dichotomous variables which are known to facilitate the
transmission of I-llV: hepatitis B and other sexually transmitted diseases (SIDs). There is a
variety of evidence to suggest that previous SIDs are independently associated with HIV
infection (see Chapter 1).
3. Results
First the bivariate relationships with HIV and selected independent variables are examined (see
Table 5.2). Then findings from the regression analyses will be presented
3.1. Sociodemographic characteristics and HIV prevalence
Several of the sociodemographic variables had significant relationships with HIV prevalence.
First. there was a significant positive association with age at time of interview and HIV
prevalence. For example, HIV prevalence was 49.1 percent for women aged 24 or less compared
to 68.1 percent for women aged 35 or more. The linear trend test was significant. This
association is most likely a function of exposure, as opposed to a direct determinant of fllV.
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Second., those women who left full-time education before they were 13 years old (only 29.1
percent; Table 4.1; Chapter 4) were twice as likely to be HIV-positive than those who left school
at age 16 or older.
. Imprisonment since first injection was also significantly associated with HIV prevalence, with
those who had been in prison since their first injection nearly three times more likely to be HIV-
positive.
Finally, not having a fixed address also nearly tripled the risk for HIV infection.
3.2 Drug-using habits and mv prevalence
Age at first injection was significantly negatively associated with HIV prevalence. Those who
started injecting by age 16 were three times more likely to be HIV -positive than those who started
at age 20 or later.
Needle and/or syringe sharing was also significantly related to HIV prevalence. More surprising
was a significant negative association found between needle sharing in the last six months and
mv prevalence. Inother words, it would seem that those women who were aware that they were
HIV-positive have ceased sharing needles.
Finally, it is worth mentioning that of the 89 women who reported having been in prison. 34.8
percent reported injecting whilst in prison and 87.1 percent of these were HIV-positive. Although
the relationship did not attain statistical significance (Table 5.2), it is worth noting that the very
high rate of HIV amongst female IDUs who injected drugs in prison probably reflects a
cumulative aggregation of risk factors. The association between female !DU and previous
imprisonment will be explored further in Chapter 6.
3.3. Sexual habits and mv prevalence
Significant relationships were found with mv prevalence for ever having had an HIV sexual
partner, a casual sexual partner, a casual IDU sexual partner, a casual I-llV sexual partner, and a
client.
The frequency of condom use for vaginal intercourse with a regular sexual partner was negatively
associated with the dependent variable, whereas no significant relationships were found for
condom use with a casual sexual partner or casual client. The latter finding suggests that those
who are IDV-positive are more inclined to always use condoms with their regular partners.
3.4 Reproductive health and mv prevalence
The information collected on the relationship between reproductive and sexual health and HIV
infection amongst female IDUs is, as far as we know, almost unique. Moreover the sample
population is consistent with the atypical characteristics of a marginalised population. The
majority of women reporting not having regular periods are mv -positive, Another interesting
result, which would also require further research to identify a causal effect, was the women who
reported an abnormal smear test. These women also reported a higher prevalence of mv which
may have arisen due to the higher risk ofHIV infection for women with cancerous cells.
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A number of studies have suggested that pregnancy may be a risk factor for HIVinfection.
Although as yet there is no consensus, the bivariate analysis suggests that "ever-pregnant" women
are 2.2 times more likely to be infected by HIV.
Another important observation with regard to contraceptive use, was the high (although non-
significant) rate of HIV prevalence amongst women who use spermicides, This confirms a
previous observation which speculated that the use of petroleum-based products has a detrimental
effect on effectiveness of condoms as a barrier contraceptive and thus is associated with an
increased risk in HIV infection (European Working Group on H1V Infection in Female
Prostitutes, 1993).
Finally, there was a high prevalence of SIDs amongst female roUs, which was significantly
associated with HIV. For example, HIV prevalence amongst women who had no STD disease in
the last year was 50.0 percent versus 81.9 percent who had a STD. Approximately one-quarter of
the women interviewed reported having had hepatitis B, and this was also significantly related to
being HIV-positive.
3.5. Results of bierarcbicallogistic regression analysis
The results of the first stage of the analysis can be found in Table 5.3. A number of observations
can be made from these results. First, as illustrated by the significant decline in the -2 log
likelihood (-2LL) value, each model is an improvement on the preceding model with the sole
exception of Stage 1 (which measured the improvement - i.e., 7.89 - from the constant value to
the addition of the age variable). The second observation regards the variables that are eliminated
from the model. These are: source of income; regular partner who is an IOU; number of clients
per month; condom use; heroin+cocaine injection; prostitution; age at first injection; and,
hepatitis B infection. It is important to realise that although. these variables are not included in the
model, they may still be indirectly related to HIV. Third, for those variables included in the final
model (Group 5), a regular partner who is mv-positive is by far the most important variable (i.e.,
OR = 12.2). Other significant factors revealed in the final model include: age 35 and over, no
fixed address; ever shared needles; and co-infection with an STD.
It should be noted that although a direct association with mv is often detected as a variable and is
introduced in the model, thereafter this association seems to become indirect. For example, in
Groups 1,2 and 3 the age group 30-34 is a significant predictor ofHIV serostatus (OR = 2.7,3.7
and 3.1 respectively). However, for Groups 4 and 5, when other variables are introduced, the size
and significance of the association declines.
4. Discussion
This chapter analyses the variety of factors including age, socioeconomics, marginalisation, risk
behaviours, arid co-infections that may be determinants of the HIV serostatus in an urban
population of female IDUs. Before making any conclusions from these data, it is worth
reiterating the limitations of this study. As noted in Chapter 3, a cross-sectional study is carried
out at just one point in time and therefore it only measures prevalence as opposed to the incidence
of a disease. Furthermore, as the period of time which has elapsed since infection is unknown,
the data may be biased with regard to factors associated with disease progression. Another
limitation to the adopted study design, was the necessity to use a convenience sample as opposed
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to an equal probability scheme. Given these limitations it should also be noted that the
multivariate logistics regression model does not examine risk factors (i.e., determinants) of mv,
but looks at statistical association in the data-set. For example, variables concerning risk
behaviour during the whole injecting career (such as imprisonment) are included with variables
. concerning risk behaviour in the previous six months (such as shared needles/syringes in last six
months).
Keeping in mind the caveats of this analysis described above, and the fact that mv prevalence in
Spain is one of the highest in Europe, a number of preliminary inferences can be made from these
results.
First, it appears the sexual behaviour of these women is one of the strongest determinants of mv
infection. As unequivocally demonstrated in the regression analysis, having a partner who is
HIV-positive increases the likelihood of mv infection. Although the study design precludes us
from making asswnptions about directionality of this relationship, we believe it is more likely that
the women are being infected by their male partners than the reverse based on scientific evidence
suggesting that the relative efficiency of male-female transmission is two to three times more
efficient than that of female-male transmission (Nicolosi et al., 1994a). Given that nearly 50
percent of this population offemale IDUs reported having a regular partner who is HIV-positive,
the importance of this factor cannot be underestimated, Clearly, one of the important conclusions
to be made from this study is that the sexual partners of female IDUs are as important a
component in explaining the mv epidemic in this population as other risk factors, including high-
risk drug-taking behaviour. Accordingly, and as discussed in further detail in Chapter 8, policy
should emphasise this and provide information to female IDUs on reducing sexual risk behaviour.
For example, the relatively low use of condoms with regular partners reported in Table 4.3
(Chapter 4), needs urgent attention.
Another sexual behaviour which warrants attention is prostitution. Although not an important
factor in the regression analysis, sexual behaviour with a client did have a significant relationship
with HIV prevalence, which has been demonstrated in previous studies in other western countries
(Serraino et aI., 1991; Zunzunegui et al., 1992). Another interesting. although non-significant,
observation was the normal distribution with the average number of clients per month (not shown
in Table 5.2). This has also been previously shown for prostitute populations in Amsterdam
(Fennema et al., 1995) and Spain (Estebanez et al., 1996) where it has been suggested that after a
certain point HIV prevalence decreases as women become more professional and reduce their
risk- taking behaviour. It should also be noted that as mentioned above, IDV infection is more
likely to be transmitted from men to women and that this pathway could be a contributory factor
in HlV infection amongst female prostitutes (Nicolosi et al., 1994a).
The sharing of injecting equipment was also a significant determinant in the regression analysis.
This finding was not too surprising, as a number of studies have demonstrated that the sharing of
drug-injecting equipment is a principal risk factor associated with the transmission ofHIV in IOU
populations (e.g., Marmor et al., 1987; Des Jarlais, 1992; Nicolosi et al., 1992; Vlahov et al.,
1990; Sasse et al., 1989; and Serraino et al., 1991). The fact that there is also a negative
association between sharing injection equipment in the last six months and mv prevalence is
good news. Apparently those women who were aware that they were IDV-positive have ceased
sharing needles. This is an observation that has been noted elsewhere (Delgado-Rodriguez et al.
1994), and emphasises the need for policy makers to provide easily accessible voluntary testing
facilities to marginalised groups. A more in-depth look at the sharing of injection equipment in
this population is undertaken in Chapter 8.
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Age appears to have a direct as well as indirect influence on HIV status. One interpretation of
this direct relationship found between age and HIV prevalence is that there is an exposure effect:
the older an IDU gets the more likely she will become infected with the HIV virus. However" it
is also important to consider a recent study by Castil1a et al. (1997), who found a relationship
. between specific birth cohorts and AIDS incidence amongst Spanish roUs. The cohorts with the
highest incidence of AIDS were born between the late-1950s to the late I960s. The authors
suggest that this peak in incidence possibly reflects the spread of injection drug use in Spain
(particularly heroin) since the late 1970s. This peak roughly corresponds to the users in our study
between the ages of27 and 37, offering another possible explanation of the higher prevalence of
HIV in the older age groups. However" this finding should not direct interest away from the
younger age groups which are experiencing higher rates of HIV incidence, particularly among
heterosexuals (Houweling, 1998). The indirect influence of age on HIV prevalence will be
studied further in subsequent chapters in which we will look at its relationship to prostitution,
imprisonment, and treatment attendance.
The direct relationship between no fixed address and HIV prevalence is also an interesting result
Very few studies have looked at the relationship between homelessness and HIV prevalence in
IDUs. Given that earlier studies have noted more HIV risk practices among the homeless (Fisher
et al., 1995; Nyamathi et al., 1997), we anticipated an indirect relationship between homelessness
and.HIV prevalence with risk behaviours and prostitution acting as intervening variables. We
were surprised to find in our model that the addition of "risk behaviour" actually improved the
relationship between no fixed address and HIV prevalence, and the addition of "STD co-
infection" only weakened the relationship slightly. Although more research needs to be done to
replicate this finding in other IDU populations and to establish the directionality of this
relationship, public health officials ought to consider that this may be an important subgroup of
IDUs to target with HIV prevention interventions.
The association found between "ever being pregnant" and HIV (OR=2.2;CI= 1.2 to 4.0; Table 5.2)
is an important finding of this study. Although we did not find evidence of a direct relationship
with.HIV infection in this study, we do feel it is important to consider as an indirect determinant.
The relationship between mv infection and pregnancy has been the subject of various studies. It
is possible that pregnancy may accelerate progression to AIDS through temporary
immunosuppression during which women are at greater risk of contracting infections
(Schoenbaum et al., 1988). A number of studies have concluded that female IDUs are as likely to
have children as the general population (reviewed in Wens and Jackson, 1992). In the current
sample, 75.7 percent of women reported "ever being pregnant" (Table 4.6). This is nearly
identical to the 70.0 percent of "ever-pregnant" female IDUs reported from an American study
(Brown, 1989). There are a number of reasons why female IDUs have a higher rate of pregnancy
and, in particular, teenage pregnancy. For example, female IDUs often lead a somewhat
"traditional" lifestyle with low levels of educational attainment and employment (Wells and
Jackson, 1992). Self-esteem is probably low, and it may be perceived that childbirth may break
this cycle. Although the current data do not provide evidence to examine this hypothesis, the
inclusion of a question on desired family size in future studies may be of use.
A number of studies have also suggested that pregnancy itself may be a risk factor for HIV
infection. Although as yet there is no consensus, the current data suggests that "ever-pregnant"
women are 2.2 times more likely to be infected by HIV. What cannot not be disputed is the
increase in the number of IDV-infected pregnant women. Indeed this is probably a reflection of
the sociodemographic characteristics of HIV in women. In Europe, for example, 76 percent of
HIV-infected females are in the 15-49-year age group. It is therefore important that policy makers
and public health practitioners alike are aware of the effects of pregnancy on the natural history of
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HIV. It has been suggested that HIV pregnant women may be susceptible to atypical
immunological changes and that this would facilitate the progression from HIV to AIDS. To
date, studies examining immunological changes have produced contrasting results. More
evidence, However" is available with regard to the effects of drug use. Whilst there seems to be
. no relationship between opiate use and disease progression, there is evidence that continued IDU
may accelerate progression from IDV to AIDS. Although there is no evidence of gender-specific
differences in the progression rate, the interaction of pregnancy and/or IDU with IDV-infected
women makes this likely. The confused state of knowledge with regard to the reproductive health
of pregnant women demonstrates the need for cohort studies to examine the association between
IDV/AIDS and pregnancy.
Another important finding is the relationship between co-infection with an SID and HIV
prevalence. As noted throughout the previous chapter, the relationship between SID and IDV is
well reported. The fact that SID co-infection is a significant risk factor in the final logistic
regression model (i.e., Model 5 in Table 5.3) of the multivariate analysis re-enforces this finding.
As also noted previously, this is most likely due to the ease with which HIV can be transmitted
following ulcerations, weakening of the tissues, and other physical changes associated with SIDs
(Holst et al., 1987). As discussed in Chapter 4, it has also been suggested that IDU facilitates this
process (Musicco et al., 1994). However" there is much discussion as to whether or not the
relationship between IDV and SIDs is a direct or indirect relationship (Beck et al., 1996). Direct
transmission could be facilitated by breaks in the anatomical barriers due to ulcerating diseases,
like genital ulcers and warts. Alternatively, since infected monocytes and macrophages constitute
a main reservoir of HIV in infected individuals, they could act as transport vehicles for the virus
within the infected host and between individuals. Thus effective and inexpensive containment
strategies would include antimicrobial treatment for SIDs and prevention of infection (via
condom use) in non-infected individuals (Beck et al., 1996; Kreiss et al., 1988).
Previous imprisonment and injection whilst in prison are factors that need further attention. The
results of the current study revealed that a third of the women who had been to prison injected
drugs whilst in prison, and that this was associated with HIV infections (although the result was
non-significant). A previous study into the prevalence ofHIV amongst IDU prostitutes identified
imprisonment as an important determinant (Estebanez et al., 1995). In that paper, it was
questioned if previous imprisonment was acting as a generic marker for a marginalised
population or if it was a causal risk factor ofmv infection. Likewise, a multifactorial analysis of
612 IDUs in Berlin, revealed that the most important risk factor for IDV infection was needle
sharing in prison (Muller et al, 1995). Thus, regardless of whether there is a direct relationship
between imprisomnent and HIV prevalence, or imprisonment is merely acting as an indicator of
high-risk behaviour whilst outside of prison, the fact that we have identified an association
between HIV infection and imprisonment (and that there is also an association between HIV
infection and injecting in prison) presents a major challenge to public health practitioners. Drugs
are apparently readily available in prison whilst the availability of sterile syringes and needles
and/or disinfectant is limited. Therefore it would seem that drug behaviour in prison is a factor
which requires further research, and is examined further in Chapter 7.
Finally, this model needs to be validated on another independent group of women. Conceptual
models of disease determination, such as the model presented here, are going to be of much use to
policy makers.
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5. Conclusions
C Sexual behavior plays an important role in determining HIV serostatus in IDU women.
. C Those who continue to share injection equipment are at a high risk for contracting HIV, and
those aware of their HIV-positive status appear to be discontinuing this practice.
C Co-infection with an SID is an important marker for those at risk for HIV.
C The roles of imprisonment and pregnancy in the transmission of HIV need to be further
studied with prospective cohorts.
C It is important to note that the aim of this study was not to prove causal relationships with
I-llV, but to identify factors which can provide guidelines for the formulation of policy.
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Table 5.1 Selected variables describing HIV prevalence
. Variable N percent
Ever been tested for HIV (N=304)
Yes 292 96.1
No 12 3.9
No response 0 0.0
Outcome of past HIV test (N=292)
mv+ 166 54.6
arv . 124 40.8
Not applicable/No response 12 4.6
Sample taken for current aN test (N=304)
Yes 7 2.3
No 297 97.7
Written confirmation of aN test (N=304)
Yes 257 84.5
No 47 15.5
Current RIV prevalence (N=304)
mv+ 160 52.6
nrv- 97 31.9
Not known 47 15.5
Headline HIV prevalence (N=257)a
arv- 160 62.3
mv- 97 37.7
a Headline rate excludes not-known current mv prevalence results.
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Table 5.2 HIV prevalence" by selected variables
Variable Total HIV OR(O.95 %} P
+(%) -(%)
Sociodemographics
Age
24 or less 57 49.1 50.9 1(reference) *a
25-29 89 61.8 38.2 1.7(0.8-3.5)
30-34 69 72.5 27.5 2.7( 1.2-6.1)
350rmore 47 68,1 31.9 2.2(0.9-5.4)
Age left education
13 or less 74 73.0 27.0 2.2( 1.1-4.3) *a
14-15 74 63.5 36.5 1.4(0.7-2.7)
16ormore 112 55.4 44.6 1(reference)
Been in prison since first injection
Yes 89 77.5 22.5 2.8(1.5-5.0) ***
No 173 55.5 44.5
Abode
No fixed address 57 78.9 21.1 2.7( 1.3-5.3) **
Fixed address 205 58.5 41.5
Income
lllega.l+prostitution 122 67.2 32.8 1.4(0.8-2.4) n.s.
Legal 140 59.3 40.7
Drug-using habib
Age began injecting drugs
16 or Jess 74 78.4 21.6 3.1(1.5-6.4) **~
17 -19 71 62.0 38.0 1.4(0.7-2.7)
20ormore 117 53.8 46.2 1(reference)
Ever shared needles/syringes
Yes 203 70.9 29.1 4.3(2.3-8.0) **.
No 58 36.2 63.8
Ever shared needles/syringes in last 6 months
Yes 93 61.3 38.7 0.4(0.2-0.8) .*
No III 78.4 21.6
Injected in Prison
Yes 31 87.l 12.9 2.6(0.8-8.5) n.s.
No 58 72.4 27.6
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Table 5.2 (continued) mv prevalence by selected variables
Variable Total HIV OR{U95 %} (!
+(%) -(%)
Sexual habits
Ever had a regular sexual partner
Yes 254 62.6 37.4 0.6(0.1-2.8) n.s.
No 8 75.0 25.0
Ever had a regular sexual IDU partner
Yes 226 64.6 35.4 1.6(0.8-3.3) n.s.
No 36 52.8 47.2
Ever had a regular sexual HIV partner
Yes 133 88.0 12.0 14.4(7.5-27.6) ***
No 116 3J6 66.4
Frequency of condom use with regular sexual partner
-Vaginal intercourse
Never/sometimes 99 47.5 52.5 0.3(0.1-0.7) **
Always 33 75.8 24.2
Ever had a casual sexual partner
Yes 216 68.1 31.9 3.3(1.7-6.4) ***
No 46 39.1 60.9
Ever had a casual sexual IOU partner
Yes 145 75.2 24.8 3.6(2.1-6.1) ***
No III 45.9 54.1
Ever had a casual sexual HIV partner
Yes 52 86.5 13.5 6.5(2.8-15.4) **.
No 149 49.7 50.3
Frequency of condom use with casual sexual partner
-Vaginal intercourse
Never/sometimes 45 71.1 28.9 0.9(0.3-2.3) n.s.
Always 38 73.7 26.3
Ever had a client
Yes 128 68.8 31.3 1.6(1.0-2.7) •
No 134 57.5 42.5
Frequency of condom use with casual client
-Vaginal intercourse
Never/sometimes 24 62.5 37.5 0.8(0.3-2.3 ) n.s.
Always 48 66.7 33.3
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Table 5.2 (continued) HIY prevalence by selected variables
Variable Total HIY OR{CI.95 %} [2
+(%) _ (0/c)
Reproductive habits and infections
Regular periods
No 187 71.1 28.9 3.3(1.8-6.0) ***
Yes 75 42.7 57.3
Age at first pregnancy
< 18 62 71.0 29.0 1.3(0.7-2.5) n.s.
18 or more 136 65.4 34.6
Contraception currently
Yes 134 64.2 35.8 1.1(0.7-1.9) n.s.
No 124 61.3 38.7
IUD used in last 5 years
Yes 19 36.8 63.2 0.3(0.1-0.8) *
No 243 65.0 35.0
Condom used in last 5 years
Yes 223 65.0 35.0 1.8(0.9-3.5) n.s.
No 39 51.3 48.7
Spermicide used in last 5 years
Yes 41 73.2 26.8 1.7(0.8-3.6) n.s.
No 221 61.1 38.9
Contraceptive pill used in last 5 years
Yes 76 38.2 61.8 0.2(0.1-0.4) •••
No 186 73.1 26.9
Ever been pregnant
Yes 202 67.3 32.7 2.2(1.2-4.0) **
No 60 48.3 51.7
Abnormal smear test
Yes 44 75.0 25.0 2.6(1.2-5.6) >I<
No 142 53.5 46.5
STD in last 5 years
Yes 72 81.9 18.1 4.5(2.2-9.5) ***
No 162 50.0 50.0
Hepatitis A in last 5 years
Yes 8 100.0 0.0 *
No 238 60.5 39.5
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Table 5.2 (continued) HIV prevalence by selected variables
Variable Total HIV OR(CL95 %} U
+(%) -(%)
Hepatitis B in last 5 years
Yes 67 76.1 23.9 2.5(1.3-4.7) **
No 179 56.4 43.6
Hepatitis C in last 5 years
Yes 84 59.5 40.5 0.9(0.5-1.5) n.s.
No 162 63.0 37.0
Hepatitis D in last 5 years
Yes 2 100.0 0.0 n.s.
No 244 61.5 38.5
Tuberculosis in last 5 years
Yes 45 86.7 13.3 5.1(2.1-12.5) ***
No 201 56.2 43.8
Some infection last year
Yes 139 68.3 31.7 1.9(1.1-3.3) *
No 107 53.3 46.7
Type of Treatment
Methadone maintenance 64 79.7 20.3 4.7(2.0-10.9)***
Other treatment 128 64.1 35.9 2.1(1.1-4.0) *
No treatment 70 45.7 54.3 1.O( reference)
a: p value of linear trend test.
b: IDV prevalence is the headline rate presented in Table 5.1 and excludes not-known cases.
Figures presented as percentages.
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Chapter Six
HIV, Drugs and Prostitution:
An Examination of the Determinants of Prostitution
amongst Female IDUs
1. Introduction
The close links between IDU and prostitution have been known for some time. For example,
Goldstein (1979) suggested that between 30 to 70 percent of female IDUs were also prostitutes,
and that 40 to 85 percent of prostitutes were also drug users. More recently, studies have
reported broadly similar findings (see Gossop et al., 1994). However, differences in rates have
been reported by other studies, and these probably reflect real differences in sociocultural context
as well as differences in sampling. Nevertheless, as noted by Gossop et al. (1994), there is
consistent evidence of an association between drug use and prostitution. Thus, with the
emergence of the AIDS pandemic, the nature of this relationship has assumed increased
importance.
At the beginning of the AIDS pandemic, it was thought that female sex workers, or prostitutes,
might constitute a high-risk group for the transmission of the human immunodeficiency virus
(HlV). Based on prevalence studies that showed high rates of infection in African prostitutes, it
was feared that such women might also be spreading mv heterosexually in Europe and the
United States. This beliefhas resulted in even greater stigmatisation of sex workers, and in some
places has led to restrictive legislation, such as mandatory HIV testing and the quarantine of
infected persons (Committee on AIDS Research and the Behavioural, Social and Statistical
Sciences, 1990).
Prostitutes, however, are a heterogeneous group in regard to their working environment,
socioeconomic situation, health status, and their knowledge and practice of protective measures.
Seroprevalence rates in this group vary a great deal from country to country, within the same
country, and from one type of prostitute to another. More than sexual promiscuity itself, mv
infection has been seen to be associated with other risk factors, such as the use of intravenous
drugs, having a steady partner who is an intravenous drug user, and the presence of sexually
transmitted diseases (Hankins et al., 1994).
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The justification for taking an in-depth look at prostitution arises from its importance in this
community. It will be recalled from Chapter 4 that 46.1 percent of female IDUs reported ever
having a client. It is therefore of interest to examine the characteristics of female IDU prostitutes
and to see how. if at all. policy should differ for this subgroup of women. The objectives of this
chapter are to:
1)Look at the relationships between IDU, HIV risks, and prostitution;
2) Examine the determinants of prostitution amongst our study population of female IDUs; and
3) Propose some directions for future research as well as interventions that could be undertaken
to reduce risk behaviours and the practice of prostitution.
98
2. Methods
. The methods used for this study, including the bivariate and multivariate analyses, are described
in Chapter 3. The only variation from those methods occurs in the logistic regression model in
which the following four groups of explanatory variables were identified:
Modell: Age
Biological age is the first explanatory variable entered into the model because of its anticipated
relationship with prostitution among IDUs, as well as its influence on other independent
variables.
Model 2: Socioeconomicstatus
Three variables were selected to define the general socioeconomic status of female IDUs: age left
full-time education (coded into four categorical age groups: 13 or less; 14-15; 16-18; and 19+);
place of residence in past six months (no fixed abode versus abode); and living with children
(coded into three categories: has no children; has children and lives with them; and has children,
but doesn't live with them). These variables were selected based on evidence in the literature that
they are important socioeconomic markers for this population.
ModeI3:~rgjnaIWatioo
In addition to socioeconomic status, five variables were chosen to characterise the extreme
marginalised nature of the sample population. These variables were: one categorical variable -
age at first pregnancy (coded into two groups: younger than 18 and 18 or more), and four
dichotomous variables (yes versus no): previous imprisonment; having a current regular partner;
having a regu1ar sexual partner who was an IDU; and having a casual sexual partner who was an
IDU. All of these variables have been documented in the literature as having a relationship with
prostitution. Early sexual experience, for example, has been described as a determinant of
prostitution (James and Meyerding, 1971) and a marker for risky sexual behaviour in women
(Greenberg et aI., 1992). Prison experience has been noted as an important determinant offITV
risk amongst prostitutes in Spain (Estebanez et al., 1992). Finally, it has been found that
prostitutes engage in more risky sexual behaviour (e.g. less frequent condom use) with non-
paying partners (Ward et al., 1993) and that having an IDU partner is a predictor offITV amongst
non-IOU prostitutes (Estebanez et al., 1992).
Model 4: Risk behavioun aod HIV seroprevalence
Specific known risk behaviours and HIV seroprevaIence were entered into this model to assess
whether the relationships with prostitution are direct or mediated through the socioeconomic and
marginalisation variables.
The risk behaviours included: ever having regular IDV-positive partner; cocaine injecting;
heroin+cocaine injecting; age at first injection; ever sharing needles; age at first injection and
using alcohol. IDV seroprevaIence was coded into three groups: positive, negative, and unknown.
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3. Results of Descriptive Analysis
The principal data from the descriptive analysis are presented in Table 6.1. Amongst the IDUs of
our study, 46.1 percent (140 women) reported having ever practiced prostitution, of whom 39.3
. percent (55) were considered ex-prostitutes, having not had a client in the six months prior to the
interview, another 15.0 percent were characterised as having a low level of promiscuity with
fewer than 50 clients per month, while 42.9 percent were high promiscuity, having 50 or more
clients per month.
When the date of initiating prostitution was compared to the date of initiating drug use, we found
that drug use was initiated first in 79.3 percent of the cases, prostitution came before drug use in
12.1 percent, and 6.4 percent reported initiating both simultaneously. No data was available for
the final 2.1 percent.
Almost two thirds of our sample request that their clients use condoms, while 15.0 percent
reported not making this request, and 22.1 percent preferred not to respond to this question.
4. Results of Bivariate Analysis
The bivariate relationships with prostitution and selected independent variables are examined in
Table 6.2. Following are the principal findings from this table.
4.1. Sociodemographic characteristics and prostitution
No association was found between prostitution and the age of the women. Leaving school at a
later age appears to have a certain protective relationship with prostitution, with more than half of
the female IDUs who left school before age 16 practicing prostitution, compared to 37.9 percent
of those who left school after age 16.
4.2. Marginalisation variables
Not having a fixed address or living in a rented room paid for on a daily basis was found to have
the strongest relationship with prostitution, carrying over five times the risk. Previous
imprisonment was also significantly related, nearly doubling the risk of practicing prostitution.
However, caution is warranted in the interpretation of these findings given that directionality of
the relationship cannot be determined in cross-sectional designs. Therefore we can' t really say
that not having a fixed abode or previous imprisonment are determinants of prostitution. In fact
in both cases, the relationship could even be reciprocal. For example, the circumstances
surrounding the world of prostitution frequently result in prison and vice versa Likewise, the
circumstances surrounding not having a fixed abode may lead one into prostitution, while it can
also be argued that the practice of prostitution implies this type of housing. Meanwhile, in other
cases, both circumstances may have a common determinant The only real conclusion we can
establish is that prostitution is more common when a stable domicile doesn't exist and when one
has been to prison.
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We found an association between prostitution and living with one's children. Those who have
children but don't live with them have the highest rate of prostitution (71.3 percentjcompared
to those who live with their children (31.1 percent), and those who reported having no children
(40 percent). This result seems logical, due to the incompatibility between the lifestyle and
schedules assumed by a prostitute and the responsibility of caring for a child.
4.3. Drug-using habits
Amongst injected drugs, we only found an association between prostitution and the injection of
heroin+cocaine, with 51.7 percent of the IDUs who injected this combination reporting to have
practiced prostitution, compared to 40.5 percent who had not injected this combination. The use
of barbiturates is more than twice as likely among those who practice prostitution. In all
probability, the odd hours implicit in prostitution may cause these women to begin using
barbiturates to induce sleep which later becomes an abuse problem, reinforcing their drug
addiction. ..
We did not find an association between age of beginning to inject drugs and prostitution. But
there were some positive associations between other risk behaviours and prostitution. 'Those who
had ever shared injection material and those who had shared injection material in the last six
months were two times more likely to practice prostitution. Furthermore, those who had injected
while in prison were nearly three times more likely to practice prostitution.
4.4. Sexual habits
As far as having a relationship with a stable partner, even if the partner is an IDU or HIV-
positive, there were no significant differences between those who practiced prostitution and those
who didn't.
Those who reported having ever had a casual partner were more than four times more likely to
practice prostitution than those who didn't. Similarly, it is more common for those who have
had a casual HIV-positive partner (OR=2.5~CI=1.4-4.7) or IDU partner (OR=3.2~CI=2.0-5.1) to
work as prostitutes.
4.5 Reproductive habits and infections
An elevated percentage (59.1 percent) of women who currently use some type of contraception
work as prostitutes compared to 32.1 percent of those who don't currently use contraception. Of
all the contraceptive methods, the condom is used most. and its use in the last years maintains a
strong positive association with prostitution (OR=8.3;CI=3.6-19.1). The use of spermicides also
has a strong positive association with prostitution (OR=5.I;CI=2.4-10.8).
When the first' pregnancy occurred before the age of 18, we found a higher percentage of women
who had practiced prostitution (66.2 percent), than when the first pregnancy took place at age 18
or later (42.7 percent).
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Those who reported having an STD in the past five years were more than twice as likely to have
practiced prostitution.
The association between HIV positivity and prostitution, however, was weak (OR=1.6;CI=1.O-
2.6). The same occurred in the case of hepatitis B (OR=1.8;CI=1.0-3.0).
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Table 6.1 Descriptive analysis of prostitution
Variable Total %
Prostitution
Yes 140 46.1
No 164 53.9
Number of clients/month last 6 months
o (ex-prostitute) 55 39.3
<50 21 15.0
50+ 60 42.9
No response 4 2.9
What came first?
Drugs 111 79.3
Prostitution 17 12.1
Both 9 6.4
No response 3 2.1
To ask clients about using condom
Yes 88 62.9
No 21 15.0
No response 31 22.1
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Table 6.2 Proportion of women reporting having clients by selected variables
Variable Total Prostitute OR(CI.95%} p
Yes(%) No(%)
Sociodemogra phics
Age
24 or less 73 43.8 56.2 1.2(0.6-2.8) n.s."
25 -29 110 50.9 49.1 1.6(0.8-3.4)
30-34 72 45.8 54.2 1.3(0.6-3.0)
350rmore 49 38.8 61.2 1(reference)
Age leaving education
13 or less 88 51.1 48.9 1.7(1.0-3.1) *a
14-15 82 53.7 46.3 1.9(1.1-3.5) *a
Ie or more 132 37.9 62.1 1(reference)
Marginalisation variables
Previously imprisoned
Yes 98 56.1 43.9 1.8(1.1-3.0) *
No 206 41.3 58.7
Abode
No fixed address 96 72.9 27.1 5.3(3.0-9.4) ***
Fixed address 208 33.7 66.3
Lives with children
She has no children 150 40.0 60.0 1(reference) **~
She lives with 74 31.1 68.9 0.7(0.4-1.3)
She doesn't live with 80 71.3 28.8 3.7(2.0-7.0)
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Table 6.2 (continued) Proportion of women reporting having clients by selected variables
Variable Total Prostitute OR{CI.95%} p
Yes(%) No(%)
Drug-using habits
Age began injecting drugs
lo or less 81 4'8.1 51.9 l.2(0.7-2.2) n.s."
17 - 19 81 49.4 50.6 1.3(0.7-2.3)
20ormore 141 43.3 56.7 1(reference)
Injecting heroin + cocaine
Yes 151 51.7 48.3 1.6(1.0-2.5) *
No 153 40.5 59.5
Use barbiturates
Yes 71 62.0 38.0 2.3(1.3-4.0) **
No 233 41.2 58.8
Use hashish
Yes 126 38.9 61.1 0.6(0.4-1.0) *
No 178 51.1 48.9
Ever shared needles/syringes
Yes 217 51.6 48.4 2.2( 1.3-3.7) **
No 86 32.6 67.4
Ever shared needles/syringes in last 6 months
Yes 104 55.8 44.2 1.8(1.1-2.9) *
No 200 41.0 59.0
Injected in Prison
Yes 32 71.9 28.1 2.7(1.1-6.7) *
No 66 48.5 51.1
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Table 6.2 (continued) Proportion of women having clients by selected variables
. Variable Total Prostitute OR{CI.95%} n
Yes(%) No(%)
Sexual habits
Ever had a regular sexual partner
Yes 293 46.4 53.6 1.3(0.6-2.8) n.s.
No 11 36.4 63.6
Ever had a regular sexual HIV+ partner
Yes 138 49.3 50.7 1.3(0.8-2.1) n.s.
No 152 42.8 57.2
Ever had a regular sexual IDU partner
Yes 257 45.9 54.1 l.0(0.5-1.8)' n.s.
No 47 46.8 53.2
Frequency of condom use with regular sexual partner
Vaginal intercourse
Never/sometimes 122 36.9 63.1 0.6(0.3-1.3) n.s.
Always 35 48.6 51.4
Ever had a casual sexual partner
Yes 241 52.7 47.3 4.6(2.3-9.1) ***
No 62 19.4 80.6
Ever had a casual sexual HIV+ partner
Yes 53 56.6 43.4 2.5( 1.4-4.7) **
No 186 33.9 66.1
Ever had a casual sexual IDU partner
Yes 156 59.0 41.0 3.2(2.0-5.1 ) ***
No 141 31.2 68.8
Frequency of condom use with casual sexual partner
-VaginaJ intercourse
Never/sometimes 48 66.7 33.3 1.8(0.8-4.2) n.s.
Always 50 52.0 48.0
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Table 6.2 (continued) Proportion of women reporting having clients by selected variables
Variable Total Prostitute OR{CI.95%} I!
Yes(%) No(%)
Reproductive habits and infections
Regular periods
Yes 99 35.4 64.6 0.5(0.3-0.8) **
No 205 51.2 48.8
Age at first pregnancy
< 18 74 66.2 33.8 2.6( 1.5-4.7) ***
18ormore 150 42.7 57.3
Contraception currently
Yes 159 59.1 40.9 3.1( 1.9-4.9) ***
No 140 32.1 67.9
IUD used in last 5 years
Yes 21 33.3 66.7 0.6(0.2-1.4) n.s.
No 283 47.0 53.0
Condom used in last 5 years
Yes 247 53.8 46.2 8.3(3.6-19.1) ***
No 57 12.3 87.7
Spermicide used in last 5 years
Yes 45 77.8 22.2 5.1(2.4-10.8) ***
No 259 40.5 59.5
Contraceptive pill used in last 5 years
Yes 91 42.9 57.1 0.8(0.5-1.4) n.s.
No 213 47.4 52.6
Ever been pregnant
Yes 230 50.0 50.0 1.9(1.0-3.5) *
No 74 33.8 66.2
Abnormal smear test
Yes 49 57.1 42.9 1.9(1.0-3.5) *
No 224 41.5 58.5
STD in last 5 years
Yes 77 61.0 39.0 2.7(1.5-4.8) ***
No 196 36.7 63.3
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-I-UV +
Yes 165 53.3 46.7 1.6(1.0-2.7) *
No 97 41.2 58.8
-Hepatitis A in last 5 years
Yes 8 62.5 37.5 2.1(0.5-8.8) n.s.
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Table 6.2 (continued) Proportion of women reporting having clients by selected variables
Variable Total Prostitute OR(CI.95%} ~
Yes(%) No(%)
Reproductive habits and infections (continued)
HIV+
Yes 165 53.3 46.7 1.6(1.0-2.7) *
No 97 41.2 58.8
Hepatitis A in last 5 years
Yes 8 62.5 37.5 2.1(0.5-8. 8) n.s.
No 276 44.6 55.4
Hepatitis B in last 5 years
Yes 72 55.6 44.4 1.8(1.0-3.0) *
No 212 41.5 58.5
Hepatitis C in last 5 years
Yes 89 49.4 50.6 1.3(0.8-2.1) n.s.
No 195 43.1 56.9
Hepatitis D in last 5 years
Yes 2 0.0 100.0 n.s.
No 282 45.4 54.6
Tuberculosis in last 5 years
Yes 45 53.3 46.7 1.5(0.8-2.8) n.s.
No 239 43.5 56.5
Some infection last year
Yes 148 51.4 48.6 1.7(1.0-2.8) *
No 136 38.2 61.8
Type of Treatment
Methadone maintenance 65 40.0 60.0 1.O(reference)
Other treatments 143 51.7 48.3 1.6(0.9-3.1) n.s.
1.1(0.5-2.1) n.s.No treatment 96 41.7 58.3
a: p value of linear trend test
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5. Results of Hierarchical Logistic Regression Analysis
In the first model, none of the age categories enter significantly into the equation. In the second
model, two variables representing the socioeconomic level appear in the equation: place of
. residence, and living with children. The place of residence maintains a strong association with
the dependent variable, with those IDUs who don't have a fixed address presenting a higher
probability of having practiced prostitution (OR=4.7~CI=2.7-8.1). This finding hardly varies in
subsequent models. To examine the variable "living with children" we compared those "not
living with their children" to those "living With children" or "not having children". The women
who don't live with their children have an elevated probability of having practiced prostitution
(OR=3.6~CI=2.0-6.4). This probability descends slightly when we incorporate the variables
representative of marginalisation in the third model (OR=2.7~Cl=1.4-5.1), but suffers few
changes in the final model.
Of the six variables selected to study the relationship between the degree of marginalisation and
prostitution, only two remain in the equation: 1) Having had. a casual IDU partner, and 2) Age at
first pregnancy. Having had. a casual IDU partner appears to be a relatively strong determinant of
prostitution (OR=2.9;CI=1.7-S.0). This finding does not change in subsequent models. Having
had. a first pregnancy before the age of 17 is also a significant determinant of prostitution
(OR=2.0;CI=1.0-4.0) in both the third and fourth models. It is interesting to note that previous
imprisonment does not enter into the model, suggesting an indirect relationship with prostitution.
Of the variables selected to represent risk behaviour and infections, only HIV seroprevalence
entered the model. Not knowing one's HfV status appears to have a negative relationship with
prostitution, and being HIV-positive appears to have no relationship with prostitution.
6. Discussion
The findings of this study are consistent with many previous studies in which the exchange of sex
for money or drugs stood out as a common practice among female IDUs (Franceschi, 1988;
Lewis, 1991; Saxon, 1991; Van den Hoek, 1988; Astemborski, 1994). In our study, more than 45
percent of the women reported having practiced prostitution at some point in their life. For the
great majority of these women, it was the need to pay for their drug habit which drove them to
prostituti on.
Although in the bivariate analysis we observed a statistically significant association between
prostitution and HIV infection, once we control for other variables in the logistic model, this
association fails to be significant, indicating an indirect relationship. Furthermore, the negative
relationship with unknown HIV status suggests that prostitutes are more likely to have been
tested or at least more likely to have returned a physician's report on their HIV status. This
finding of no relation between prostitution and seropositivity coincides with the findings of other
European studies (Estebanez, 1995; Rhodes, 1994; Van den Hoek, 1988~Tirel1i, 1989) in which
the transmission of fflV among female prostitutes who also inject drugs is associated more with
the use of drugs than with prostitution. Some studies such as Astemborski (1994) find significant
llO
differences in the prevalence of fllV between prostitutes with a high level of promiscuity (50 or
more clients per month) and those of low promiscuity (fewer than 50 clients per month), while
they don't find a difference in prevalence between the latter group and non-prostitute IDUs. We
did not find a significant difference using the promiscuity index.
There are no differences in condom use with regular partners or casual partners. Even though
one knows that condoms are a reasonably safe way to prevent fllV infection, they are not
particularly popular in private sexual relations. The obstacles to condom use which are typically
mentioned are, in general, social factors. .Prostitutes are reluctant to use condoms in private
sexual relations, and not using them constitutes an essential distinction between the two types of
relations (private versus commercial). Sexual relations without condoms with a private partner
who injects drugs, exposes prostitutes to a greater risk of HIV infection than their relations with
clients.
In the final interpretation of the logistic model of our study, the profile of the female prostitute
IDU varied from that of a non-prostitute in that the formerlacked to a greater degree a fixed
address, they were less likely to live with their children, and the median age of the first pregnancy
was lower. A higher level ofhomelessness among prostitute IDUs perhaps reflects a greater level
of economic oppression amongst prostitute IDUs and possibly a reason for turning to prostitution
as a source of income in the first place. An earlier age of first pregnancy is an interesting finding
as earlier studies have linked both early age of first pregnancy and prostitution to childhood
sexual abuse (Zierler et al, 1992). Furthermore, early sexual experience has been identified as a
factor in prostitution (James and Meyerding, 1977) and age at first coitus as a marker for risky
sexual behaviour (Greenberg, Magder and AmI, 1992). The implications of these findings are
that early sexual experiences, including childhood. sexual abuse, can be used as markers for high-
risk sexual behaviour, and interventions aimed at delaying a woman's first sexual experience
may lower the likelihood of later engaging in prostitution and other risky sexual practices.
Up until this point, the data are comparable to the possible differences one might find between
prostitutes and non-prostitutes in a non-drug using population. But in the case of the IDUs, it
stands out that the group of prostitutes is strongly associated with the existence of casual IDU
sexual partners. Future investigations should attempt to verity this result in a non-drug-dependent
population.
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7. Conclusions
. C This study makes it evident, once again, that the use of drugs and prostitution are directly
associated.
C In the population studied of female IDU prostitutes in Madrid, the prevalence of HIV is
slightly higher than non-prostitutes, but this difference disappears when we control for
socioeconomic status and marginalisation variables.
C Condom use, while relatively frequent with clients, is less common in private sexual
relations, which is comparable to what occurs with non-prostitutes.
C The degree of marginalisation and living conditions of IDUs who work as prostitutes, are
even more unfortunate than those ofIDUs themselves.
C This study provides further evidence that the age of first pregnancy or early sexual experience
is an important determinant of prostitution.
C Those who are homeless, use drugs, and get pregnant at a young age are at higher risk for
practicing prostitution.
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Chapter Seven
Determinants of Previous Imprisonment amongst Female IDUs
1. Introduction
There is a considerable body of evidence to suggest that prisoners have a history of drug use before
entering prison. For example, a survey of pre-arrest drug use amongst 1,741 men serving prison
sentences in England and Wales, found that 11.0 percent of inmates had injected drugs (Maden,
Swinton and G~ 1992). Likewise, a series of surveys in Scottish prison have reported previous or
current !DU to range between 16.8 (Bird, Gore, Burns and Duggies, 1992a,b) and 33.5 percent
(Taylor et a1. 1995). Finally, in the USA in 1989, inmates were twice as likely as the general
population to have ever used drugs: 78.0 percent of inmates had used drugs during their lifetime;
44.0 percent had used drugs in the month before their current offense; 20.0 percent daily or almost
daily; and 27.0 percent were under the influence when they committed their current offense
(polonsky, 1994). Although less evidence is available, data from all female prison populations
indicate that female prisoners also have a history of IDU. In a study of 145 female prisoners
conducted at HMP (Her Majesty's Prison) Cornton Vale, Scotland, 46 percent of female inmates
had injected drugs (Gore et al., 1997). In a larger scale study of the same prison population, 21.3
percent of3,389 consecutive admissions admitted to drug misuse in the six months prior to custody
(Stuart, O'Rourke & Power, 1997). In the USA in 1989, one in three female inmates had been
imprisoned for drug-related offenses as compared to one in five male inmates (polonsky et al.,
1994).
Towards the beginning of the acquired immunodeficiency syndrome (AIDS) pandemic, it was
realised that the prevalence of the human immunodeficiency virus (HIV) was disproportionately
high in prison populations when compared to the population per se. Indeed, this is verified in the
current study where previous imprisonment is demonstrated to be an important factor in the
multivariate logistic regression models presented in Table 5.3 (Chapter 5).
In 1983, a study of an American prison population in New York State demonstrated the importance
of intravenous drug use (IOU) in the transmission of HIV (Wormer et al., 1983; Harding and
Schaller, 1992). At the time the population represented a convenient sample of drug users and little
attention was given to the actual transmission of ffiV in prisons (Harding and Schaller, 1992).
Since then, however, the prime objective of a nwnber of studies has been to examine the prevalence
of HIV in prison populations and to identify relevant risk factors. Many of these studies conclude
that the high prevalence of HIV arises because prison populations are predominantly drawn from
young, sexually active groups who disproportionately engage in high-risk activities, including, for
example, intravenous drug use. Moreover, many people who have a high risk of HIV transmission
are also at risk of imprisonment
If it is assumed that the high incidence of HIV among women were recorded at the outset of a
prison sentence, then one can infer that HIV-infected women are more likely to be imprisoned than
Hlv-infected men Studies of prisoners suggest that jails are places where a disproportionate
number of individuals have a history of risk factors associated with illY infection (Gaughwin et al.,
1990). These include, for example, the injection of illicit drugs (Dolan, Donoghoe and Stimson,
1990), unprotected sexual intercourse (Magma, Shapiro and Kang 1994) and under-provision of
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health care (Kendig et aI., 1994). Although few studies have been published on risk factors of HIV
for women entering prisons, evidence can also be accumulated from data based on male subjects
and from studies of women in other high-risk populations .
.As partly il1ustrated in Chapter 6, a further compounding factor in examining the characteristics of
female prisoners, mv prevalence and IDU is the proportion of prisoners who have exchanged sex
for drugs or money. In the HMP Corton Vale study by Stuart and colleagues (1997), 16.5 percent of
the 616 female drug abusers were in prison on charges of prostitution. Gore et al. (1997) reported
that 20 percent of the female injector-irurtates in their study had worked as prostitutes. In a
multicentre study of female sex workers in Spain, 13.9 percent reported having been previously
incarcerated (Estebanez et al., 1995).
In addition to the unrepresentative proportion of IDUs and female sex workers seemingly
characteristic of prison entrants, these women are also susceptible to a gamut of diseases associated
with both poverty and IDU/prostitution itself For example, the presence of SIDs has been shown
to be another major factor that has been associated with sexual transmission ofHIV. As previously
mentioned, diseases that cause genital ulcers may facilitate both transmission of and susceptibility
toIDY.
Other bloodbourne viruses, including hepatitis B and C, have been identified in both male and
female prison entrants. In an Australian study the incidence for hepatitis B was 12.6 percent and,
for hepatitis C, was 18.3 percent (Crofts et al., 1995). In an examination of265 male prison inmates
in Maryland, USA, intake prevalence for hepatitis C was 38.0 percent and seroincidence was 1.1
percent per person year in prison (Vlahov et al., 1993).
Finally, prison populations have long been considered to be at high risk of tuberculosis (TB)
(Darbyshire, 1990). Most studies have either examined the incidence of TB within prison
(Darbyshire, 1990) or have examined the prevalence of TB using a cross-section of prisoners
(Martin et al., 1994). In the latter study, 56.2 percent of prisoners were infected with
Mycobacterium tuberculosis, although the data do not permit the calculation of the prevalence for
new entrants. Studies are therefore needed to examine the prevalence of TB, and other bacterial
diseases, amongst prison entrants.
To examine the potential for the transmission of HIV and other diseases amongst prisoners,
information is needed on risk activities whilst incarcerated. Evidence would then enable the
development of effective and equitable policies for the care and treatment of HIVIAIDS prisoners.
For example, in the current study nearly a third of those who had been in prison (n=98) reported
injecting whilst in prison.
It is the aim of this chapter to look at the determinants of previous imprisonment amongst female
IDUs. As with prostitution in Chapter 6, the main justification for so doing is to try to create a
better understanding of the causes, and consequences, of a very marginalised environment/lifestyle
with respect to HIV. Thus by examining prostitution and previous imprisonment (which were both
associated with HIV prevalence in Chapter 5), it might be possible to build a more comprehensive
picture. However, it should be noted that - as in Chapter 6 - in the proceeding bivariate and
multivariate analyses the characteristics are examined; not risk factors.
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Therefore the objectives of this chapter are:
1) To discern the profile of female IDUs that have been in prison, as well as the relationships with
other marginalisation factors such as prostitution and I-UV;
2) To examine the determinants of imprisonment in female IDUs using the data from this study;
and
3) To facilitate the design of new strategies intended to prevent the transmission of HIV within
pnsons.
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2. Methods
The methods used for this study, including the bivariate and multivariate analyses, are described in
Chapter 3. The only variation from those methods occurs in the logistic regression model in which
the folJowing four groups of explanatory variables have been identified:
Modell: Age
In order to evaluate the effect of age on the dependent variable (previous imprisonment) the
biological age (coded into four categorical age groups: 24 or less; 25-29; 30-34; and 35+) was the
sole variable used in this group.
Model2: Socioeconomic status and marginalisation
Based on the literature and results of the bivariate analysis, three variables were selected to define
the general socioeconomic status of female roUs: age left full-time education (coded into four
categorical age groups: 13 or less; 14-15; 16-18; and 19+); source of income during past six months
(illegal and prostitution versus legal); and, place of residence- in past six months (no fixed abode
versus abode).
In addition to socioeconomic status, two variables were chosen to characterise the extreme
marginalised nature of the sample population. These dichotomous variables (yes versus no) were:
ever had clients and having a regular partner who was an IDU.
Modell: Risk behaviours
Specific known risk behaviours of previous imprisonment were included in the third model: ever
have regular HJV+ partner, cocaine injecting; heroin+cocaine injecting; age began injecting; ever
share needles; and number of clients per month.
Model 4: Gynaecological background and infections.
The variables introduced in this model were: previous pregnancy; some SID in the past year; and
hepatitis B during the past year.
3. Results
First we will examine the bivariate relationships with previous imprisonment and selected variables
presented in Table 7.1. Then we will present findings from the multivariate logistic regression.
3.1. Sociodemographic characteristics and previous imprisonment
There is a clear positive association between age and prison stay: the older the age the higher the
probability of having been in prison. Compared to the youngest stratwn (24 years or less), those in
the three older strata (25-29; 30-34; over 34) were two to three times more likely to have been in
pnson.
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3.2. Marginalisation variables
The extreme marginalisation of the !DU popuJation which has been to prison becomes evident
when we examine the pJace of residence and source of income. Forty-nine percent of female !DUs
'that don't have a fixed address had been in prison, compared to 27.2 percent of those that do have
one (OR=2.6;CI=1.5-4.5). Furthermore, 42.3 percent of the women whose source of income was
iUegal or prostitution had been in prison, compared to onJy 24.0 percent of those who had a legal
source of income (OR=2.3;CI=I.4-3.9).
The age of Jeaving school did not have a significant p-value in the Linear trend test; however, the
stratum of those who left school at age 13 or younger had a higher rate of having been in jail (43.2
percent) compared to those who stayed in school until age 16 or older (35.6 percent).
3.3. Drug-using habits
The age of beginning to inject drugs maintains a strong relationship with previous incarceration.
Those that began injecting younger (16 years or less) are more than 3 times more likely to have been
in prison compared to those who began at age 20 or later. Those who began between' ages 17 and
19 are nearly twice as likely to have been to prison.
Those who have ever exchanged injection material are twice as likely to have been incarcerated.
However there is not a significant association between having shared injection material in the last 6
months and having been in prison.
No significant associations were found between the use of any specific drugs and imprisonment.
3.4. Sexual habits
No significant associations were found between having a steady sexual partner and having been in
prison, even when the partner was anDlf, It is useful to remember that almost all of these women
(94 percent) reported having had a steady partner, and in the great majority of cases (85 percent),
this partner was also an mu. However, a positive association does appear between those women
who had a steady sexual I-flV-positive partner and imprisonment, with those who had an HIV-
positive partner presenting an OR=2.l(CI=1.2-3.4) compared to those who hadn't. No relationship
was found between condom use with regular partners and prison.
Although no association was found between having had a casual partner and prison, we did find an
association when this partner was HIV-positive or an IDU. Having an IllV-positive casual partner
produced an OR of2.7(CI=1.4-S.l), and when the casual partner was an!DU the OR is 2.1(CI=1.2-
3.4). No association was found with condom use with casual partners.
Prostitution is also associated with previous imprisonment: the women with a history of prostitution
have nearly double the odds compared to those who never practiced prostitution.
No association appears between prison and the use of condoms with clients.
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3.5 Reproductive habits and infections
We found a significant association between having a regular menstrual period and the dependent
variable. When menstruation is regular. 21.2 percent have been in prison whereas the proportion
'increases to 37.6 percent when it is not regular (OR=O.4;CI=O.3-0.8).
No association was found between imprisonment and the various types of contraception used in the
past five years. Nor was their a finding with current use of contraception.
We found a strong relationship between having ever been pregnant and the dependent variable.
Those reporting a previous pregnancy were three times more likely to have been imprisoned
compared to those who had never been pregnant
Having had any type of STD in the five years prior to the interview also nearly tripled the odds of
previous imprisonment
As expected and in agreement with data presented in Chapter 5. there is a positive association
between HIV and prison. The risk of having been in prison for those who are HIV-positive is 2.8
times greater than for those who are HIV- negative or unaware of their serostatus (0=1:5-4.9).
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Table 7.1 Proportion ofwomeo previously imprisoned by selected variables
Variable Total Iml2risonment OR(CI95%} n
Yes(%) No(%)
Sociodemographics
Age
24 or less 73 17.8 82.2 1(reference) **a
25 -29 110 33.6 66.4 2.3(1.1-5.1)
30-34 72 41.7 58.3 3.3( 1.5-7.6)
350rmore 49 36.7 63.3 2.7(1.1-6.7)
Age left education
13 or Jess 88 43.2 56.8 1.4(0.7-2.7) n.s."
14-15 82 28.0 72.0 0.7(0.3-1.5)
16ormore 73 35.6 64.4 1(reference)
Abode
No fixed address 69 49.3 50.7 2.6( 1.5-4.5) ***
Fixed address 235 27.2 72.8
Income
lllegal+prostitution 137 42.3 57.7 2.3(1.4-3.9) ***
Legal 167 24.0 76.0
Drug-using habits
Age began injecting drugs
16 or Jess 81 48.1 51.9 3.3( 1.8-6.2) **~
17 - 19 81 33.3 66.7 1.8(0.9-3.4)
20ormore 141 22.0 78.0 1(reference)
Ever shared needles/syringes
Yes 217 36.9 63.1 2.2( 1.2-4.0) **
No 86 20.9 79.1
Ever shared needles/syringes in last 6 months
Yes 104 40.4 59.6 1.3(0.8-2.3) n.s.
No 114 33.3 66.7
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Table 7.1 (continued) Proportion of women previously imprisoned by selected variables
Variable Total Imurisonment OR{CI95%) ~
Yes(%) No(%)
Sexual habits
Ever had a regular sexual partner
Yes 293 . 32.1 67.9 0.8(0.2-2.9) n.s.
No 11 36.4 63.6
Ever had a regular sexual fllV+ partner
Yes 138 39.1 60.9 2.1(1.2-3.4) **
No 152 23.7 76.3
Ever had a regular sexual IDU partner
Yes 257 32.7 67.3 1.1(0.6-2.6) n.s.
No 47 29.8 70.2
Frequency of condom use with regular sexual partner
-Vaginal intercourse
Never/sometimes 122 25.4 74.6 1.0(0.4-2.3) n.s.
Always 35 25.7 74.3
Ever had a casual sexual partner
Yes 241 32.8 67.2 1.1(0.6-2.0) n.s.
No 62 30.6 69.4
Ever had a casual sexual HIV+ partner
Yes 53 45.3 54.7 2.7(1.4-5.1) **
No 186 23.7 76.3
Ever had a casual sexual IDU partner
Yes 156 39.7 60.3 2.1(1.3-3.4) **
No 141 24.1 75.9
Frequency of condom use with casual sexual partner
-Vaginal intercourse
Never/sometimes 48 29.2 70.8 0.7(0.3-1.6) n.s.
Always 50 38.0 62.0
Ever had a client
Yes 140 39.3 60.7 1.8(1.1-3.0) *
No 164 26.2 73.8
Frequency of condom use with casual client
-Vaginal intercourse
Never/sometimes 26 38.5 61.5 0.8(0.3-2.2) n.s.
Always 52 42.3 57.7
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Table 7.1 (continued) Proportion of previously imprisoned women by selected variables
Variable Total Irn~risonment OR{CI95%) n
Yes(%) No(%)
Reproductive habits and infections
Regular periods
Yes 99 . 21.2 78.8 0.4(0.3-0.8) **
No 205 37.6 62.4
Age at first pregnancy
<18 74 44.6 55.4 1.6(0.9-2.8) n.s.
18ormore 150 34.0 66.0
Contraception currently
Yes 159 30.2 69.8 0.8(0.5-1.3) n.s.
No 140 34.3 65.7
IUD used in last 5 years
Yes 21 14.3 85.7 0.3(0.l-1.1 ) n.s.
No 283 33.6 66.4
Condom used in last 5 years
Yes 247 33.2 66.8 1.3(0.7-2.4) n.s.
No 57 28.1 71.9
Spermicide used in last 5 years
Yes 45 42.2 57.8 1.7(0.9-3.2) n.s.
No 259 30.5 69.5
Contraceptive pill used in last 5 years
Yes 91 28.6 71.4 0.8(0.5-1.3) n.s.
No 213 33.8 66.2
Ever been pregnant
Yes 230 37.4 62.6 3.1(1.6-6.1) ***
No 74 16.2 83.8
Regular smear test
Yes 134 30.6 69.4 0.9(0.5-1.4) n.s.
No 168 33.9 66.1
STD in last 5 years
Yes 77 49.4 50.6 2.9(l.6-5.1) ***
No 196 25.5 74.5
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Table 7.1 (continued) Proportion of women previously imprisoned by selected variables
Variable Total Imprisonment OR(CI95%) p
Yes(%) No(%)
Reproductive habits and infections (continued)
HIV+
Yes 165 41.8 58.2 2.8( 1.5-4.9) ***
No 97 20.6 79.4
Hepatitis B in last 5 years
Yes 72 40.3 59.7 1.7(1.0-3.0) n.s.
No 212 28.3 71.7
Hepatitis C in last 5 years
Yes 89 31.5 68.5 1.0(0.6-l.7) n.s.
No 195 31.3 68.7
Tuberculosis in last 5 years
Yes 45 40.0 60.0 1.6(0.8-3.0) n.s.
No 239 29.7 70.3
Herpes last year
Yes 23 47.8 52.2 2.1(0.9-4.5) n.s.
No 250 30.8 69.2
Candidiasis last year
Yes 43 46.5 53.5 2.1(1.1-4.0) n.s.
No 230 29.6 70.4
Genital warts last year
Yes 28 57.l 42.9 3.2(l.4-7.1) **
No 245 29.4 70.6
Some infection last year
Yes 148 36.5 63.5 0.6(0.4-1.0) *
No 136 25.7 74.3
Type of Drug Treatment
Methadone maintenance 65 35.4 64.6 1.0(reference) n.s."
Other treatment 143 36.4 63.6 1.0(0.5-2.0)
No treatment 96 24.0 76.0 0.6(0.3-4.5)
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3.6. Results of hierarchical logistical regression analysis
Age: Age appears to be a factor directly associated with the dependent variable, maintaining a
significant relationship, with the youngest group presenting the lowest risk of having been in prison.
'This relationship is maintained throughout the four models, increasing in its statistical significance
in the second and third models, and decreasing slightly in the final model. Interestingly, on
examination of the different models, we can observe that in the first model the group of women
over 35 years present an OR slightly lower than the group of 30- to 34-year-olds (2.7 and 3.3
respectively), thus in the older strata the risk of imprisonment had descended. But if we look
closely, this phenomenon disappears in the third model, as we adjust for risk factors, gynecological
history and infections. Furthermore, in the final model the direct relationship between age and
imprisonment remains clearly evident (the older the age, the higher the risk), with the risk in respect
to the group under 24 years varying from 2.9 (CI=1.3-6.6) for the group of 25- to 29-year-olds, to
4.5 (CI=1.9-1O.9) for the group of 30- to 34-year olds, and 4.9 (CI=1.8-13.4) for the group of 35
years or older.
Socioeconomic status and marginalisation: The source of income is a factor directly associated
with prison, although it loses significance slightly in the final model, where having an illegal source
of income presents an OR=2.2 (CI=1.2-4.0) compared to having a legal source of Income. Not
having a fixed address, though strongly associated to imprisonment in the bivariate analysis, entered
only into the second model, and with a weak significance (p=O.08). This association continues to
weaken with the introduction of subsequent models. Using the oldest age group for leaving full-time
studies (19 years and over) as a reference, two groups (13 or less and 16 to 18) maintain significant
associations with imprisonment in the second and third models, but as we proceed, the association
weakens and ceases to be significant in the final model. Having had a regular IOU sexual partner
and having practiced prostitution remained out of the equation.
Risk behaviour: Of the variables selected to represent risk behaviours, only the age of beginning to
inject drugs remains in the equation, with the rest remaining out of the equation. This variable loses
significance slightly when we adjust for the variables of previous pregnancy and having had some
SID in the previous year. When the age of beginning drug use is younger, the risk of having been
in prison increases, such that in the final model, the OR for the group of 16 years or younger is 3.0
(CI=1.5-6.0) and for the 17- to 19-year-olds is 1.6 (0.8-3.1) in comparison to the group of20 years
or older.
Gynaecological background and infections: Those who have ever been pregnant are twice as
likely than those who have never been pregnant to have been to prison (OR=2.2;CI=1.0-4.8). The
women who have had some STD in the last year are also more likely to have been imprisoned
compared to those who had not had an STD in the last year (OR=1.9; 1.1-3.6).
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4. Discussion
The main objective of the preceding analysis was to review the determinants of previous
'imprisonment amongst female IDUs. It will be remembered from Chapter 4 (Table 4.1) that 32.2
percent of the study sample reported that they had been imprisoned. As demonstrated in the
bivariate analysis (Table 7. I), the more marginalised the female IOU, the more likely she is to have
been to prison. This is demonstrated through the association between imprisonment and having an
SID in the past year and having a casual partner who is an IDU or HIV-positive, for example (Table
7.1). It should be stressed that having a partner who is HIV-positive is not a cause of imprisonment,
but a characteristic of very marginalised female IOUs. In the regression analysis the only
marginalisation variable to maintain a direct relationship with previous imprisonment is having had
an STD.
Socioeconomic status appears to play an important role in determining previous imprisonment.
Claiming one's source of income as illegal or prostitution is directly associated with imprisonment.
Age of leaving education and having no fixed address appear to be indirectly linked to
imprisonment. Socioeconomic status, as determined by living in a poor district, was also identified
as having a direct relationship with previous imprisonment amongst IDUs in a study of AIDS
patients in Barcelona (Cayla et al., 1995). Previous pregnancy, which most likely represents the
economic burden of children to support, is also directly associated with imprisonment. Perhaps
these women are pressed into illegal activities in order to support their families.
Age and age of beginning to inject drugs both have strong, direct relationships with imprisonment
The association with age is most likely a reflection of exposure. The older the woman, the longer
she's been involved in IDU and other illegal activities, the more likely it is that she has been to
prison. Early injectors have been identified in other studies as more likely to engage in drug-using
risk behaviours (e.g. frequency of injection, frequency of needle sharing, and use of shooting
galleries) and sexual risk behaviours (amongst females, e.g. prostitution, multiple sex partners)
(Battjes, Leukefeld and Pickens, 1992). Thus early injectors may represent a more hard-core group
of drug users and are an important target for HIV risk-prevention programmes within prisons.
The positive associations between prison and HIV positivity as well as prison and previous TB
infection (not significant) are interesting to consider. The association between HIV and TB with
previous imprisonment may - but not necessarily - be the effects of imprisonment. For example, up
until the beginning of the AIDS pandemic, TB was considered to be an infectious disease that was
all but eliminated from the industrialised countries of Europe. However, in the past decade a
number of studies have demonstrated a strong association with marginalised populations, including,
for example prisons (Darbyshire, 1990). This association may, in part, be confounded by the
prevalence of HIV/AIDS in these populations. For example, HIV infection has been shown to be
one of the major risk factors for TB. InBarcelona (Spain), in 1993,24.2 percent ofTB cases were
HIV positive and a further 15.4 percent were diagnosed with AIDS (Guelar et al., 1993).
Furthermore, studies of the incidence ofTB among Hl'V-infected persons in the United States have
revealed rates 100 to 1000 times higher than in the general population (Markowitz et al., 1997). In
light of these observations, it is not that surprising that the study population of female IDUs reported
to have been infected by TB.
Investigations into mY amongst female prisoners have occurred infrequently. Nevertheless, the
reported prevalence or mY among female prisoners in North America and Europe ranges from 3.3
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percent in the USA (Polonsky et al., 1994) to 26.0 percent in Spain (Estebanez et al., 1990). An
anonymous HIV surveil1ance study at the Corton Vale all female-prison in ScotJand found no
undisclosed cases and reported an overall HIV prevalence of 1.4 percent (Gore et al., 1997). Data
from male or mixed prison populations are more frequently available. Examples include the 3.4
'percent of 15,052 male prisoners from the American state of Georgia who were HIV positive
(Harding, 1990); the testing of 500 consecutive entries to prison in France that found prevalence to
be 13 percent (in Harding, 1990); and the screening of 30,392 Italian prisoners of whom 16.8
percent were HIV positive (in Harding, 1990). Harding (1987) estimated the overall prevalence of
HIV in European prisons to be in excess of 1° percent and between 0.1 and 15 percent in 1992
(Harding and Schaller, 1992). Unfortunately, however, these studies are not directly comparable
due to different methods of data collection, varying sample sizes and the nature of the prison
population from which the samples were obtained (McKee, 1992).
Although Spanish prison officials insist that IDU is not a problem in Spanish prisons, it should be
remembered from Table 4.2 that 32.7 percent of those who had been imprisoned reported injecting
whilst in prison (Table 4.2). In fact, drug use in prison has been widely reported in other countries.
For example, from a study of559 Scottish inmates (480 males and 79 females) 7.7 percent reported
IDU on at least one occasion during a period of imprisonment (power et al., 1992). A number of
surveys have been published on HIV prevalence in male Scottish prisoners, all of which have
reported IDU whilst incarcerated. For example, in Edinburgh, nearly one in five prisoners reported
IDU, of whom one half had injected whilst in prison (Bird et al., 1992b); in a young offenders
institute 17 percent of prisoners admitted misuse of intravenous drugs, of whom a quarter reported
use while in prison (Bird et al., 1992a); and, following an outbreak of hepatitis B and I-llV at
Glenochil Prison, an investigation reported that a quarter of IDUs had first injected inside prison
(Gore et al., 1995). Similar evidence was recently reported on female Scottish prisoners, with 46
percent of inmates reporting IDU, 57 percent of these injector-inmates reporting to have injected
whilst in prison, and just one woman who had first injected inside prison (Gore et al., 1997).
Unlike other IDUs, prisoners are often denied access to public health programmes, such as needle
exchanges (Gore, 1993), and therefore are at more risk of sharing HIV-contaminated injecting
equipment (Bath et al., 1993). In fact, Keene (1994) reported that the levels ofHIV risk through
IDU were higher for subjects in prison than for those out of prison on parole. Furthermore, a
multifactorial analysis of 612 IDU from Berlin, Germany, revealed that the most important risk
factor for HIV infection was needle-sharing in prison (MUller et al., 1995); and Turnbull, Dolan and
Stimson (1992) reported that in the United Kingdom several studies have found that up to a quarter
of IOUs who go to prison report that they managed to inject drugs whilst in prison and that most
people who inject in prison share syringes. Finally, although no known data is available, it is likely
that IDUs who first share needles whilst in prison continue to do so after release and thus
imprisonment is associated with a long-term change in risk-taking behaviour.
Thus not only are prisoners who inject at particularly high risk of contracting HIV based on their
out-of-prison behaviour and Jiving circumstances, but they also engage in high-risk behaviour whilst
in prison. Therefore it is critical to target HIV prevention education in prison populations, not only
because there is a "captured" audience, but because this is an audience that might not be accessed
otherwise. (Nearly one-quarter of those who had never had drug treatment had been to prison.)
Furthermore, it is critical that prison populations also receive harm-reduction interventions, such as
needle-exchange programmes, the provision of decontaminants, and the provision of condoms. In
fact, in response to the severity and urgency of I-llV/AIDS prevalence in prisons, the WHO
recommended sweeping reforms including: the availability of condoms; needle-exchange
programmes; and the provision of bleach to clean infecting equipment, if such provision is provided
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for the community at large (WHO, 1993). By linking the recommendations to that provided for the
community, the WHO affirmed the principle of equality, namely that the same prevention and
control strategy should be applied in prisons as in other parts of society (Tomasevski, 1991). A
similar approach has been recommended by other international organisations including the United
'Nations and the Council of Europe. Despite this consensus, there is still a difference between
provision of preventive programmes in the wider society versus that for female prisoners, or more
specifically for the female IDUs.
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5. Conclusions
'C Those who have been to prison are a more marginalised group of women IDUs.
C The economic burden of having children, as indicated by having ever been pregnant, increases
the likelihood of having been to prison.
C Early age of first injection has been linked to other risky behaviours and appears to be a
determinant of imprisonment in this study.
C The relationship between HIV seropositivity and previous imprisonment, though indirect in the
current study, is important to consider and to study further for reasons of prevention.
C Contrary to reports by Spanish prison officials, this study shows that injecting drug use does
occur in Spanish prisons.
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Chapter Eight
Determinants of Sbaring Needles amongst Female IDUs
1. Introduction
There is a great deal of evidence that drug users in a majority of countries are modifying their
risky practices. In a study conducted in the U.K., Hunter et al (1995) reported a decline in the
proportion of IDUs that had shared injecting material during the six months prior to the interview
over four consecutive years (from 1990 to 1993). Specifically they found a decline from 46.8
percent in 1990 to 39.3 percent in 1993. These figures are lower than those found in Berlin
(Stark et al, 1990) where 88.0 percent of the women had at some time shared a needle or those
found in Italy (Sasse et al., 1989) where 58.0 percent had engaged in needle sharing. .
In our study 71.4 percent of the women had ever shared injection equipment, yet this proportion
is reduced to almost half (34.2 percent) for those reporting equipment sharing in the six months
prior to the interview. This rate is comparable to rates found by Estebanez, et al. (1996) in other
E.E.C. countries: in the U.K there was a reduction from 69.2 percent that had ever shared
injection equipment to 38.5 percent who had shared in the previous six months; the reduction in
Germany was from 56.4 percent to 26.9 percent; in Italy from 47.2 percent to 26.3 percent; and
in France, where rates were quite a bit lower, from 34.4 percent to 10.0 percent.
Although these data provide encouraging evidence that a decline is underway in the risky
behavior of IOUs, we can't forget that more than a third of the IOUs in our study were still
continuing to engage in the risky practice of sharing needles. For this reason, the aim of the
current chapter is to identify and characterise this residual group of women at risk and attempt to
determine the direct and indirect factors associated with continuing to share needles. First, we
have conducted a bivariate analysis in which we examine the relationship between the dependent
variable "sharing needles in the past 6 months" and a variety of independent variables that could
be considered of interest Later we developed a multilevel logistic regression model to attempt to
explain the direct and indirect determinants of our dependent variable.
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2. Methods
The methods used for this study, including the bivariate and multivariate analyses, are described
in Chapter 3. First, a bivariate analysis is conducted to identify significant relationships between
. "Sharing needles in the past 6 months" and selected independent variables. Then a multivariate
analysis is conducted involving a logistic regression model with the following five groups of
explanatory variables entered stepwise:
Modell: Age
Biological age is the first explanatory variable introduced into the model in order to evaluate the
effect of age on the dependent variable (sharing needles) and on the other independent variables.
Previous research has identified a strong negative relationship between age and needle sharing.
Model 2: Socioeconomic status
Based on the literature, three variables were selected to define the general socioeconomic status
of female IDUs: age left full-time education; source of income during past six months (illegal and
prostitution versus legal); and, place of residence in past six months (no fixed abode versus
abode).
ModeI3:~~nalisation
In addition to socioeconomic status, five variables were chosen to characterise the extreme
marginalised nature of the sample population. These variables were: age at first pregnancy (17 or
less versus 18+); and four dichotomous variables: ever had clients; previous imprisonment;
having a regular partner who was an IDU; and having a casual partner who was an IDU.
Model 4: Risk behaviours
Based on the literature, the following risk behaviours of sharing needles were selected for
inclusion in the fourth model: ever have regular HIV-positive sexual partner, injecting in prison;
cocaine injecting; heroin+cocaine injecting; age at first injection; actual regular sexual partner,
regular PAP smear test; don't always use condom in vaginal intercourse with regular partner;
don't always use condom in vaginal intercourse with casual partner; don't always use condom
in vaginal intercourse with clients; and sample.
3. Results
First, the bivariate relationships with needle sharing in the past six months and selected
independent variables are examined (see Table 8.1). Then findings from the regression analyses
will be presented.
3.1. Sociodemographic characteristics and sharing needles in the past six months
Several of the sociodemographic characteristics had significant relationships with recent needle
sharing. First, we found a strong association between age at the time of interview and having
recently shared injection material, with those less than 25 years old more than three times more
likely to have recently shared needles than the reference stratum of those 25 years old or older.
We also found an association between level of education, reflected by the age of leaving school,
and needle sharing. Those who left school before the age of 16 were two times more likely to
have recently shared needles than those who left school after the age of 16.
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The living situation of these women also proved to have a strong relationship with needle
sharing. Those living at home with parents or other family members were much less likely to
share needles compared to women who lived alone or with others. Furthermore those who
. claimed to have no fixed address were four times more likely to have recently shared needles
than those with a fixed address.
The source of income is another factor possibly related with the behaviour of sharing needles.
Those whose source of income is illegal or Prostitution were slightly more likely to have recently
shared needles than those with a legal source of income (non-significant finding).
3.2. Marginalisation variables
Amongst marginalisation variables, only previous imprisonment and the absence of drug
treatment proved to have significant relationships with needle sharing. Nearly twice as many
women who had been in prison engaged in recent needle sharing compared to those who had
never been in prison
The absence of prior treatment is considered to be an indicator of the degree of marginalisation
of roUs. We chose to use as a reference stratum "having received methadone maintenance
treatment", as this group bad the lowest proportion of having shared needles in recent months
(24.6 percent). Results of the linear trend test showed that those that had received no treatment
were twice as likely to have engaged in needle sharing in the last six months compared to the
methadone group.
HIV status itself is not a factor likely to be associated with needle sharing in the last six months,
yet a large number of those who knew of their HIV-positive status reported to have quit sharing
injection material. For this reason, being mY-positive seems to have a protective relationship
with needle sharing, although the association is not statistically significant
3.3. Drug-using habits
When drug use began at an early age (16 years old or less), we found a greater proportion of
women that had recently shared injection equipment (45.7 percent) compared to 30.2 percent of
those who began using drugs between the ages of 17 and 19 or 24.8 percent of those who began
at the age of 20 of later. We used the latter group as reference stratum to conduct a linear trend
test, finding that those of the intermediate age group had an OR of 2.0 and the youngest age
group an OR of2.6.
The use of certain non-injectable drugs such as amphetamines and benzodiazepines were
associated with the habit of needle sharing with an OR of 3.4 and 1.8 respectively. But the
strongest association was with those who had injected heroin in recent months, who were nearly
three times more likely to have shared injection material than those who had not injected heroin.
We did not find any significant relationships with the users of other types of intravenous drugs.
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3.4. Sexual habits
For the analysis of sexual habits in our population, we found it worthwhile to differentiate
between sexual habits with a regular partner, with a casual partner and with clients (in the case of
. prostitution). Having ever had a regular partner, whether ffiV-positive or an mu, did not have a
significant relationship with sharing injection material. However, we did find a strong
relationship with another risky behavior - not always using condoms for vaginal penetration. In
effect, those women who did not always use condoms with their regular partner were 3.5 times
more likely to have shared injection material in the last 6 months.
Amongst those who had ever had a casual sexual partner, we had a similar finding. Though there
was no direct association with needle sharing, there was a strong association for those women
who did not always use condoms for vaginal penetration with their casual partners. This time the
OR was 7.3.
We did find a positive association between having ever had sex with a client and the habit of
needle sharing. Those who had ever practiced prostitution were nearly two times more likely to
have shared needles than those who had never had clients. Although the age of starting into
prostitution did not have a statistically significant association, we did see a clear tendency for the
younger a woman began working as a prostitute the more likely she was to share needles. We
also found a strong relationship between not always using condoms with clients for vaginal
penetration and needle sharing, with an OR of 4.8.
3.5 Reproductive habits and infections
Using less viable methods of contraception such as "withdrawal" was related to the habit of
needle sharing. We found that those who practiced withdrawal were two times more likely to
have shared needles compared to those who didn't practice withdrawal.
The age of first pregnancy was strongly related to the behaviour of needle sharing. Pregnancy at
a young age indicated an important degree of marginalisation and generally was accompanied by
other risky behaviours. Those that had their first pregnancy at age 17 or younger were four times
more likely to have shared needles than those who had their first pregnancy at the age of 18 or
later.
It is evident from these results that not only are risky behaviours frequently associated but
protective behaviours as well. For example, those women who had PAP smear tests taken
regularly tended to share injection material in a lesser proportion (20.9 percent) than those who
didn't have smear tests regularly (45.2 percent). In other words, there appears to be a protective
relationship between having a regular smear test and sharing needles (OR=O.3; CJ=O.2-O.5).
Having recently had an infection may be an indicator of other risk behaviours. The women who
had had an infection during the past year were twice as likely to have shared needles than those
who hadn't had an infection.
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3.6. Origin of the sample
It appears that more of the women who attend the methadone services were reached by messages
to avoid sharing injection equipment than those who don't use the methadone services. When
the interview was conducted in a methadone service, the rate of women that had shared needles
was 28.0 percent, whereas if the woman was interviewed in another drug service or on the street,
the rate of sharing needles was over 35 percent.
3.7. Results of hierarchical logistic regression analysis
Table 8.2 presents the results of the four models. In the first model, we find that being 25 years
old or older is a protective factor for the behaviour of sharing needles. In particular the group of
25- to 29-year-olds and the over 35-year-olds presented as significant protective factors, and the
group of 30- to 34-year-olds did not reach significance in this first model but did become
significant in the third model.
The second model adds variables representing socioeconomic status. The age of leaving school
dropped out of the equation while the variables "abode" and "income" remained. The place of
residence manifests itself as a variable with a great deal of influence over the behaviour of needle
sharing, with those without a fixed address having an OR=5.8 (CI=3.0-11.2) compared to those
with a fixed address. When the source of income was illegal or from prostitution, contrary to
what was expected, a protective relationship appeared, although this factor did not become
significant until the third model. Age maintained a level of significance similar to the first model.
In the third model those variables which express the degree of marginalisation of the women are
added. A number of variables dropped out of the equation for lack of significance, including:
having had a regular !DU sexual partner; having had a casual sexual IDU partner; not having ever
received drug treatment; and having ever been in jail. The age at first pregnancy appears in this
model as an influential factor in the habit of needle sharing. Those women who had their first
pregnancy before the age of 18 were three times more likely to have engaged in needle sharing,
than those who experienced their first pregnancy after 18. This model also introduces "ever
practicing prostitution" as a risk factor with an OR=1.7. In this third model, significance is
improved for age as well as for the socioeconomic variables.
In the fourth model we added other variables considered to be related to the habit of sharing
injection material, including: having had a regular sexual HIV-positive partner; having injected
drugs in prison.; having injected cocaine; heroin or cocaine+heroin; place where subjects were
recruited; and knowing one is HIV-positive. None of these variables were significant and
consequently all were dropped out of the final equation.
Also included in this fourth model were variables that imply risky behaviour. These variables are:
not getting a PAP smear test with regularity; not always using a condom in vaginal intercourse
with a casual sexual partner; not always using a condom in vaginal intercourse with a regular
sexual partner; not always using a condom in vaginal intercourse with clients; and not having a
current regular sexual partner. Of these five variables, the first two appear to be important
determinants. Not getting PAP smear tests with regularity carries an OR=2.3(CI=1.24.2) and not
always using a condom in vaginal penetration with a casual partner has an OR=4.5(CI=1.6-12.7).
The introduction of this new group of variables reinforces and improves the ORs of the variables
from the marginalisation group, although it somewhat lowers the OR of the variable "no fixed
address", and has no effect on the rest of the variables.
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4. Discussion
. Our study provides further evidence that IDUs are reducing their unsafe practices of sharing
injection equipment For the third of our sample which continues to share injection equipment,
the bivariate and regression analyses presented in this chapter help to characterise this residual
risk group by revealing a variety of related characteristics and behaviours. First of all, the
younger IDUs appear to be more likely to share needles, a finding also reported by other Spanish
studies (Hernandez-Aguado et al., 1994; Bravo et al., 1994). One possible explanation for this is
that the younger population (adolescents in particular) tend to perceive themselves as
invulnerable to many health threats and are therefore more likely to engage in risk-taking
behaviours. This might also explain the positive associations with other risk-taking behaviours,
including not always using a condom with a casual partner, not having a regular smear test, and
the use of amphetamines, benzodiazepines, and heroin injecting. Bravo et al. (1994) also noted
less frequent condom use amongst IDUs who shared injecting equipment
The regression analysis indicated that the residual risk group is quite economically oppressed and
marginalised, having no fixed address and tending to have the first pregnancy at an early age.
They were also more likely to have been to prison and to be prostitutes, according to the bivariate
analysis. A relationship between needle sharing and prostitution was also reported by Bravo et al.
(1994).
The relationship between not currently sharing needles and having been in methadone
maintenance treatment provides evidence of the potentially positive impact drug treatment
programmes can have on Hl'V risk behaviours. Of course the converse of this is also possible -
those most likely to share needles are an oppressed, marginalised subgroup with less access to
this type of drug treatment As other studies have suggested, this residual risk group may be
better accessed through needle exchange schemes. For example, Archibald et al. (1998) found
that frequent attendance at a needle exchange program was associated with borrowing used
needles, and amongst women it was independently associated with frequency of injection of any
drug, shooting gallery attendance and having an illegal source of income.
Reducing the needle-sharing practices in this residual risk group of female mus poses a major
challenge to future mv prevention programmes. In particular, programme planners may want to
target the younger population with strategies to increase their perceived susceptibility to
contracting Hlv, especially considering that this population may be simultaneously engaged in a
variety of high risk behaviours. Although data on the impact of needle exchange programs on
mv incidence are inconsistent, the fact that they attract IDUs who have high risk behaviours or
unstable lifestyles makes them a potentially important venue for preventive interventions with
this hard-to-reach population.
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5.Conclusions
C Our data confirm that IDUs are making changes in their risky behaviours, particularly in the
habit of needle sharing.
C The residual risk group of female IDUs which continues to engage in needle-sharing
practices is characterised by being younger, having a lower socioeconomic status, being more
marginalised, and practicing other risk-taking behaviours.
C The relationship between not always using a condom with a casual partner and recent needle
sharing indicates a particularly high risk subgroup and suggests a possible route of
transmission into the non-drug-using population.
C The lower rate of sharing needles among those who had received methadone maintenance
treatment provides further evidence of the potential benefits of HIV risk-reduction
interventions within drug programmes.
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Table 8.1 Proportion of women sharing needles by selected variables
. Variable Total Sharing needles OR(Cl.95%} I!
Yes(%) No(%)
Sociodemographics
Age
24 or less 73 50.7 49.3 3.6(1.5-8.7) ***3
25 -34 182 30.7 69.3 1.5(0.7-3.5)
35 or more 49 22.4 77.6 1(reference)
Age leaving education
15 or less 170 40.6 59.4 1.9(1.2-3.1) *
16 or more 129 26.4 73.6
Living with
Parents or relatives 89 18.5 81.5 0.3(0.2-0.6) ***
Other/alone 212 41.0 59.0
Abode
No fixed address 69 60.9 39.1 4.3(2.5-7.6) ***
Fixed address 235 26.4 73.6
Income
DIegal+prostitution 137 37.2 62.8 1.3(0.8-2.5) n.s.
Legal 167 31.7 68.3
Who finances your expenses
Yourself 182 30.2 69.8 0.6(0.4-1.0)
Your parents 122 40.2 59.8
Marginalisation
Prison
Yes 98 42.9 57.1 1.7( 1.1-2.9) *
No 206 30.1 69.9
Injected in Prison
Yes 32 46.9 53.1 1.3(0.5-3.0) n.s.
No 66 40.9 59.1
IDV+
Yes 165 34.5 65.6 0.9(0.5-1.5) n.s.
No 97 37.1 62.9
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Table 8.1 (continued) Proportion of women sharing needles by selected variables
Variable Total Sharing needles OR{CI.95%) U
Yes(%) No(%)
Drug treatment
Methadone 65 24.6 75.4 1(reference) *a
Other treatment 143 34.3 65.7 1.6(0.8-3.3)
None 96 40.6 59.4 2.1(1.0-4.5)
Drug-using habits
Age began injecting drugs
16 or less 81 45.7 54.3 2.6(1.4-4.8) *
17 - 19 81 39.5 60.5 2.0(1.1-3.7)
20ormore 141 24.8 75.2 1(reference)
Use amphetamines
Yes 22 45.7 54.3 3.4(1.4-8.6) *
No 222 32.2 67.8
Use benzodiazepines
Yes 113 42.5 57.5 l.8(l.1-2.9) *
No 191 29.3 70.7
Heroin injecting
Yes 240 38.3 61.7 2.7( 1.4-5.3) **
No 67 18.8 81.3
Cocaine injecting
Yes 160 32.5 67.5 0.8(0.5-l.4) n.s.
No 144 36.1 63.9
Heroin+Cocaine injecting
Yes 151 37.7 62.3 1.4(8.4-2.2) n.s.
No 153 30.7 69.3
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Table 8.1 (continued) Proportion of women sharing needles by selected variables
Variable Total Sharing needles OR(O.95%} l!
Yes(%) No(%)
. Sexual habits
Ever had a regular sexual partner
Yes 293 33.4 66.6 0.4(0.1-1.4) n.s.
No 11 65.5 45.5
Ever had a regular sexual fllV+ partner
Yes 137 31.9 68.1 0.8(0.5-1.3) n.s.
No 152 37.5 62.5
Ever had a regular sexual IOU partner
Yes 257 34.6 65.4 1.1(0.6-2.2) n.s.
No 47 31.9 68.1
Frequency of condom use with regular sexual partner
-Vaginal intercourse
Never/sometimes 122 36.9 63.1 3.5(1.3-9.7) *
Always 35 14.3 85.7
-Anal intercourse
Never/sometimes 39 38.5 61.5 6.2(0.7-53.9) n.s.
Always 11 9.1 90.9
-Oral intercourse
Never/sometimes 123 38.2 61.8 n.s.
Always 3 0.0 100.0
Ever had a casual sexual partner
Yes 241 33.2 66.8 0.8(0.4-1.4) n.s.
No 62 38.7 61.3
Ever had a casual sexual HIV+ partner
Yes 53 35.8 64.2 1.4(0.7-2.7) n.s.
No 186 28.5 71.5
Ever had a casual sexual IOU partner
Yes 156 36.5 63.5 1.2(0.8-2.0) n.s.
No 141 31.9 68.1
Frequency of condom use with casual sexual partner
-Vaginal intercourse
Never/sometimes 48 54.2 45.8 7.3(2.7-19.3) ***
Always 50 14.0 86.0
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Table 8.1 (continued) Proportion of women sharing needles by selected variables
Variable Total Sharing needles OR{CI.95%} I.!
Yes(%) No(%)
Sexual habits (continued)
-Anal intercourse
Never/sometimes 9 22.2 77.8 n.s.
Always 6 0.0 100.0
-Oral intercourse
Never/sometimes 68 34.8 65.2 1.1(0.2-4.7) n.s.
Always 9 33.3 66.7
Ever had a client
Yes 152 41.4 58.6 1.8(1.1-2.9) *
No 164 28.0 72.0
Age at first client
17 or less 20 55.0 45.0 2.7(0.9-8.7) *3
18 -22 52 46.2 53.8 1.9(0.8-4.4)
23 + 65 30.7 69.3 1 (reference)
Frequency of condom use with client
-Vaginal intercourse
Never/sometimes 26 61.5 38.5 4.8(1.7-13.2) **
Always 52 25.0 75.0
-Oral intercourse
Never/sometimes 55 40.0 60.0 1.4(0.5-4.1) n.s.
Always 22 75.9 68.8
-Anal intercourse
Never/sometimes 13 46.2 53.8 1.7(0.3-10-0) n.s.
Always 9 33.3 66.7
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Table 8.1 (continued) Proportion of women sharing needles by selected variables
Variable Total Sharing needles OR(CI.95%) p
Yes(%) No(%)
Reproductive habits and infections
Ever used condom
Yes 257 32.3 67.7 0.6(0.3-1.1 ) n.s.
No 47 44.7 55.3
Regular periods
Yes 99 28.3 71.7 0.7(0.4- 1.1) n.s.
No 205 37.1 62.9
Contraception currently
Yes 159 30.2 69.8 0.7(0.4-1".1) n.s.
No 140 38.6 61.4
Used withdrawal last 5 years
Yes 123 43.1 56.9 1.9(1.2-3.1) **
No 181 28.2 71.8
Ever been pregnant
Yes 230 35.7 64.3 1.3(0.7-2.3) n.s.
No 74 29.7 70.3
Age at first pregnancy
17 or less 74 56.8 43.2 4.2(2.2-7.9) ***
18 + ISO 24.0 76.0
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Table 8.1 (continued) Proportion of women sharing needles by selected variables
Variable Total Sharing needles oR(CI.95°/.,} ~
Yes(%) No(%)
Reproductive habits and infections (continued)
Ever have miscarriages
Yes 66 47.0 53.0 2.0( 1.1-3.5) *
No 238 30.7 69.3
Ever had abortions
Yes 119 28.6 71.4 O.7(4.0-1.1) n.s.
No 185 37.8 62.2
Regular smear test
Yes 134 20.9 79.1 0.3(0.2-0.5) *.*
No 168 45.2 54.8
Hepatitis B last year
Yes 72 38.9 61.1 1.4(0.8-2.4) n.s.
No 212 31.6 68.4
TBC last year
Yes 45 46.7 53.3 1.9( 1.0-3.7) *
No 239 31.0 69.0
Some infection in last year
Yes 148 40.5 59.5 2.0(1.2-3-4) **
No 136 25.7 74.3
Place where the interview was conducted
Sample
Drug services 107 35.5 64.5 n.s.
Methadone services 50 28.0 72.0
On the street 147 35.4 64.6
a:p significance of linear trend test
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Chapter Nine
Determinants of Never Used Condoms amongst Female lDUs
1. Introduction
The sexual behaviour of female IDUs is comparable to that of non-IDUs, presenting similar
attitudes and having similar problems with condom use. In all developed societies, it is assumed
that it is the man who should initiate the use of a condom, making it difficult for a woman to
impose her desire for one to be used. It is common to find a condom in a man's wallet, while it's
unusual to find one in a women's purse, which would be considered libertine by society and by
her own partner. The use of condoms with a steady partner is less frequent than "with casual
partners or clients, in the case of prostitution (Chapter 4: Tables 4.5, 4.6, and 4.8). Effectively,
many women who use condoms regularly with their clients refuse to use them with their habitual
partners, even when the partner is an IDU, thus exposing themselves to a higher risk of
contracting HIV from their partner than from the practice of prostitution.
Although the last decade has seen an important reduction in certain risk behaviours of IDUs, such
as needle sharing (Chapter 8), there has been less success in increasing the conduct of safe sex
(Hart, 1989; McKeganey, 1990; Harris, 1990), especially the use of condoms with a steady
partner. In some cases, perhaps in response to safe-sex campaigns, there has been a decrease in
the number of casual partners, but rarely has there been a parallel increase in condom use
(Chitwood, 1990).
In their study of women and AIDS, McCoy and Inciardi (1993) proposed a model of social
determinants of sexual risk behaviours. They suggest that the social determinants include such
factors as: attitudes about condom use and with whom they should be used; the extent to which
drug use by the woman impedes her judgment about participating in risky behaviours; her
dependence on an .!DU partner for her support and that of her children; and cultural expectations
about female partners during sex. The model also includes a number of other factors which have
been found to be associated with unsafe sexual practices, including: limited education, financial
dependency, and having child care responsibilities. The theoretical model proposed by these
authors provides a useful framework for studying sexual risk taking by women.
In this chapter we have chosen to focus our study of sexual risk taking on those women who
reported never using condoms in their sexual relations (n=47). It seems to us to be of vital
interest to identify this residual group of risk and to analyse the characteristics and circumstances
of these women in order to facilitate the design of new strategies intended to increase condom use
in this group.
Thus the principal objectives of this chapter are to determine the profile of female IDUs who still
have never used condoms and to identify the social determinants of not using condoms.
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2. Methods
. The methods used for this study, including the bivariate and multivariate analyses, are described
in Chapter 3. "Never used condoms" is the dependent variable, and the logistic regression model
involves the following four models of explanatory variables:
Modell: Age
The biological age (coded into four categorical age groups: 24 or less; 25-29; 30-34; and 35+) was
the sole variable used in this group in order to evaluate the effect of age on the dependent variable
("never used condoms") and on the other independent variables.
Model 2: Socioeconomic status
Three variables were selected to define the general socioeconomic status of female IDUs: age left
full-time education (coded into four categorical age groups: 13 or less; 14-15; 16-18; and 19+);
source of income during past six months (illegal and prostitution versus legal); and, place of
residence in past six months (no fixed abode versus abode). .
Model3: Marginalisation
In addition to socioeconomic status, six variables were chosen to characterise the extreme
marginalised nature of the sample population. These variables were: age at first pregnancy (17 or
less versus 18+); drug treatment received (any treatment and none versus methadone
maintenance); and four dichotomous variables (yes versus no): ever had clients; previous
imprisonment; having a regular partner who was an IDU; and having a casual partner who was an
IDU.
Mode14: Reproductive background
Specific known reproductive circwnstances that have an influence on condom use were included
in the fourth model. These dichotomous variables (yes versus no) are: to have regular periods; use
contraception currently; ever been pregnant; and ever had abortions.
Model 5: Risk behaviours
Specific known risk behaviours thought to be related to "never used condoms" were included in
this model: ever have regular I-llV+ partner; cocaine injecting; heroine+cocaine injecting; age at
first injection; actual regular sexual partner; use crack; ever share needles; know HIV serology;
and place where interview was conducted
3. Results of Bivariate Analysis
The bivariate relationships between "Never used condoms" and selected independent variables
are examined in Table 9.1.
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3. 1. Sociodemographic characteristics and never used condoms
As expected, we found a negative association between age at the time of interview and having
never used a condom. In effect, the younger the age, the greater the risk of having never used a
condom. Results of the linear trend test were very significant. Those under 25 years were 4.3
times more likely to have never used condoms than those over 35 years. This excess of risk
decreased sharply for the other age strata, with both the 25- to 29-year-olds and the 30- to 34-year-
olds presenting an OR of 1.6 when compared to those over 34 years.
The relationship with age at the time of leaving school was again negative, but not significant.
There was also no clear association with the persons with whom they live, nor the place where
they live. Nor did we find a significant relationship when we looked at source of income,
comparing illegal+prostitution to legal.
Knowing that it is more common for prostitutes to use condoms than other marginalised groups,
we decided it was logical to regroup the source of income variables to compare illegal versus
legal+prostitution. This produced a strong positive association, with illegal having an OR of 2.5
compared to the group legal+prostitution. .
There was also a significant association with the variable of who finances one's expenses. When
the woman is responsible for her own expenses, the risk of having never used condoms was cut in
half when compared to being dependent on someone else. In this case, one must be aware of the
potential for confounding, either by the age of the woman or by the fact that women who cover
their own expenses may be working as prostitutes and as we just mentioned, prostitutes have a
higher rate of using condoms.
3.2. Marginalisation variables
Of the three variables which we considered to be indicators of marginalisation, two (having ever
been to prison and having injected in prison) were not significantly associated with having never
used a condom.
Nevertheless, we found a strongly significant association between knowledge of one's HIV status
and condom use. Those female IDUs who knew of their seropositivity were much less likely to
have never used a condom than those who didn't know they were seronegative or had never been
tested.
3.3. Drug-using habits
No significant relationships were found between condom use and age of initiating drug use.
Having used methadone in the six months prior to the interview lowered the risk of having never
used a condom by one-fifth. This might be explained by the fact that the great majority of these
women had been enrolled in drug or methadone treatment services during this time, which makes
them more likely to have received safe-sex messages as welJ as to have had better access to
condoms.
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Considering that women who have been in methadone treatment are at a lower risk for having
never used a condom (as just mentioned), we compared this group with those that received any
other type of treatment and with those who never received any treatment. The group that had
received other treatment presented a slight positive association though not significant, while the
group that had never received any treatment presented a strong positive association with an odds
ratio of 4.5 for having never used a condom. The result of the linear trend test between these
groups was significant.
Those women who used crack in recent months were three times more likely to have never used a
condom. These data coincide with data obtained in a Spanish study (Bravo, 1996) in which crack
users, of both sexes, presented an association with not always using a condom.
Although no relationship was found with having ever shared injection material, there was a
positive association with having shared in the past six months. Those who reported recent sharing
of injection equipment were nearly two times more likely to have never used condoms.
3.4. Sexual habits
Having a steady sexual partner was positively associated with having never used a condom, even
if the partner was an IOU. The corresponding odds ratios for these variables were 1.8 and 1.6,
respectively (though non-significant). In other words, there is a greater probability of having
never used a condom when one has maintained sexual relations with a stable partner, and this
holds true even if the partner is an IOU. One must realise that many of these women share
injection material with their partner, and consequently may consider the use of a condom
unnecessary (in that they are already exposing themselves to whatever risk their partner poses).
The situation changes when the stable partner is Hlv-positive. In this case, the odds are halved,
suggesting that knowledge of a partner's mv positivity doubles the likelihood of condom use.
When the woman maintains sexual relations with casual partners, there is a clear increase in
condom use, which is maintained for IDU partners as well. In both cases, when one had a casual
partner and when this partner was an IOU, the odds ratios for having never used a condom are
0.2. When the casual partner was mv-positive, the use of condoms was maintained equally high,
with an OR9>.4. In a study conducted by Helal et a1. (1995) in France, it was found that 33
percent of the subjects had never used condoms with their casual partners. Nevertheless condom
use was significantly greater when the partner was seropositive (38 percent versus 12.7 percent).
As we have already mentioned, one decisive factor for the use of condoms is the practice of
prostitution, which presented a strong negative association with having never used a condom
(OR=<l.I), in fact one of the strongest of the study.
3.5 Reproductive habits
Women with regular menstrual periods use condoms less than those who have irregular cycles.
The OR for those who have regular periods is 2.8. This association demonstrates one of the
principal reasons for condom use - contraception, as condoms are used more amongst women
who can't trust the regularity of their cycle. This conclusion is confirmed by evidence that those
women who currently use some type of contraception present a strong negative association with
having never used a condom. In other words, the condom is a contraceptive method which has
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been widely diffused in this population.
Those women who have ever been pregnant, as well as those who have ever had an abortion,
were half as likely to have never used condoms than those who have never experienced these
circumstances.
3.6. Origin of the sample
Of the women recruited in methadone services, only 6 percent had never used a condom.
Therefore this stratum was selected as a reference for the linear trend test., which indicated that
those recruited in other drug services were more than twice as likely to have never used a
condom, while those recruited from the street were four times more likely.
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Table 9.1 Proportion of women who never used condom by selected variables
Variable Total Ever used condom OR{CI.95%) Q
No(%) Yes(%)
Sociodemographics
Age
24 or less 73 27.4 72.6 4.2(1.2-15.9) **a
25 -29 110 12.7 87.3 1.6(0.5-6.3)
30 - 34 72 12.5 87.5 1.6(0.4-6.7)
35+ 49 8.2 91.8 1 (reference)
Age leaving education
13 or less 88 19.3 80.7 1.6(0.7-3.6) n.s"
14 - 15 82 15.9 84.1 1.3(0.5-2.9)
16 + 132 12.9 87.1 1(reference)
Living with
Parents or relatives 92 14.1 85.9 0.9(0.4-1. 7) n.s.
Other/alone 212 16.0 84.0
Abode
No fixed address 69 20.3 79.7 1.6(0.8-3.1 ) n.s.
Fixed address 235 14.0 86.0
Income
Illegal 74 25.7 74.3 2.5(1.3-4.8) **
Legal + prostitution 230 12.2 87.8
Who finances your expenses
Yourself 182 12.1 87.9 0.5(0.3-1.0) *
Your parents 122 20.5 79.5
Marginalisation
Prison
Yes 98 13.3 86.7 0.8(0.4-1.5) n.s.
No 206 16.5 83.5
Injected in Prison
Yes 32 15.6 84.4 1.3(0.4-4.5) n.s.
No 66 12.1 87.9
HIV+
Yes 166 9.0 91.0 0.3(0.2-0.7) ***
No 138 23.2 76.8
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Table 9.1 (continued) Proportion of women who never used condom by selected variables
Variable Total Ever used condom OR{O.95%} U
No(%) Yes(%)
Drug-using habits
Age started injecting drugs
16 or less 81 16.0 84.0 1.0(0.4-2.3) n.s.
17 -19 81 14.8 85.2 0,9(0,4-2,1)
190rmore 141 15.6 84.4 1(reference)
Use methadone
Yes 72 4.2 95.8 0.2(0.1-0.6) **
No 232 19.0 81.0
Use crack
Yes 46 30.4 69.6 3.0( 1.4-6.1) **
No 258 12.8 87.2
Ever shared needles
Yes 217 12.9 87.1 0.6(0.3-1.1 ) n.s.
No 86 20.9 79.1
Shared needles in last 6 months
Yes 104 20.2 79.8 1.7(0.9-3.2) n.s.
No 200 13.0 87.0
Drug Treatment
Methadone 65 7.7 92.3 1(reference) ***u
Other treatment 143 11.2 88.8 1.5(0.5-4.9)
None 96 27.l 72.9 4.5( 1.5-14.2)
Sexual habits
Ever had a regular sexual partner
Yes 293 15.7 84.3 1.8(0.2-14.9) n.s.
No 11 9.1 90.9
Ever had a regular sexual IOU partner
Yes 257 16.3 83.7 1.6(0.6-4.4) n.s.
No 47 10.6 89.4
Ever had a regular sexual IDV+ partner
Yes 138 10.9 89.1 0.5(0.2-0.9) *
No 152 21.1 78.9
Ever had a casual sexual partner
Yes 241 10.0 90.0 0.2(0.1-0.4) ***
No 62 37.1 62.9
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Table 9.1 (continued) Proportion of women who never used condom by selected variables
Variable Total Ever used condom OR{CI.95%) R
No(%) Yes(%)
Sexual habits (continued)
Ever had a casual sexual!DU partner
Yes 156 6.4 93.6 0.2(0.1-0.4) ***
No 141 26.2 73.8
Ever had a casual sexual HIV+ partner
Yes 53 9.4 90.6 0.4(0.1-1.0) *
No 186 21.0 79.0
Ever had a client
Yes 140 4.3 95.7 0.1(0.1-0.3) ***
No 164 25.0 75.0
Place where the interview was conducted
Methadone services 50 6.0 94.0 1(reference)
Drug services 107 13.1 86.9 2.4(0.6-10.9)
On the street 147 20.4 79.6 4.0(1.1-17.4) **&
Reproductive habits
Regular periods
Yes 99 25.3 74.7 2.8( 1.5-5.3) ***
No 205 10.7 89.3
Contraception currently
Yes 159 8.2 91.8 0.3(0.2-0.6) ***
No 140 22.9 77.1
Ever been pregnant
Yes 230 12.6 87.4 0.5(0.2-0.9) *
No 74 24.3 75.7
Ever had abortions
Yes 119 10.1 89.9 0.5(0.2-0.9) *
No 185 18.9 81.1
a p significance of Chi-square of Linear trend test
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4. Results of Hierarchical Logistic Regression Analysis
Table 9.2 presents the odds ratios and confidence intervals of each of the variables entered into
the regression model and the new odds ratios, as subsequent groups of variables are entered into
the regression.
Age (Introduction of Model I)
We found a negative association between having never used condoms and age at the time of the
interview. It was the youngest group (24 or less) who were most likely to have never used
condoms, with an OR of 4.2 (CI=1.4-13.3). For the other age groups the association was weaker.
As we proceed to add the other models, we see that this association loses its intensity, becoming
non-significant by the time the reproductive variables of Model 4 are introduced When the risk
behaviours and interaction factor are incorporated in Model 5, the value of the OR for the
youngest group decreases to 1.3 (CI=O.3-5.6), no longer significant.
Socioeconomic Status (Introduction of Model2)
For those who don't have a fixed address, the risk of having never used a condom is higher than
for those who do. This association becomes stronger with successive models, such that by the
final model the OR has increased more than 5 points (from 2.1 in Model2 to 7.2 in
ModelS).
The source of income (illegal+prostitution versus legal) presents a protective OR (0.5; CI=O.2-
1.0), which is explained by the more frequent use of condoms among those practicing
prostitution, although this association is weak and continues to weaken with successive models,
becoming practically non-existent in the final model (OR=O.9;CI=O.3-2.7). The age of leaving
school never entered the equation in the second model.
Marginalisation (Introduction ofModel3)
Never having had a casual IOU partner presented as a variable positively associated with the
dependent variable (OR=4.4;CI=1.9-10.6). This association is maintained in subsequent models,
though weakening slightly in the final one (OR=3.7;CI=1.4-9.8). We know from previous
studies, that even if condom use is infrequent with a steady partner, it is more frequent with casual
partners, and even more frequent with clients. (In our study condoms were always used for
vaginal intercourse with the habitual partner by 22.3 percent, with the casual partner by 51.0
percent and with clients by 66.7 percent).
The variable with the strongest association with the dependent variable in the various models is
the practice of prostitution. Those that don't practice prostitution present an OR of9.3 (CI=3.3-
26.7) in Model 3, increasing to 12.1 (CI=3.1-47.2) in the final model. The following variables
remained out of the equation: habitual IOU partner. previous incarceration; age at first pregnancy;
and having received any drug treatment
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Reproductive Background (Introduction ofModel4)
. It seems evident that the regularity of the menstrual cycle creates a certain confidence in women
which leads them to risk having sexual relations without contraception. Thus we found that those
women with regular menstrual cycles presented an OR=2.5 (CI=1.1-S.6) for the dependent
variable, compared to those who have irregular cycles. In the subsequent and final model, the
level of association of this variable hardly varied (OR=2.6;CI=l.0-6.9).
Those that were not using any methods of contraception at the time of the interview presented a
positive association with having never used a condom (OR=2.S;CI=1.1-5.6). This association is
duplicated in the subsequent model, when we control for risk behaviours (OR=5.2;CI=1.9-14.1).
This finding suggests that the condom plays an important part in the contraceptive methods
utilized by this population.
Previous pregnancies appear to predispose one to use condoms, perhaps because many of these
women are all too familiar with unwanted pregnancies resulting from a lack of contraceptive
planning. This would also explain the positive association found between having never been
pregnant and having never used condoms (OR=2.2;CI=I.O-S.O), which is maintained in the
subsequent model (OR=2.1;CI=O.8-5.2).
The variable of having had a previous abortion did not enter the equation.
Risk Behaviour (Introduction of Model 5)
The proportion of women interviewed in methadone centres who never used condoms was the
lowest of the three groups (6.0 percent), which is why we used this group as a reference stratwn.
A significant association was not found between the group of women recruited in other drug
centres and the dependent variable when compared to those recruited in the methadone centres
(OR=!.1 ~CI=O.2-5.4).
However, a strong positive association was found between those recruited in the street and the
dependent variable (OR=4.5;CI=1.5-13.0). Although the women recruited in the street probably
belong to a more marginalised group than those recruited in the centres, one can't discard the
possibility that those recruited in the treatment centres may feel morally coerced to over-report
the practice of protective behaviours (or conversely, under-report the practice of risky behaviours)
either for fear of rejection by the centre, or with the intention of pleasing the centre.
The groups which began injecting drugs earlier are the most marginalised and with risk
behaviours more evident at every level. Thus when the age of the first injection was 16 years or
less, we found a noticeably higher risk of having never used condoms if we compare it with the
group who began injecting themselves at age 20 or later (OR=2.7;CI=O.9-8.0). However, the
group who began injecting between ages 17 and 19, did not present a clear association compared
to the reference group (OR=O.8;O=O.2-2.3).
Amongst possible interaction effects, a significant interaction effect was identified between the
variables "knowing one's serostatus" and "having ever had a steady partner". This interaction
effect was entered into the final model and maintained a significant relationship with "having
never used condoms". Specifically, those who knew of their seronegativity and who had never
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had a steady partner presented an important risk of never having used condoms (OR=5.0;CI=1.9-
13.5), compared to the rest.
. Remaining out of the final equation were the following variables: use of crack in the previous six
months; having ever exchanged injection material; having a steady HIV-positive partner. having
injected cocaine or heroin+cocaine in the last six months; having a current steady partner and
knowing (or believing to know) one's HIV status.
5. Discussion
The results of the bivariate and regression analyses help us to characterise the residual risk group
of female roUs who continue to be at high risk for HIV due to their failure to use condoms. One
of the most important factors appears to be not practicing prostitution. The use of condoms
seems to be a well-diffused behaviour among prostitutes in our study, at least in their relations
with clients. Other studies have also noted that condom use tends to be more frequent with
clients and casual partners than regular partners (Rhodes et al., 1994; Paone et al., 1995).
Another striking feature of this residual risk group who has never used condoms is that they are
quite marginalised. They tend not to have a fixed address, they began injecting drugs at an early
age, and they were recruited from the street. In other words, this is a subgroup which may have
less access to HIV prevention information as well as less access to condoms themselves. Other
studies have also documented low rates of condom use among homeless women (Nyamathi et al.,
1997; Fisher et al., 1995). Future educational campaigns should be aware of the important
challenge of reaching this subgroup.
Conversely, we can also interpret from the above results that those who were enrolled in any drug
treatment programme were more likely to use condoms, suggesting the potential positive effect
these programmes can have on other risk behaviours. Of course, this finding should be qualified
by the possibility of over-reporting bias at the drug centres, as mentioned previously. Still, the
potential for drug treatment programmes to be used as a venue for implementing mv risk
reduction cannot be overstated. In fact, EJdridge et al. (1997) have reported success in reducing
sexual risk for HIV infection among female entrants to an inpatient substance abuse treatment
centre using a brief skills training intervention.
Analysis of the reproductive history provides further insights into this subgroup. Those who have
never used condoms tend not to be using any contraception, are perhaps relying on the rhythm
method due to their regular periods, and have never been pregnant. Moreover condom use would
appear to be a widely diffused (91.8 percent) method of contraception amongst those who
reported to be currently using contraception.
Younger women originally appeared to be at higher risk for having never used condoms, but the
regression analysis revealed that age was merely a marker for other more important variables,
such as prostitution, ever being pregnant, irregular menstrual cycles, frequenting of
drug/methadone centers, etc., which become more common over time.
A number of studies have noted that condom use is more frequent or consistent among those
aware of their seropositivity when compared to those who were not aware or were seronegative
(Van den Hoek, 1990; Wilson et al., 1998). Further evidence of this relationship is provided by a
study carried out in Europe by Desenclos (1993), who found that roUs who knew of their
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seropositivity were three times more likely to always use a condom than those who had never
been tested. They also conclude that the seronegative IDUs tend to be less accepting of condom
use than other risk-reducing behaviours, such as not sharing needles. A study carried out amongst
. female IDUs participating in New York City syringe exchange programmes indicated that
mowing one's HIV status was one of three independent predictors of consistent condom use with
primary partners (Paone et al., 1995). Shedding further light on this relationship, Friedman
(1994) found that condom use was quite frequent among seropositive roUs, especially if the
partner was not an IDU. The authors offered two possible explanations: the first being an
altruistic desire to protect one's partner, and the second being a strong predisposition on the part
of the partner to use condoms mowing that he/she is maintaining relations with someone who
presents a high risk.
In our study, we also found a significant bivariate relationship between knowing one's serostatus
and condom use. However, the regression analysis revealed that the interaction between mowing
one's serostatus and having ever had a steady partner was a more important direct determinant of
condom use. Inother words, it was not merely knowing one's' serostatus that determined condom
use, but knowing of one's seronegativity combined with having never had a steady partner which
had a direct effect on having never used a condom. This finding suggests that women who knew
they were seropositive and had a steady partner were more likely to have used condoms probably
to protect the steady partner.
Another important determining factor revealed in the regression analysis was never having had a
casual IDU partner. Although this is not particularly useful information as a descriptor of the
subgroup who has never used condoms, we can make some inferences. As the bivariate analysis
revealed, condoms are more likely to be used with casual partners or clients than regular partners.
The use of condoms in these situations, particularly with IDU or HIV-positive casual partners,
appears to be driven by perception of risk. Unfortunately, perception of risk is lower with a
known partner, even if the known partner is an IDU. Future interventions should help these
women to more accurately assess the risk of not using condoms with steady partners.
Furthermore, future studies couId elaborate on the reasons why these women don't use condoms
with a regular partner and propose appropriate strategies for correcting this problem.
Ideally, women need a form of barrier contraception which they can control, not requiring the
man's participation or initiative. The female condom has emerged in recent years as a possible
solution. Studies have indicated that it provides contraceptive efficacy in the same range as other
barrier methods when used correctly and has shown to be acceptable amongst women and their
partners, though cost remains an issue (Farr et al., 1994~Ray et al., 1995). Of course, the female
condom still requires male willingness to use it making safer sex negotiation skills as important as
ever. Furthermore, future studies should compare the acceptability of female condoms versus
male condoms amongst steady partners.
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6.Conclusions
From the simultaneous observation of the bivariate analysis and the multilevel logistic regression
model we can extract the following conclusions:
C Although the use of condoms is relatively accepted with clients and casual partners, it is still
not as common among stable partners, even when the partner is high risk (illU or HIV +)..
C The visit by a female lDU to a drug/methadone treatment centre apparently has a positive
effect on her risk behaviours.
C The residual risk group of female mus which has never used condoms tends to be a
marginalised group having no fixed address, having begun injecting drugs at an early age, and
having been recruited from the street
C The female lDU who knows she is seropositive and has a steady partner is more likely to use
condoms.
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Chapter Ten
Determinants of Never Received Treatment amongst Female mus
1. Introduction
This chapter introduces the topic of drug treatment. The primary issues which we wish to
consider include: access to and utilisation of treatment amongst IDUs, success in treatment; and
the effect of treatment on risk behaviours.
There exists little docwnentation of the utilisation of drug-dependency services by IDUs,
although it seems that uptake is low. Of the 104 confirmed seropositive IDUs examined by
Rhodes et al. (1993), 43.1 percent had never received help or treatment for drug dependency and
52.2 percent had not been formerly tested for my It was also observed in London that 42
percent of heroin addicts and 75 percent of cocaine users had never received treatment for drug
dependency (Strang et al., 1994). In a study carried out in Madrid amongst IDUs, only 42.0
percent of those interviewed in the street had received some type of help or treatment for drug
dependency. Of these: 21.6 percent had received treatment in a municipal centre for drug
dependence; 21.1 percent had received methadone treatment; 22.9 percent had been to a hospital
detoxification unit; 22.9 percent had received ambulatory detoxification; and 30.0 percent had
received care in the community (Zunzunegui et al., 1993). According to the results of a
European study (conducted between 1989 and 1990 in 12 countries) on the knowledge, attitudes
and beliefs of IDUs about measures taken for HIV prevention, the low utilisation of drug-
dependency services could be due to the low opinion of these services amongst IDUs. By
comparison, the direct provision of sterile injection equipment was generally welcomed
(Richardson et al., 1994).
Inequalities between men and women also occur with regard to attending services and to
assimilating information. A multi-site U.S. study on access to care for drug abusers with IDV
reported that multiple barriers in access to service exist for drug-using women (Weissman et al.,
1995). The most important barriers were cost and waiting times. The authors also noted that
significantly fewer women than men received pre- and post-test counseling and were advised to
get medical services after their first positive HIV test
According to the data recorded amongst drug addicts interviewed in Madrid in 1990, women had
a lower rate of uptake into drug-dependency services, although the differences were not
statistically significant (Zunzunegui, 1993). About 50 percent of men and 40 percent of women
in the study were recruited from drug-dependency centres, suggesting a lower rate of access
and/or utilisation for these women Although data on the use of social services amongst these
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women was not recorded, it is probable that drug-dependent women have lower rates of access
due, in part, to feelings of guilt and/or the fear that the state might consider removing their
children .
. Gender differences in the process and response to drug treatment have also been examined. As
men have traditionally accounted for a higher proportion of those addicted to heroin and
therefore a higher proportion of those entering treatment facilities, it has only recently been
questioned whether treatment intervention methods and goals are too "male-onented" and not
appropriately geared for women. In general; women are found to be more likely to drop out of
treatment than men, although when they do carry through with treatment they have similar rates
of success (reviewed in Anglin et al., 1987). Studies of the factors which contribute to positive
treatment outcome for women, though few, have consistently indicated that a partner's
involvement in entry into treatment and continued support in attending treatment are critical
(reviewed in Anglin et al., 1987).
Furthermore, a more recent study into the apparent gender paradox in drug treatment that
although women have more "risk factors" associated with drug use relapse they are no more
likely to relapse than men, found that women become more engaged in treatment specifically by
participating more in group counseling (Fiorentine et al., 1997). They did not find support for the
drug severity hypothesis (women are less likely to relapse because their drug-use histories are less
severe) or the social support hypothesis (women are less likely to relapse because they have
higher levels of social support, facilitating recovery). The authors attribute the differences in
treatment engagement to gender norms concerning help-seeking, personal independence,
strength, and control.
The relationship of drug treatment to HIV risk behaviours has not been clearly defined. First of
all, most studies have failed to adequately control for differences due to selection bias between
those seeking treatment and not seeking treatment as well as between those recruited at different
sites of treatment In fact, few studies have examined the differences between those who seek
treatment and those who do not. Ross et al. (1993), comparing those who had never been in
treatment with those who had previously been in treatment and with those currently in treatment,
found that those who had never been in treatment were younger, used and injected drugs less
frequently, had a lower level of HIV risk-related injecting behaviours (though no difference in
risk-related sexual behaviours), and reported less involvement in the drug subculture.
Most research examining the relationship between treatment and risk behaviour has come from
evaluations of methadone maintenance treatment (MMT). In general, these studies have found
that MMT has a positive effect on risky drug-taking practices, though no effect on risky sexual
practices. For example, Baker et al. (1995) found that those currently enrolled in MMT reported
a lower frequency of injecting and a higher frequency of cleaning injection equipment with
bleach than those previously or never enrolled in MMT. No differences were found in needle
sharing practices or sexual risk-taking behaviour.
The overall aim of this chapter is to shed further light on the relationship between drug treatment
and HIV risk-taking behaviours. First, we will examine determinants of having never attended
any treatment to identify differences between those who seek or have access to treatment and
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those who do not. Secondly, we will look for direct relationships between treatment and risk
behaviours to estimate the potential impact of treatment on HIV risk.
2. Methods
The methods used for this study, including the bivariate and multivariate analyses, are described
in Chapter 3. Drug treatment is defined broadly, including services ranging from short-term
counseling to residential detoxification and rehabilitation. We have also included methadone
treatment and any harm-reduction programmes, such as those which supply needles or condoms.
"Never had any treatment" is the dependent variable in the multilevel logistic regression model
which involves the fol1owing four models of explanatory variables:
Modell: Age
In order to evaluate the effect of age on the dependent variable ("never had treatment") and on
the other independent variables, the biological age (coded into four categorical age groups: 24 or
less; 25-29; 30-34; and 35+) was the sole variable used in this group.
Model 2: Socioeconomicstatus
Three variables were selected to define the general socioeconomic status of female IDUs: age left
full-time education (coded into four categorical age groups: 13 or less; 14-15; 16-18; and 19+);
place of residence in past six months (no fixed abode versus abode); and living with children
(coded into three groups: she lives with her children; she doesn't live with her children; and she
has no children).
ModeI3:Ma~nalisation .
In addition to socioeconomic status, three variables were chosen to characterise the extreme
marginalised nature of the sample population. These variables were: age at first pregnancy (17 or
less versus 18+); and two dichotomous variables (yes versus no): having a current regular sexual
partner, and having a casual partner who was an IOU.
Model 4: Risk behavioun
Specific known risk behaviours that had significant associations with "never had treatment" in the
bivariate analysis were included in the fourth model. Six dichotomous variables (yes versus no):
ever have regular HIV-positive partner, use alcohol; cocaine injecting; heroine+cocaine injecting;
never use condom; and ever sharing needles in last six months; age at first injection (coded into
three groups:16 or Jess, 17 - 19, and 20 or more); and HIV result (coded into three groups:
positive, negative, and unknown).
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3. Results of the Bivariate Analysis
The bivariate relationships with drug treatment (never versus ever) and selected independent
variables are examined in Table 10.1. A summary of the results of Table 10.1 are presented in
the foJlowing sections.
3.1. Sociodemographic characteristics
Age is a factor strongly associated with having never had drug treatment (the linear trend test is
very significant). The youngest group (age 24 or younger) was more than ten times more likely
to have never had treatment when compared to the oldest group (35 years or more). The other
two age groups do not present an elevated risk, both having non-significant associations. So it is
the youngest group in which almost half (47.9 percent) have never received any treatment. This
percentage drops sharply for subsequent age groups, with 18.2 percent for 25- to 29-year~lds,
11.1 percent for 30- to 34-year~lds, and 8.9 percent for 35 and over .
.
The age of leaving full-time studies did not present a clear association with the dependent
variable. The linear trend test was not significant; although the highest percentage of no treatment
corresponds to the group who had left their studies earliest (31.8 percent).
3.2. Marginalisation variables
In general, we observed that the group of characteristics reflecting greater marginalisation has a
higher risk of having never had treatment for drug addiction. In effect, those that don't have a
fixed address are twice as likely to have had no treatment compared to those who do have a fixed
address. On the other hand, if a woman lives with her children, the percentage of cases without
anti-drug treatment is lower (12.2 percent), than if she lives without her children (18.8 percent),
and still higher if she doesn't have children (28.7 percent). It could be that having children,
especially when they live at home, provides a stimulus for a woman to decide to seek treatment
No significant associations were found between source of income or previous imprisonment and
the dependent variable.
3.3. Drug-using habits
The age of beginning drug use is significantly associated with having received drug treatment
The linear trend test is significant, with the women who started earlier less likely to have never
received treatment. Of the group who began using drugs at age 16 or younger, 14.8 percent had
never received treatment, compared to 22.2 percent for those who began between ages 17 and 19,
and 26.2 percent for those who began at age 20 or later.
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Although the association between having ever shared injection material and having never had
treatment is not significant, we do find a clear association when this risk behaviour was
undertaken in the six months prior to the interview. Those who had recently shared needles were
over two times more likely to have never received treatment.
Having injected heroin+cocaine in the six months prior to the interview nearly doubles the odds
of having never attended treatment though the association doesn't quite reach significance
(p=O.06).
3.4. Sexual habits
Women that have never had a regular sexual partner have a much higher rate of having never had
drug treatment (54.5 percent) than those who have had a regular sexual partner (26.5 percent).
Interestingly, when the regular partner is HIV-positive, the proportion that have not received
treatment is almost one-third (10.9 percent) that of when the partner is not HIV-positive (34.2
percent).
A similar phenomenon occurs with casual partners, where we see that when the partner is HIV-
positive or an IOU, the proportion of women who have never received treatment is significantly
less.
We did not find a significant association between prostitution and the dependent variable.
3.5 Reproductive habits and infections
Having regular menstrual cycles was strongly associated with having never received treatment
Those women reporting regular periods were three times more likely to have never received
treatment. This can be interpreted that those IDUs who still have regular cycles are most likely in
less advanced stages of drug addiction and have experienced little physical deterioration (it is
well known that the use of certain drugs, especially heroin, can alter the menstrual cycle), such
that they haven't yet considered it necessary to seek treatment.
A strong relationship was also found with having ever used a condom. Those who had never
used a condom were five times more likely to have never been in treatment. Of the female roUs
who had ever used a condom, 16.7 percent had never been in treatment, compared to 51.1
percent of those who have never used a condom.
No association was found between having suffered from any type of STD and not having
received drug treatment
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Having had hepatitis B and hepatitis C in the past year both presented as protective factors
against the dependent variable, with an OR=O.5 and 0.2 respectively. This most likely reflects the
fact that in many cases the centres are detecting the hepatitis through routine physical exams
while those who haven't sought treatment are probably going undetected.
As far as the relationship between HIV serology and never having had treatment, no significant
differences were found between HlV-positives and HlV-negatives, while these differences are
evident between both groups and those who don't know their HIV serologic status.
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4. Results of the Hierarchical Logistic Regression Analysis
Table 10.2 presents the odds ratios and confidence intervals of each of the variables entered into
. the regression model, and the new odds ratios as subsequent groups of variables are entered into
the regression.
Age (Introduction of Model I)
Using the oldest age group as a reference, the youngest age group (24 years or less) presents
significant associations with having never had treatment This association strengthens with the
introduction of successive models.
Socioeconomic status (Introduction of Model 2)
The age of leaving full-time studies does not maintain a clear association with the dependent
variable until the final model, where after adjusting the model for variables representing risky
behaviours, the group who quit studying at age 13 or younger presents an OR=4.0 (CI=1.2-12.6)
for never having received treatment. in comparison to the age group who quit school latest.
Not having a fixed address is also a factor directly associated with the dependent variable. This
association continues to strengthen in subsequent models, resulting in an OR of3.3 (CI=1.5-7.3)
in the final model.
Living with children remained out of the equation indicating that it is not directly associated with
never having received treatment
Marginalisation variables (Introduction ofModel3)
Not having had a casual IDU partner presented, inexplicably, as a factor directly associated with
the dependent variable. However, in the final model, after adjusting for the variables
representing risk behaviours, this association disappears.
The most marginalised group of women, who had their first pregnancy at age 17 or younger, are,
paradoxically, at less risk of having never received drug treatment (OR=().3; CJ=().1-0.9).
Risk behaviour variables (Introduction ofModel4)
As we found in the bivariate analysis, the group of women with a regular IDV-positive sexual
partner have a lower probability of having never received treatment in relation to the group that
had not had a regular Hl'V-positive partner (OR=O.4;CI=O.I-1.0).
The age of beginning to inject drugs is also directly associated with the dependent variable.
Those who began injecting later (over age 20) were three times more likely to have never
received treatment than those who began injecting earliest (before age 17).
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Other risk behaviours, such as injecting heroin+cocaine and never having used a condom, also
present a higher probability of having never received treatment (OR= 2.9 and 4.2 respectively).
Those women who don't know their HIV serostatus have a higher probability of having never
received treatment than those who are HIV-positive (OR=2.9;CI=O.9-9.8).
5. Discussion
In this chapter we have examined the relationship between treatment and risk behaviours and we
have attempted to identify the characteristics or factors directly and indirectly associated with
having never attended treatment Unfortunately, the limitations of the study design preclude us
from making any strong conclusions, because we are unable to firmly establish the direction of
the relationships we are examining. For example, in this type of study it is impossible to establish
whether treatment has reduced risk behaviours or people with fewer risk behaviours have better
access to treatment So it is with these limitations in mind that we present the following findings .
.In attempting to define the subpopulation which treatment programmes apparently don't reach,
we found that this subgroup tended to be younger, less educated, homeless, young in their drug-
using careers, and more likely to engage in recent needle sharing, less condom use and more
injecting of heroin+cocaine. .In other words, it would appear that the IDU women who are not
being reached by drug treatment programmes are at very high risk for contracting HIV. Clearly,
this is an urgent public health problem for Madrid that needs to be addressed.
Moreover, the characteristics identified in this study are not altogether different from
characteristics identified in previous studies. For example, Ross et al. (1993) found that those
never in treatment were younger and reported lower drug use and less involvement in the drug
subculture. We also observed indirect relationships with having regular menstrual periods and
not having a casual !DU partner, which might indicate lower drug use and less involvement in the
drug subculture.
Baker et al. (1995) also found that those never enrolled in methadone treatment were younger
(non-significant trend), started injecting later (non-significant trend), and were more likely to be
homeless. Thus, on the one hand, those who have never received treatment appear to be those
who are young in their drug-using careers, and their habit has not become severe enough to lead
them to seek treatment On the other hand, never having received treatment is also associated
with a more marginalised lifestyle, suggesting that some of these women may not have access to
treatment
We also found that those who had never attended any treatment were more likely to have had
their first pregnancy at a later age and to have not had a regular HIV-positive sexual partner. .In
other words, those who attended treatment were more likely to have had their first pregnancy at a
young age, and the early pregnancy may have led them into treatment in an effort to protect their
unborn child or to take control of their life for the sake of the child. Having had a regular HIV-
positive sexual partner may indicate that these women are recognizing the risks to their health
and are seeking drug treatment in attempt to save their lives. On the other hand, it could indicate
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that an HIV-positive partner is concerned for his partner's health and more supportive of entry
into drug treatment Clearly male sexual partners play an important role in the drug treatment
process, as has been demonstrated in previous studies (reviewed in Anglin et aI., 1987).
The risk behaviours observed to have a significant relationship with treatment were: injecting
heroin+cocaine; recent needle sharing; and having ever used a condom. Those who had been in
treatment were less likely to report injecting heroin+cocaine in the previous six months. As the
direction of this relationship cannot be determined, it is difficult to say whether drug treatment is
reducing the tendency to inject heroin+cocaine or treatment programmes are simply less likely to
reach those who inject heroin+cocaine. Of course, the latter needs to be considered, as injectors
of heroin+cocaine have been found to engage in other HIV risk behaviours. Chitwood and
Comerford (1990) found that injectors of cocaine used in combination with opiates were more
likely to have multiple sex partners and high-risk injecting behaviour than cocaine-only or opiate-
only injectors. Kowalewski (1990) reported that the disinhibiting effects of cocaine may
predispose users to HIV infection through high-risk sexual behaviour. These findings are
supported by the work of Joe & Simpson (1995) who reported that HIV risks increased as a direct
function of cocaine usage level, though only for males. Among females, low-to-intermediate
levels of cocaine use (less than weekly) were associated with high-risk behaviours.
Needle sharing in the previous six months was not a significant factor in the regression model,
though many studies have reported reductions in needle sharing after exposure to treatment. This
study may not have been able to detect a direct effect of treatment on needle sharing because of a
pre-existing trend towards reducing needle sharing.
Unlike other studies, which have not found changes in sexual risk-taking, especially increases in
condom use, we found that treatment was directly related to condom use. Although the study
design precludes us from making assumptions about the directionality of this relationship, there is
evidence from other studies that treatment programmes which implement specific sexual risk
reduction interventions (such as skills training) can have success in reducing sexual risk for HIV
infection among female entrants (Eldridge et aI., 1997). Inother words, drug treatment centres as
venues for HIV risk reduction interventions can potentially have an important impact on the
prevention of the spread of AIDS.
The relationship between HIV status and treatment is a bit difficult to interpret without knowing
the direction of causality. In the bivariate analysis we observed a non-significant trend between
being HIV-positive and ever receiving treatment This could be explained by the fact that HIV-
positives frequently begin drug treatment in the hope of improving their physical state and ability
to combat the deterioration of their immune system. There was also a weaker, though positive
relationship between treatment and being HIV-negative. This may indicate that many of those
who have tested negative consider it a good time to quit using drugs, now while there is still time.
This variable was later recoded to reflect "knowledge of HIV status" and a strong positive
relationship was detected, suggesting either that knowledge of one's status prompts drug users to
seek treatment or that drug treatment successfully encourages HIV testing. Of course, this
relationship may also be reflecting an attitude of apathy in which the same individual who
doesn't seek treatment also failed to provide a medical report on their HIV status.
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Finally, although this study did not address gender differences in treatment, it seems apparent that
women have an array of different needs that ought to be considered by drug, treatment
programmes. For example, studies have indicated that women in treatment report more medical,
psychiatric, family-social, and employment problems than men (Mclellan et al., 1992; Brown et
al., 1993). More specifically, these needs and concerns include: reproductive health needs, such
as STD detection and treatment and family planning; child care responsibilities; assertiveness
training for negotiating safer sex and drug use with their partners; the involvement of male sexual
partners in the treatment programme; and vocational skiJIs training to help them re-integrate into
society without having to rely on trading sex for money or financial assistance from drug-using
partners.
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6. Conclusions
From the simultaneous observation of the bivariate analysis and the multilevel logistic regression
model we can extract the following conclusions:
C IDU women who are not being reached by drug treatment programmes tend to be younger,
less-educated., homeless, less involved in the drug subculture and engaging in more high risk
behaviour, such as needle sharing, injecting heroin+cocaine, and not using condoms.
C Exposure to treatment appears to be associated with more condom use, suggesting that drug
treatment centres as venues for HIV risk reduction interventions can potentially have an
important impact on the prevention of the spread of AIDS.
C Drug treatment is reaching IOU women who get pregnant at a young age.
C A woman's decision to seek treatment is influenced by her male partner.
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Table 10.1.
Proportion of women reporting never bad drug treatment by selected variables
Variable Total Had drug treatment OR(CL95%} ~
Never(%) Ever(%)
Sociodemogra ph ics
Age
24 or less 73 47.9 52.1 10.4(3.1-37.9)***a
25 -29 110 18.2 81.8 2.5(0.7-9.2)
30-34 72 11.1 88.9 1.4(0.4-6.0)
350rmore 49 8.2 91.8 1(reference)
Age leaving education
13 or less 88 31.8 68.2 1.7(0.9-3.2) n.s."
14-15 89 12.2 87.8 0.5(0.2-1.1)
16ormore 132 22.0 78.0 1(reference)
Abode
No fixed address 69 33.3 66.7 2.2( 1.2-4.0) **
Fixed address 235 18.7 81.3
Income
IIIegal+ prostituti on 137 23.4 76.6 0.9(0.5-1.5) n.s.
Legal 167 21.0 79.0
Ever been in prison
Yes 98 17.3 82.7 0.7(0.4-1.2) n.s.
No 206 24.3 75.7
Drug-using habits
Age began injecting drugs *a16 or less 81 14.8 85.2 1(reference)
17 - 19 81 22.2 77.8 1.6(0.7-4.0)
20ormore 141 26.2 73.8 2.1(1.0-4.5)
Ever shared needles/syringes
Yes 217 19.4 80.6 0.6(0.3-1.1 ) n.s.
No 86 27.9 72.1
Ever shared needles/syringes in last 6 months
Yes 104 26.9 73.1 2.4( 1.2-4.9) **
No 114 13.2 86.8
169
Table 10.1 (continued)
Proportion of women reporting never had drug treatment by selected variables
Variable Total Had drug treatment OR(CI.95%} ~
Never(%) Ever(%)
Injected Heroin+Cocaine
Yes 151 26.5 73.5 1.7(1.0-2.9) *
No 153 17.6 82.4
Ever used condom
Yes 257 16.7 83.3 0.2(0.1-0.4) ***
No 47 51.1 48.9
Sexual habits
Ever had a regular sexual partner
Yes 293 20.8 79.2 0.2(0.1-0.7) *
No 11 54.5 45.5
Ever had a regular sexual HJV+ partner
Yes 138 10.9 89.1 0.2(0.1-0.4) ***
No 152 34.2 65.8
Ever had a regular sexual IDU partner
Yes 257 21.0 79.0 0.7(0.3-1.4) n.s.
No 47 27.7 72.3
Frequency of condom use with regular sexual partner
Vaginal intercourse
Never/sometimes 122 28.7 71.3 6.6( 1.5-29.2) **
Always 35 5.7 94.3
Ever had a casual sexual partner
Yes 241 20.7 79.3 0.7(0.4-1.3) n.s.
No 62 27.4 72.6
Ever had a casual sexual HIV+ partner
Yes 138 10.9 89.1 0.2(0.1-0.4) ***
No 152 34.2 65.8
Ever had a casual sexual IDU partner
Yes 156 14.7 85.3 0.4(0.2-0.7) ***
No 141 30.5 69.5
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Table 10.1 (continued)
Proportion of women reporting never had drug treatment by selected variables
Variable Total Had drug treatment OR(CI.95%) p
Never(%) Ever(%)
Frequency of condom use with casual sexual partner
Vaginal intercourse
Never/sometimes 48 18.8
Always 50 20.0
81.3
80.0
0.9(0.3-2.5) n.s.
Ever had a client
Yes 140 20.0 80.0 0.8(0.5-l.4) n.s.
No 164 23.8 76.2
Frequency of condom use with client
Vaginal intercourse
Never/sometimes 26 7.7 92.3 0.2(0.0-1.0) n.s.
Always 52 28.8 71.2
Reproductive habits and infections
Regular periods
Yes 99 35.4 64.6 3.0(l.7-5.2) ***
No 205 15.6 84.4
Age at first pregnancy
< 18 74 18.9 81.1 1.3(0.6-2.6) n.s.
18 or more 230 23.0 77.0
Contraception currently
Yes 159 26.4 73.6 1.7(l.0-3.0) n.s.
No 140 17.1 82.9
IUD used in last 5 years
Yes 21 14.3 85.7 0.6(0.2-2.0) n.s.
No 283 22.6 77.4
Condom used in last 5 years
Yes 247 16.6 83.4 0.2(0.1-0.4) ***
No 57 45.6 54.4
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Table 10.1 (cont) Proportion of women reporting never had drug treatment by selected variables
Variable Total Had drug treatment OR(O.95%} ~
Never(%) Ever(%)
Reproductive habits and infections (continued)
Spermicide used in last 5 years
Yes 45 31.1 68.9 1.8(0.9-3.5) n.s.
No 259 20.5 79.5
Contraceptive pill used in last 5 years
Yes 91 19.8 80.2 0.8(0.5-1.5) n.s.
No 213 23.0 77.0
Ever been pregnant
Yes 230 19.6 80.4 0.6(0.3-1.0) n.s.
No 74 29.7 70.3
Regular smear test
Yes 134 23.1 76.9 1.1(0.6-1.9) n.s.
No 168 21.4 78.6
STD in last 5 years
Yes 77 11.7 88.3 0.4(0.2-0.9) *
No 196 25.0 75.0
HIV
Positive 165 13.9 86.1 I(reference) ***u
Negative 97 22.7 77.3 1.8(0.9-3.6)
Unknown 42 52.4 47.6 6.8(3.0-15.4 )
Hepatitis A in last 5 years
Yes 8 12.5 87.5 0.5(0.1-4.5) n.s.
No 276 20.7 79.3
Hepatitis B in last 5 years
Yes 72 12.5 87.5 0.5(0.2-1.0) *
No 212 23.1 76.9
Hepatitis C in last 5 years
Yes 89 5.6 94.4 0.2(0.1-0.4) ***
No 195 27.2 72.8
Tuberculosis in last 5 years
Yes 45 20.0 80.0 1.0(0.4-2.1) n.s.
No 239 20.5 79.5
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Chapter Eleven
Conclusion and Policy Recommendations
1. Introduction
This chapter is divided into four sections.
The first section will provide a summary of the major research findings which have been found in
the study of determinants or predictors ofHIV and HIV risk behaviour in female IDUs in Madrid.
The study of I-llV risk behaviour included: examination of the determinants of risky sexual
behaviour (lack of condom use); and risky injection practices (needle and syringe sharing).
Having experienced prison and exchanged sex for drugs or money will also be summarized in
relation with other risks and sociodemographic characteristics. Finally, we will summarise the
role of treatment. '
The second section will consider the methodological issues regarding this research and their
implications.
As a consequence of this study and based on the limitations of this research, the third section will
present a number of issues worthy of further research and propose new methods which should be
implemented
The final section, perhaps the most beneficial to the women IDUs and consequently to society,
will consider the implications for public health and briefly outline a policy agenda based on the
more relevant findings of this work, some of which may call for urgent implementation,
2. Summary of Findings
We have studied the social determinants of the risks of I-ITV and other diseases among a sample
of IDUs in Madrid First, considerable support was found for the relationship between poor
lifestyle and risk behaviour. Even though in many cases we didn't find strongly significant
statistics due to the relationships among variables that have influenced the dependent variable
both directly and indirectly, the general conclusion would be that this population is in a state of
high risk for both health and psychosocial problems.
Overall, many of these women were poorly educated and unemployed, had jail or prison
experience, were without a fixed address, and a considerable number had worked as street-
workers. The ,majority of them live with an IDU partner and live in an unstable situation, with a
multitude of risk factors for iJl health, particularly for HIV and SIDs. Thus our sample indicates.
in comparison with other studies, that women who continue to inject drugs are a higher risk
population, in general.
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One of the most pervasive factors identified by this study was having no fixed address. It was
directly related to prostitution, recent needle sharing. lack of condom use, no exposure to
treatment, and even maintained a direct relationship with HIV prevalence. Furthermore, we
found an indirect association with previous imprisonment. Previous research has found elevated
levels of HIV risk practices in homeless populations, including mu, crack-cocaine use, sexual
relations with an IDU, exchange of sex for money or drugs, multiple sexual partners, and
inconsistent condom use (Fisher et al., 1995; Nyamathi et al., 1997), but little information is
available on the specific risks associated With homelessness in an IDU population. Clearly this
subgroup of IDUs appears to be at higher risk for HIV while being more socially isolated, with
less access to drug treatment CertainJy the interpretation of these findings must be qualified by
the limitations imposed by the design of this study; however, they do have important implications
for future research and policy (to be discussed in subsequent sections.)
On nearly all of the characteristics examined, even when ail variables were controlled in the
multivariate analysis, findings indicated that first pregnancy at a younger age was a relevant
predictor for risk behaviour in IOU women, There was a relationship to prostitution and sharing
needles; ever being pregnant was correlated positively with previous imprisonment and
negatively with high-risk sexual activity. First pregnancy at a younger age is also positively
related to treatment The rou women that experienced their first pregnancy before age 18 may
also have a lower socioeconomic status and need money to support themselves as well as their
children, which may lead them into a life of prostitution or crime just to survive. Earlier studies
have linked both early age of first pregnancy and prostitution to childhood sexual abuse (Zierler
et ai, 1992). Fmthermore, early sexual experience has been identified as a factor in prostitution
(James and Meyerding, 1977), and age at first coitus as a marker for risky sexual behaviour
(Greenberg, Magder and AraJ, 1992). The implications of these findings are that early sexual
experiences, including childhood sexual abuse, can be used as markers for high-risk sexual
behaviour and interventions aimed at delaying a woman's first sexual experience may lower the
likelihood of later engaging in prostitution and other risky sexual practices. We did not look at
the relationship with rape or sexual assault in this study, but many authors have considered this
Issue.
More than half(53.4 percent) started injecting drugs before the age of20. This, without a doubt,
will have an important impact on their psychological development and social behaviour as it is in
this stage of life when the basis of their adult personality is established. Therefore, in these
women, future behavioural problems are found with greater frequency than in those who started
injecting drugs later in life.
The preceding chapters identified a number of risk factors associated with HIV infection,
including the observation that female IOUs were at greatest risk ofHIV infection through sexual
partners who were either drug addicts and/or HIV-positive. The partner aIso has a great influence
in the introduction of drug use to the woman. Almost half of the women questioned (49 percent)
injected drugs for the first time with their regular partner. Having a steady HIV-positive partner
also played a significant role in seeking treatment This demonstrates the great influence a
regular male Partner has over a woman, and this influence must be taken into account when
developing strategies against drug addiction. Perhaps one of the most effective measures to
prevent drug addiction in women would be to persuade the drug-using partner to discourage the
women from taking drugs and to inform him of the enormous influence he can have in this regard
and the consequent responsibility. Furthermore, it is imperative for treatment programmes to
involve the regular partner in the treatment process.
175
When we studied the HIV risk behaviour of sharing injection equipment, we found-that those
women who reported sharing habitually with partners were clearly taking high risks, just because
of the frequency with which they used unsterile needles and syringes, particularly when we know
that a great proportion of these partners are HIV-positive. Most studies indicate that women
exchange needles more than men when both partners are at risk of HIV transmission and when
needles and syringes are shared between them. However, given that the majority of women are in
relationships with injectors whereas the same is not true among men, one would have to conclude
that in this respect women are at higher risk' of HIY.
Unlike men, very few women (1 percent) participate in drug-taking behaviour alone. This
implies that women, more than men, need to feel supported by someone in making decisions of
this kind. involving the transgression of a behavioural norm. This is another indication of the
great difference between men and women in the drug-injecting experience. Women are seen to
be more affected by prejudice than men and thus need to have someone reaffirm their behavior
and push them into action. The explanation for this can be found in the roots of a society which
establishes different roles according to one's sex, producing gender differences.
Women most commonly shared needles with a regular sexual partner (47.5 percentj.whilst 17.8
percent shared with a male friend and 10.9 percent with a female friend The main source of
injecting equipment for women was the pharmacy or chemist, although 56.6 percent of women
reported the use of needle-exchange schemes. This observation, however, probably reflects the
sample characteristics of recruitment and thus any comparison with other (associated or
independent) studies would be meaningless.
This leads to relevant observation that the risk for HIV among female heroin addicts is influenced
by their relationship with male sexual partners. Women who were living with a drug user were
less likely to use condoms. Fwthennore, having an HIV-positive partner was one of the strongest
determinants of HIV for the population studied. despite the fact that we found an interaction
indicating that women who know that their partner is HIV-positive use more condoms than other
IOU women, and this issue will be considered later.
It should also be noted that in the multivariate analysis, having shared a needle in the past six
months was negatively associated with HIV prevalence, regardless of the type of partner, which
may imply that those women who knew they were HIV-positive had stopped sharing needles,
although such a hypothesis cannot be confirmed by these data.
When we studied the predictive factors for continuing to share needles, we found that this
residual risk group was quite marginalised, as indicated by: not having a fixed address; younger
age of first injecting drugs; younger age at first pregnancy; prison; and prostitution. Thus it
appears that female heroin addicts who continue to engage in risky injection practices are
embedded in a high-risk lifestyle.
Sexual behaviour in this population reflects the net effect of almost all of the variables. As
unequivocally demonstrated (Table 5.3, Chapter 5), having a partner who is HIV-positive
increases the likelihood of HIV infection. Given that nearly 50 percent of this population of
female IOUs reported having a regular partner who is Hl'V-positive, the importance of this factor
cannot be underestimated. Clearly the most important conclusion to be drawn from this study is
that the sexual partners (and therefore sexual behaviour) of female IOUs are as important a
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component in explaining the HIV epidemic in this population as other risk factors, including
high-risk drug-taking behaviour. .
As it was noted by Barnard (1992), in the sphere of sex and the negotiation of sexual encounters,
with regard to heterosexual relationships, expectations of behaviour appropriate to a woman
place the woman in a more disadvantaged position. First of all, both men and women are
socialised into a culture which on the whole encounters difficulties in the discussion of sexual
matters. This situation is further exacerbated by expectations of male dominance and female
modesty. In sexual issues, women are not expected to take the lead over men. Given an existing
power balance in favour of men, it may be extremely difficult for a woman to assert her desire
that a condom be used. Thus in general, it is quite unusual for women to carry condoms even
when they are working as a prostitute. The low rate of condom use in sexual relations with long-
term partners raises a different set of issues, including the idea that condom use decreases
emotional intimacy and physical closeness, and the social construction of the condom as a barrier
in physical terms. Another issue is that requesting the use of a condom may imply mistrust in the
relationship. Finally, as Day et al. (1993) discovered., many female sex workers find that they
need to make clear the distinction between personal and commercial sex, causing them to shun
the use of condoms in private relationships.
In summary, the female IDUs in this study are particularly vulnerable to HIV infection because of
their higher level of risk practices as well as their sexual behaviour with regular sexual partners.
As it has been shown in the outcome of regression, the strongest determinant of HIV infection in
women is to have an mv-positive sexual partner.
When we look at the social determinants of sexual risk behaviour among female roUs, studying
in particular never using condoms, we found that, once again, the most important contributors to
the model were the social marginalisation factors. In fact, the residual risk group who has never
used condoms tends not to have a fixed address, began injecting drugs at an early age, and were
recruited from the street In other words, this is a subgroup which may have less access to HIV
prevention information as well as less access to condoms themselves. Those who began injecting
drugs earlier are the most marginalised and have risk behaviours more evident at every level.
Another important determinant of never using condoms was not practicing prostitution. The use
of condoms seems to be a well-diffused behaviour among prostitutes in our study, at least in their
relations with clients. Other studies have also noted that condom use tends to be more frequent
with clients and casual partners than with regular partners (Rhodes et al., 1994; Paone et.al,1995).
We also detected a link between sexual risk behaviour and drug-taking risk behaviour. There are
significant associations between not always using condoms with casual partners, regular partners,
or clients, and having shared needles in the last six months. In fact, the strong relationship
between needle sharing and lack of condom use with casual partners suggests not only a
particularly high-risk subgroup, but also a potential bridge for HIV transmission to the general
population.
Among sociodemographic factors, previous imprisonment was a relevant determinant of HIV
status. Although it didn't emerge as a significant direct determinant in the regression analysis,
prison experience did show a strong relationship with mv in the bivariate analysis and has been
identified consistently as a direct determinant in earlier studies. It is evident that in the current
study imprisonment is strongly associated with other factors, such as having an HIV-positive
partner and history of an SID, which were significant determinants of HIV in the model. In
other words, prison is an indirect determinant of HIV and is an important marker for a high-risk
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population due to both their behaviour in and out of prison as well as their living situation out of
pnson.
In general, the environmental and socioeconomic conditions of women who engage in drug use
may result in a variety of interrelated risk factors for HIV infection which result in a greater risk
than the sum of the risks for each individual factor. In addition, such women usually come from
socially and economically deprived backgrounds and may suffer from generally poor health due
to inadequate nutrition caused by drug addiction, lower access to health services, frequent
abortions, use of various types of drugs, high stress levels and exposure to violence, to name but a
few. Their health may be further compromised by other social situations, including prostitution
and prison.
Moreover, the relationship between drug users and prostitution is of great interest as prostitutes
constitute a possible source for the heterosexual transmission of HlV from female IDUs to the
general population. These data, however, did not clarify the relationship between prostitutes and
drug use and, if anything, indicate that IDU prostitutes do not act as a bridge to the general
population given the high rate of condom use. However, there was a significant relationship
between prostitution and ffiV, albeit indirect Clearly the IDUs in this study who engaged in
trading sex for drugs were more "down and out" than their counterparts who had never had sex
with clients. They were more likely to report no fixed address, to have been incarcerated, to
have been younger at their first pregnancy, and to lack social support.
Likewise, we have also confirmed what is already well documented: the connection between
syphilis and other sexually transmitted diseases and the prevalence of HlV. This relationship is
most likely a consequence of risky sexual behaviour, although there is also evidence that physical
damage caused by sexually transmitted diseases, such as lesions, promote the transmission of
HIV. It is also interesting to note that in the current study the rate of sexually transmitted disease
was extremely high, probably as a result of poverty, social disintegration, and kind of partner, but
the rate of condom use was also quite low.
J. Methodologicallssues
The objective of this section is to examine the limitations of the study and to discuss the
development of a new model explaining risk behaviour amongst female IDUs. The foremost
conclusion of the study was that there was no apparent association between HIV status and some
risk behaviours. It is likely that this is a consequence of the study's cross-sectional design. as
HIV infection may have occurred before the "study period". For example, the implementation
of campaigns in Spain in 1992, including testing for HIV, would have meant that women who
were measured in 1995 as being HIV-positive had past risk behaviours which were changed as a
result of public health intervention before and during the course of the study.
Second, the study is subject to both selection and measurement biases due to the atypical
characteristics of the population. Whilst continued high-risk behaviour of the population makes
it important that the results are not generalised to other groups of IDUs, it is nevertheless
important to study this residual group of women as an understanding of their behaviour could
result in significant changes in public health policy. Consequently, to reduce biases in the study,
it was considered important to use a multi-site / multi-sampling design This would mean that the
effects of any outliers would be reduced, and that the combined data would provide insights into
the behaviour of female IDUs.
178
Third, regression analysis in this group is limited by several factors. First, as noted above, the
limitations of a cross-sectional design may result in spurious findings. This is likely in this
population as behaviour has been changing in recent years. Moreover, the population is not
isolated, and its characteristics are determined by a range of other factors, all of which may
themselves influence behaviour. Furthermore, the correlational nature of multiple regression
does not allow us to make causal inferences on the relationships between background factors and
risk behaviour or dependent variables.
Given the above, although initially we analysed the model using a simple parsimonious logistic
regression, it became clear that this was unsuitable in these circumstances. The objective of a
parsimonious model is to identify the most efficient explanatory variables, which will fail to
quantify socially important pathways. This is il1ustrated by X and Y who demonstrate that
regression analysis has two objectives. The first is to be predictive, i.e., to know the best way to
determine the effect of independent variables on the outcome. The second is to be estimative,
i.e., to identify the relationship between the independent and-dependent variables. Our aim was
to use a predictive model, therefore we used a hierarchical stepwise regression because we wish
to understand the relationship of all variables. In this model, we can look at the complexity of
many variables, and examine whether they have a direct or indirect effect on the dependent
variable, which would not be possible using a parsimonious model. In fact, the change in our
thinking during the course of the study demonstrates the importance of using a pragmatic and
flexible approach when examining outcomes in highly marginalised populations.
Finally, and as an illustration of the above, foJJowing the discovery that most of the women had
changed their behaviour, we decided to introduce new research questions to identify the reasons
why some had not changed their behaviour. For example, we have studied the unsafe behaviours
(e.g., never use condoms). Likewise, after showing that a large number of women had previously
been in prison and/or were prostitutes, we also looked at these outcomes as dependent variables.
In summary, this study has presented a methodological challenge in planning, implementing and
analysing epidemiological studies of marginalised populations. In such circumstances it is
important not to restrict our mind-set to purely statistical power, and be wiJJing to explore the
social context of the data that are being examined. This would include developing an
understanding of the lifestyle of female IDUs and the networks within which they live.
4. Future Research Implications
As discussed above, there are major difficulties in analysing data resulting from cross-sectional
studies. Indeed the particular characteristics of IDUs are further complicated by recent changes
in behaviour, thereby suggesting that this design is now redundant. Furthermore, this is
confounded by the problems of identifying an appropriate model that adequately describes the
lifestyle of different populations of roUs, prostitutes, prisoners, etc. It is therefore important that
further methodological advances be made. For example, the use of path analysis (using LISREL)
may be of help. Similarly there is a need to develop multi-dimensional models which
accommodate the subtlety and complexity of the data. It is important that such models are able
to take into account temporal changes in behaviour, etc.
We have found in this study that the real risk for IOU women is when their partner is an IOU. It
therefore makes sense that future studies focus on the relationship between a male IOU and his
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partner. For example, non-IDU female partners of male IDUs have the risk of becoming an IDU
and therefore would make an excellent population to target
Future studies should also seek to explain and further explore the relationships identified in this
study between not having a fixed address, risk behaviours, and HIV prevalence in an IDU
population. IDUs who are also homeless may prove to be an important target population for
future I-UV prevention programmes. Furthermore. researchers should also study the relationship
between psychological problems and HIV risk behaviour in this population.
As we have demonstrated that imprisonment is an important predictive variable for a number of
outcomes, it is important that further research be implemented to examine HIV prevalence and
!DU in female prison populations. Likewise. similar studies should look at the relationship
between IDU and prostitution.
Further research should examine other health issues in female IDUs, such as their nutritional
status, health habits. experiences with regard to births and abortions and gynaecological health.
More knowledge is needed in these areas so that appropriate strategies can be designed to
improve the health status of women.
Despite extensive research into !DU, there have been very few attempts to study in an integrated
way the different life events of IDUs which directly affect their behaviour. The particular nature
of these studies makes it hard to assess the characteristics of the circumstances of IDU and how
one interferes with the other.
There is also a need to study the relationship between sexuality and power in decision making.
Such research could provide valuable insights as to how women might gain a more balanced
position when it comes to making decisions about sex. Qualitative research could also be useful
to discover the motives and reasons for the failure of many women to use condoms in their sexual
relations even with partners they know to be HIV-positive,
More research is needed regarding the relative efficacy of different models of outreach and
intervention with !DU women and the non-!DU partners of IDU men.
Additional research is required to assess the extent to which risk behaviour among identified
groups of women with IOU partners or ex-addicted partners vary over time and to identify those
factors affecting change.
We need more research on developing and testing protective methods that are controlled by
women. including the recently introduced female condoms, spermicides, etc., and further
research is needed in this area to examine the role of spermicides with petroleum in facilitating
fflV transmission especially among prostitutes. despite the fact that we have not studied this issue
in the current study.
The paucity of studies in gender-differences in treatment and the recent conclusions by Hodgins
et aI (1997) about the efficacy of single-gender treatment groups indicate the urgent need to
conduct research on gender differences in treatment process as well as outcome.
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More research from prospective studies could provide useful information on the nature of the
relationship between. for example, pregnancy and HIV infection. Furthermore, more studies are
needed to identify appropriate methods of family planning and fITV prevention for female IDUs.
Finally, it would be worthwhile to study the relationship between teenage pregnancies and
socioeconomic stressors as they combine to create a higher risk environment in which risk
behaviours are more readily engaged in.
S. Public Health Implications and Policy Agenda
Our study has implications both for the prevention and control of the spreading of AIDS as well
as in the area of prevention of drug use and harm-reduction programmes for IDU women.
We have examined the contexts within which risk behaviour took place and the determinants of
each different situation, and we have found relevant factors. First. we found that age was a
critical factor in several contexts. In particular, the younger women (adolescents) were more
likely to engage in risky behaviour (they continued to share needles and were more likely to have
never used condoms), and they were less likely to have received any treatment. Early' age of first
injection (less than 16) was also a direct determinant of prison and never using condoms. Early
age of first pregnancy (less than 18) was a direct determinant of prostitution and needle sharing.
Thus adolescence appears to be a time of high-risk behaviour, and if certain high-risk behaviours
can be delayed or avoided. women might lower their risk of future problems. Clearly
intervention with this age group of female IDUs is imperative. Adolescent females, particularly
those with a low level of education are in need of specific strategies to prevent drug use and
pregnancy. Ideally these strategies should be implemented in schools as treatment-based
strategies don't appear to reach this sub-group. Furthermore, school-based strategies need to be
targeted to young teenagers, before they begin engaging in risky behaviour and before they leave
school.
Second, the sexual partners appear to exert an important influence on the risk behaviours of IDU
women. Almost half of the women questioned (49 percent) injected drugs for the first time with
their regular partner. And, unlike men, very few women (1 percent) participate in drug- taking
behaviour alone. Women most commonly shared need1es with a regular sexual partner (47.5
percent). whilst 17.8 percent shared with a male friend, and 10.9 percent with a female friend.
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Hence future health education should be targeted in three directions:
1) toward the sexual partners of IDU women to increase awareness of risks of HIV transmission
as well as their potential influence in reducing risk behaviour of their partner,
2) toward the IOU woman herself to improve her assertiveness and safe sex negotiation skills;
and
3) toward IDU couples to improve awareness about the risk ofHIV transmission via heterosexual
relations.
Third, the IDU women who claimed to have no fixed address may prove to be an important target
group for future HIV prevention programmes. This subgroup appeared to be less likely to be
reached by drug treatment programmes and exhibited a number of high-risk practices as wen as a
higher prevalence ofHIV. Clearly, public health policy makers in Spain need to focus on finding
ways to access this hard-to-reach and high-risk subgroup. Furthermore, the planners of HIV
prevention programmes for this population need to take into account the psychological problems
which may be prevalent in this population and which can act as barriers to adopting safe
behaviours, .
Another important target group for HIV prevention education and harm-reduction programmes is
prison populations. As was observed in this study, injecting drug use does occur in Spanish
prisons. Administrators need to acknowledge the high-risk behaviour which occurs and initiate
programmes to both educate prisoners about the risks and to reduce the spread of HIV within
prisons.
Another point is that the message about risk in the area of drug-taking shouldn't be focused only
on heroin. As it is carried out in Spain, AIDS prevention and drug-use prevention have to begin
by educating IDUs about the additional risks associated with drugs other than heroin, such as
amphetamine, cocaine, etc., because heroin use is decreasing and its social image is diminishing,
so an attempt should be made to prevent other epidemics of injected drugs even if they are legal.
The gender-distinct nature of many of the social determinants of risk behaviour is also reflected
in sharing patterns, sexual behaviour, and gender-related attitudes. This suggests that strategies
of public health should be targeted according to women's experiences of a drug-injecting lifestyle
and, on a related note, their particuJar risks of HIV transmission. So it is necessary to: increase
and improve drug-abuse treatment programmes, especially with regard to single-gender
programmes; make sterile syringes and needles freely available to those who need them, together
with instructions on how to clean them; and promote the use of condoms. This should include
interventions in prisons where many high-risk individuals can be reached and where high-risk
activities occur.
Moreover, several types of female condoms have been developed, but are not yet widely
available due to a high cost; these shouJd be made freely available as quickly as possible so that
women have another option for barrier protection which they can control.
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So we must recognize that the more immediate goal of HIV prevention may not be realized
without addressing the broader social issues affecting these women's lives. More intervention
programmes need to be carried out among female IOU prostitutes with specific reference to the
use of spennicides.
Given the importance of social services to IDU and HIV-positive women, efforts should be made
in improving their provision to this population. An effort must be made to try to do away with the
administrative barriers and constraints. These efforts should include peer education, since health
education programmes are more likely to be successful if the person delivering the intervention is
someone whom the target population can identify with.
Based on the findings of this study as well as those of earlier studies, women have a range of
special needs, such as reproductive health, and require more resources than do men.
Unfortunately, as IDUs and therefore drug-treatment recipients have been predominately men,
women's needs have gone unnoticed until now. Treatment programmes usually fall short in
providing adequate resources for issues of particular concernto women, such as: meeting female
gynecological and prenatal health needs; providing assistance in finding child care facilities;
offering appropriate methods in family planning; offering objective counselling on options for
HIV-positive pregnant IDUs-providing the most up-to-date information on possible risks for the
mother and child., but always respecting the right of each woman to make the final decision; and
eliminating sex stereotyping in career counseling which is detrimental to the rehabilitation
process for women.
In the area of TB, hepatitis, and other SIDs, clinical strategies for their control should be
implemented more strongly. That is, if possible, all diagnosed hepatitis and TB patients should
be monitored and studied to examine all risks associated with these diseases including the
particular needs of IDUs with regard to treatment and the implementation of public health
initiatives to control the spread of hepatitis and tuberculosis amongst this marginalised
community of female IDUs. This should include health education, screening and vaccination
programmes.
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